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 1 
CHAPTER I 
 
INTRODUCTION 
 
 Epicardial mesothelium (epicardium) is a progenitor tissue critical for 
coronary vessel development. Epicardial researchers aim to understand the 
signaling cascade regulation of epicardial development with the goal of 
reawakening this progenitor function in human adults after myocardial infarction 
(MI). Still, the cooperative signaling relationships and cellular mechanisms 
facilitating this program are largely undefined. This dissertation seeks to identify 
cooperative signaling cascade relationships regulating epicardial behaviors, 
cellular mechanisms imparting epicardial behaviors and regulators of these 
mechanisms. 
 This chapter will first introduce epicardium, the principle tissue utilized in 
these studies. Epicardial ex vivo and cell line models were studied here because 
the tissue participates in a myriad of cellular behaviors that occur concurrently. 
Studying epicardial cells afforded the opportunity to develop a novel Small 
Organic Molecule (SOM) screening methodology to identify regulators of 
epicardial behaviors and describe their coordination. Additionally, epicardial cells 
are highly migratory during development and injury repair (Mikawa and Gourdie 
1996; Lepilina et al, 2006), and epicardial cell lines can recapitulate migratory 
behaviors in culture (Wada et al, 2003; Pae et al, 2008). Using these assays 
elucidated an interaction between Blood vessel epicardial substance (Bves) and 
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N-myc Downstream Regulatory Gene 4 (NDRG4) in epicardial movement. 
Bves/NDRG4 interaction regulates migration through trafficking of fibronectin in 
the newly identified autocrine ECM production mechanism. Additionally, data 
presented here demonstrate that Bves interacts with VAMP3 to regulate cell 
adhesion through recycling endosome trafficking of the transmembrane adhesion 
molecule, β1-integrin. Taken together, these studies elucidate regulation of 
epicardial cell behaviors, reveal a novel epicardial behavior, and suggest a global 
mechanism for Bves diverse effects on cell-cell adhesion and cellular movement.   
 
 Epicardial Mesothelium Development 
 A mesothelium is a specialized epithelial layer derived from the embryonic 
mesoderm (Mutsaers and Wilkosz 2007). Morphologically, a mesothelium is a 
cobblestone-shaped simple squamous layer of cells (Figure 1.1) that lines the 
pericardial, pleural and peritoneal body cavities and covers the internal organs. 
Juxtaposed mesothelia are protective structures for the body cavities, which 
elaborate fluids to facilitate the movement of organs against compartment walls 
Figure 1.1 Epicardial cells form simple squamous sheets. (A-B) Rat 
epicardial cell lines grown in culture form islands of cells that grow together 
with cobblestone morphology. (C) Epicardial cell sheets isolate from 
developing chick hearts also form simple squamous sheets in which zona 
occludens-1 (ZO-1; red) marks the intercellular junctions and a-Smooth 
Muscle Actin (SMA; green) marks the differentiating peripheral edge. 
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and neighboring organs (Koss and Melamed 2006; Mutsaers and Wilkosz 2007).   
The epicardial mesothelium covering the heart is also a progenitor 
population that contributes cells to the underlying myocardium in a variety of 
developmental model systems (Manasek 1969; Mikawa and Fischman 1992; 
Muñoz-Chápuli et al, 1994; Mikawa and Gourdie 1996; Männer et al, 2001; Poss 
et al, 2002; Winter and Gittenberger-de Groot 2007; Duan et al, 2011; Riley and 
Smart 2011). 
Figure 1.2 Epicardial cell development supports coronary vasculature 
formation. (A) Proepicardial cells protrude from the sinus venosus and 
migrate as an epithelial sheet to and over the apical surface of the 
myocardium; adapted from Wada et al. 2003. (B) While covering the 
myocardium, some epicardial cells delaminate, undergo epithelial to 
mesenchymal transition and invasively move into and throughout the 
myocardium. Epicadial derived cells then differentiate into multiple cell types 
and are essential for coronary vessel formation; adapted from Ratajska et al. 
2008. 
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This development program is driven by two forms of migration: lateral movement 
as an epithelial sheet from the embryonic proepicardium (PE)  
to and over the heart, and, after epithelial-to-mesenchymal transition, single cell 
invasive migration from the epicardial sheet into/throughout the underlying 
myocardium for subsequent differentiation (Reese et al, 2002).  
At murine embryonic day 8.5 (E8.5) or Hamburger and Hamilton stage 14 
(HH14) in the chick, the PE arises from the region of the sinus venosus (Ho and 
Shimada 1978; Virágh and Challice 1981). From murine E9-12.5 and HH16-27 
Figure 1.3 Epithelial to mesenchymal transition (EMT) drastically shifts 
epithelial cell character. Epithelial cells that undergo EMT, such as the 
epicardium, alter many characteristics including: apicobasal polarity, 
cytoskeletal organization, gene expression patterning, and cellular behaviors 
(e.g. proliferation or migration); image adapted from Deshire et al. 2011. 
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(E3-5) in the chick, the epicardium migrates from the sinus venosus to the dorsal 
surface of the heart where it covers the apical myocardium for the life of the 
organism [Figure 1.2A; (Komiyama et al, 1987; Männer 1992; Winter and 
Gittenberger-de Groot 2007)]. In the chick, PE villus protrusions migrating over 
an extracellular matrix bridge to the developing heart (Männer 1992; Männer 
1993; Kramer et al, 1999; Nahirney et al, 2003) while in mammalian and fish 
embryos epicardial cell clusters detach from the sinus venosus, float to the 
myocardium, and fuse to form an epicardial sheet (Virágh and Challice 1981; 
Komiyama et al, 1987; Muñoz-Chápuli et al, 1994). In all known animal models of 
PE development, cells travel to the heart and laterally spread across it as an 
epithelial sheet with apicobasal polarity and intercellular junctions (Ho and 
Shimada 1978; Komiyama et al, 1987; Männer 1992; Vrancken Peeters et al, 
1995; Nahirney et al, 2003; Lie-Venema et al, 2005).  
After lateral migration commences some epicardial cells undergo 
epithelial-to-mesenchymal transition (EMT) and delaminate into the subepicardial 
space [Figure 1.2B; (Mikawa and Gourdie 1996; Dettman et al, 1998)]. These 
cells, termed Epicardial-derived cells (EPDCs), individually spread throughout the 
heart and are found in the compact and trabecular myocardium, the endocardial 
cushions, and abundantly surrounding the coronary arteries [Figure 1.2B; 
(Mikawa and Gourdie 1996; Dettman et al, 1998; Gittenberger-de Groot et al, 
1998; Lie-Venema et al, 2005)]. EMT and delamination is a dramatic shift in 
epicardial cell morphology characterized by: asymmetric proliferation into the 
underlying myocardium, enriched EMT/EPDC gene expression, loss of 
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apicobasal polarity and intercellular junctions, with actin/intermediate filament 
reorganization to facilitate cell mobility [Figure 1.3; (Vrancken Peeters et al, 1995; 
Morabito et al, 2001; Winter and Gittenberger-de Groot 2007; Wu et al, 2010; 
Smith et al, 2011). After EMT, EPDCs have the capacity to differentiate into the 
smooth muscle, cardiac fibroblasts and endocardial cells of the coronary 
vasculature, as well as a small population of cardiomyocytes (Vrancken Peeters 
et al, 1995; Mikawa and Gourdie 1996; Dettman et al, 1998; Pérez-Pomares et al, 
1998; Männer 1999; Cai et al, 2008; Zhou et al, 2008; Smith et al, 2011). While 
the developmental programs and cell fates of PE and EPDCs are largely 
resolved, the signaling paradigms that facilitate this developmental program 
require further study.  
 
General Signaling During Epicardial Development 
Specification of the proepicardium is a complex process that relies on 
coordinated activity of multiple transcription and growth factors (Svensson 2009). 
Progenitor cells arise from the lateral plate mesoderm and express Islet-1 and 
Nkx2.5 transcription factors, but a detailed description of PE formation requires 
further study (Zhou et al, 2008). Common markers of PE cells include: T-box 
factor-18 (Tbx-18), Wilms Tumor-1 (WT1) and Transcription factor-21 [Tcf21; 
(Svensson 2009)]. The effect of hormone signaling on PE specification and 
differentiation may be time/spatially dependent. Bone Morphogenetic Protein 
(BMP)-stimulated hormone signaling is required for initial PE marker expression 
in chick and zebrafish model systems (Schlueter et al, 2006; Liu and Stainier 
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2010), yet lineage specification of PE tissue into epicardial and myocardial tissue 
depends on BMP-stimulates myocardial differentiation which is inhibited by 
Fibroblast Growth Factor (FGF) signaling (van Wijk et al, 2009). Thus, PE 
specification and early lineage differentiation entails complex crosstalk, 
overlapping uses for growth factors, and is still unresolved. 
Adherence of epicardium to myocardium requires focal adhesions and 
extracellular matrix (ECM) substrates for proper binding (Kwee et al, 1995; Yang 
et al, 1995; Sengbusch et al, 2002; Pae et al, 2008). In murine models, knockout 
of the cell surface focal adhesion component α4-integrin and its matrix substrate 
VCAM-1 causes detached epicardium, failure to produce subepicardial 
mesenchymal and coronary plexus, and embryonic lethality (Kwee et al, 1995; 
Yang et al, 1995; Sengbusch et al, 2002). It is important to emphasize that many 
integrin subtypes are expressed in the PE, and integrin adherence to substrates 
on the heart is a driving force behind epicardial development (Pae et al, 2008). 
Additionally, global or epicardial-specific knockout mice for erythropoietin 
receptor (EpoR), Transforming Growth Factor β Receptor III (TGFβR3), Activin-
Like Kinase receptor 5 (ALK-5) and Retinoid X Receptor α (RXRα) exhibit partial 
loss of epicardial adherence with developmental consequences (Compton et al, 
2005; Merki et al, 2005; Sridurongrit et al, 2008; Olivey and Svensson 2010). 
Furthermore, WT1 knockout epicardia fail to adhere and downregulate α4-
integrin expression, suggesting that integrin adhesion is the molecular framework 
through where WT1 transcription exerts its effects (Kirschner et al, 2006). While 
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many signaling cascades have been identified to regulate epicardial adherence, 
subcellular mechanisms conferring and maintaining adherence are unresolved.  
Extrinsic growth factors that initiate and regulate epicardial EMT and 
coronary vascular development include: TGFβ1-3, FGF1,2 and 7, Vascular 
Endothelial Growth Factor (VEGF), Platelet Derived Growth Factor (PDGF), 
Wnt/β-Catenin and Sonic Hedgehog [Shh; (Morabito et al, 2001; Molin et al, 
2003; Compton et al, 2005; Merki et al, 2005; Tomanek 2005; Lavine et al, 2006; 
Zamora et al, 2007; Mellgren et al, 2008; Pennisi and Mikawa 2009)]. The 
mechanisms through which these signals cooperatively regulate EMT are 
complicated by extensive crosstalk that occurs between the epicardium 
Figure 1.4 Epicardial EMT involves complex signaling events. Many  
hormones have been identified that originate from epicardial and myocardial 
cells to stimulate EMT. Some signals have paracrine effects on the adjacent 
tissue while others have autocrine effects on the secretory tissue, or both. 
Furthermore, single signals ilicit widely varied responses from the two tissues. 
How signaling cascades coordinate their effects to collectively stimulate a 
particular behavior requires further elucidation; adapted from Olivey and 
Svensson 2010. 
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(influencing myocardial growth) and the myocardium (stimulating epicardial EMT) 
as well as autocrine activation [Figure 1.4; (Olivey and Svensson 2010)]. To add 
complexity, epicardium and myocardium use overlapping growth factors to 
influence each tissue independently (Figure 1.4). For example, FGFR1/2 on 
cardiomyocyte membranes respond to epicardial-produced FGF hormones to 
promote a wave of Shh signaling that activates VEGFA-C and angiopoietin-2 
expression to induce proliferative expansion (Lavine et al, 2006). At the same 
time, epicardial FGFR1 responds to FGF hormone to complete invasion into the 
Figure 1.5 TGFβ  superfamily signaling occurs through a common 
mechanism with unique players. Both TGFβ and BMP peptide hormones 
signal by binding to specific heterotetrameric complexes of Type-I and Type-II 
receptors (R-II/R-I). Once activated by ligand binding, these receptors 
phosphorylate pathway specific cytoplamic transduction proteins, Smads. 
After binding with a common mediator Smad protein, the cytoplasmic 
complexes translocate to the nucleus and stimulate expression of hormone-
specific target genes; adapted from Pardali et al. 2010. 
 10 
underlying myocardium (Pennisi and Mikawa 2009). FGFR1 dual signal 
transduction is likely a prototypical example of the tightly coordinated signaling 
that occurs during epicardial development. While reporting the functions of all the 
molecules that influence epicardial development is outside the scope of this 
introduction, it is relevant to discuss two regulators investigated in this 
dissertation: TGFβ and BMP. 
 
TGFβ and BMP Signaling in the Epicardium 
 The TGFβ superfamily of signaling peptides encompasses many protein 
ligand families including: TGFβ, activin/inhibin, Growth Differentiation Factor 
(GDF) and (Heldin et al, 1997; Schmierer and Hill 2007). These molecules each 
elicit unique subcellular signaling cascade responses to influence cellular 
behaviors. TGFβ superfamily peptides can stimulate independent functions in 
tissues, or can work antagonistically against other hormones, including other 
TGFβ superfamily members (Guo and Wang 2009). Despite the variable 
responses elicited by TGFβ superfamily molecules, signaling proceeds through 
similarly structured signaling cascades [Figure 1.5; (Pardali et al, 2010)]. 
Canonical TGFβ signaling occurs when hormones stimulate heterotetrameric 
complexes of type-I and type-II signaling receptors, the Activin-Like Kinases 
[ALK; (Guo and Wang 2009)]. The type-II receptors phosphorylate 
serine/threonine residues on ligand-specific type-I receptors, which transduce 
signal to the nucleus via ligand-specific receptor-mediated SMAD molecules 
(Pardali et al, 2010). TGFβ ligand-stimulated ALKs 4,5 and 7 activate SMADs 2/3 
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to transduce signals, while BMP ligand-stimulated ALKs 1,2,3 and 6 mediate 
signal through SMADs 1,5 and 8 [Figure 1.5; (Pardali et al, 2010)].  Through a 
common mediate SMAD molecule, SMAD 4, activated ligand-specific SMADs 
enter the nucleus where they stimulate expression of downstream genes (Figure 
1.5). 
 Previous studies suggest that TGFβ signaling potently regulates epicardial 
development. In a Gata4-driven (epicardial-specific) deletion of the TGFβ 
receptor ALK5 epicardial cells failed to undergo EMT in vitro and displayed 
impaired myocardial attachment in vivo (Sridurongrit et al, 2008). Additionally, 
ALK5 is necessary for loss of epithelial morphology in initial stages of EMT and 
smooth muscle differentiation (Austin et al, 2008; Olivey and Svensson 2010), 
TGFβ type-III receptors are necessary for coronary vessel development in the 
mouse (Compton et al, 2005), and TGFβ1/2 ligands stimulate epicardial cell 
migration (Austin et al, 2010). Together, in vitro data suggest that TGFβ signaling 
stimulates multiple epicardial behaviors to facilitate migration, EMT and/or cell 
differentiation.  
 BMP signals are vital for specification of PE tissue and downstream 
epicardial/myocardial cell fate decisions (van Wijk et al, 2009; Liu and Stainier 
2010). Additionally, studies have demonstrated that BMP signaling facilitates PE 
villi lateral migration (Austin et al, 2010; Ishii et al, 2010), as BMP2/4 recruit PE 
villi to the atrioventricular junction of the heart via sheet movement (Ishii et al, 
2010). Ectopic expression of BMP2 aberrantly targets epicardial sheet migration 
to the heart, which can be suppressed by the BMP inhibitor, noggin (Ishii et al, 
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2010). Together, these data demonstrate that BMP signaling plays multiple roles 
in early epicardial specification and development. The exact interplay of TGFβ 
and BMP signaling is elucidated in Chapter II of this dissertation. 
 
Epicardium in Injury Repair 
Epicardium may provide a therapeutic tool to improve injury repair after 
myocardial infarction (MI). Heart disease is a leading cause of mortality in 
humans. After MI, cardiomyocyte death is followed by fibrotic scar formation at 
the lesion. Fibrosis increases stress on the remaining living cardiac muscle 
leading to dilated cardiac chambers, declined contractility and eventual heart 
failure (Segers and Lee 2008; Vieira and Riley 2011). Epicardium contributes to 
scar formation and may be a progenitor population that could be manipulated to 
support cardiac regeneration (Vieira and Riley 2011). In some lower organisms 
epicardial cells rapidly proliferate and induce growth or differentiation of newly-
formed cardiomyocytes to regenerate heart tissue after injury (Poss et al, 2002). 
While mammalian heart tissue has poor regenerative capacity, recent studies 
been developed with the aim of: a) driving epicardial progenitors to differentiation 
into nascent cardiomyocytes, or b) exogenously initiating epicardial behaviors 
that support myocardial regrowth (Ausoni and Sartore 2009; Duan et al, 2011).  
Murine lineage tracing studies suggested that a small population of 
epicardial cells might differentiate into cardiomyocytes during development, but 
the findings remain controversial (Cai et al, 2008; Zhou et al, 2008). Adult 
epicardial cells express cardiomyocyte progenitor markers, and epicardial cells 
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can be driven to express differentiated cardiomyocyte markers in vitro after 
addition of growth factors (Kruithof et al, 2006). However, the effectiveness of 
such treatments in vivo is questionable. For example, Thymosin β4 peptide has 
been shown to initiate cardiomyocyte differentiation from epicardial explants in 
vitro, and priming the tissue with this hormone may support de novo 
cardiomyocyte differentiation after MI in vivo (Smart et al, 2010). However, 
followup lineage tracing studies demonstrate that Thymosin β4 does not 
stimulate cardiomyocyte differentiation in vivo, although epicardial thickness and 
coronary vessel density improves (Zhou et al, 2012). Due to conflicting studies 
such as these, epicardial cell differentiation into cardiac muscle with a drug or 
hormone treatment currently seems an unlikely therapeutic tool that requires 
breakthrough studies before effective treatments can be developed. 
Another, perhaps more immediately promising, therapeutic tool could take 
advantage of EPDC modulatory effects on myocardial development (Winter and 
Gittenberger-de Groot 2007). For example, retinoic acid receptor signaling on 
epicardial cells elicits trophic factors that stimulate cardiomyocyte proliferation in 
vitro (Chen et al, 2002). Additionally, as discussed above, EPDCs signal through 
FGFR1 and FGFR2 on cardiomyocytes to stimulate proliferation (Lavine et al, 
2006; Pennisi and Mikawa 2009). Adult human EPDCs injected into infarcted 
murine heart tissue preserved some cardiac function and diminished ventricle 
remodeling (Winter and Gittenberger-de Groot 2007). EPDCs secrete paracrine 
factors to support angiogenesis after MI, and injection of EPDC-conditioned 
medium improves heart function (Zhou et al, 2011). Recent literature indicates 
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that epicardial cells activated through notch signaling contribute to fibrotic scar 
formation after infarct, which is both essential for initial healing, and detrimental 
in the long term (Russell et al, 2011). Thus, epicardium and EPDCs have critical 
supportive influence on adult heart tissue during repair after MI, which could be 
therapeutically manipulated.  
Improvements in these therapeutic strategies will be gained from better 
understanding of epicardial cell biology. Subcellular regulators of migration, 
adhesion, differentiation and secretion remain to be identified. Additionally, by 
elucidating the known regulatory relationships coordinating these behaviors it 
may be possible to recapitulate local factor stimulation and drive cellular 
behaviors in vivo. This dissertation seeks to explicate these regulatory questions 
for future development of novel tools to manipulate this tissue. One epicardial 
enriched protein, Bves, could regulate a variety of epicardial behaviors. 
 
Figure 1.6 Popdc family and Bves protein structure. (A) Bves is the 
prototypical member of the Popdc family of which there are three genes. (B) 
Bves is a 358 amino acid a triple-pass transmembrane protein that localizes 
at plasma membranes and on cytoplasmic vesicles, shown here is a putative 
conformation of Bves dimers at the plasma membrane (PM); adapted from 
Hager and Bader 2009. 
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Bves Structure and Tissue Distribution 
 Bves, [Popeye domain containing 1 (Popdc1)], is a heart-enriched gene 
identified using subtractive screening methods (Reese et al, 1999; Andrée et al, 
2000). Bves is the prototypical member of the three-gene Popdc family, which 
share a conserved region (popeye domain) of unknown function (Andrée et al, 
2000; Wada et al, 2001). Bves is highly conserved among all eukaryote species, 
while Popdc2 and Popdc3 are only expressed in vertebrates, but these 
molecules may provide redundancy in the case of Bves disruption [Figure 1.6A; 
(Andrée et al, 2002; Hager and Bader 2009)]. Popdc family members share no 
significant homology with other protein families based on structure, which is 
barrier in elucidating Bves function (Andrée et al, 2000; Brand 2005).  
 Bves (358 aa in mouse) is a triple-pass trans-membrane protein with a 
short extracellular N-terminal domain (AA 1-42) that contains two N-glycosylation 
sites [Figure 1.6B; (Andrée et al, 2000; Knight et al, 2003)]. The function of the N-
terminal domain is unstudied, but may involve targeting to subcellular trafficking 
compartments (Roth 2002). The C-Terminal domain begins after the third trans-
membrane pass from AA 118 to 358; the Popeye domain comprises AA 91-266 
[Figure 1.7; (Osler et al, 2005; Smith et al, 2008)]. Multiple Bves-binding proteins 
interact within the conserved Popeye domain (Kawaguchi et al, 2008; Smith et al, 
2008; Hager et al, 2010), and binding partner association is important for Bves 
function (discussed in detail below).  
 Cell types expressing Bves are widely varied. Initial studies suggested that 
expression was limited to heart and skeletal muscle 
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(Reese et al, 1999; Andrée et al, 2000). However, RT-PCR studies and 
expression databases indicate that Bves is additionally expressed in a range of 
tissues from lung to thymus (Hager and Bader 2009). Antibody labeling has 
indicated that Bves is robustly expressed in the epicardium and cardiomyocytes 
of the heart as well as in smooth and skeletal muscle (Reese et al, 1999; Andrée 
et al, 2000; DiAngelo et al, 2001; Andrée et al, 2002; Hitz et al, 2002; Osler and 
Bader 2004; Vasavada et al, 2004; Smith and Bader 2006; Torlopp et al, 2006). 
Additionally, Bves has been visually identified in epithelial tissues such as the 
endoderm of the gut and cornea of the eye, and also in the brain [Figure 1.8; 
Figure 1.7 Bves amino acid sequence. Bves protein is 358 amino acids with 
conserved transmembrane domains (red boxes), n-glycosylation sites (purple 
boxes) and the Popeye domain (black line). The function of this domain is 
unknown, but it partially contains the minimal binding domain residues 
required for the GEFT binding domain (blue line). The conserved KK domain is 
the site of Bves homodimerization (green box). NDRG4 minimal binding 
sequence is from residues 307-316 (orange box), and VAMP3 is within the C-
terminus but requires further definition (teal line denotes C-terminal construct 
domain); adapted from Osler et al. 2006. 
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(Osler and Bader 2004; Ripley et al, 2004; McCarthy 2006; Smith and Bader 
2006; Russ et al, 2010; Russ et al, 2011; Williams et al, 2011)]. Hager and Bader 
(2009) recognized that Bves-enriched tissues have adherent properties, 
suggesting that Bves facilitates cellular adhesion. 
 Bves expression has been characterized in several model organisms. 
Bves is expressed in early stages of chick development: in Henson’s Node at 
HH4, and in the developing germ layers at HH stages 8 and 11 (Osler and Bader 
2004; Torlopp et al, 2006). In later chick development Bves is expressed in the 
retina, cornea and lens of the eye, the heart and the endoderm of the gut (Wada 
et al, 2001; Osler and Bader 2004; Ripley et al, 2004). Bves has also been 
identified in follicle and nurse cells of the Drosophila melanogaster oocyte 
Figure 1.8 Bves tissue expression. Bves protein is found in adherent tissues 
ranging from (A) cardiomyocytes to (B) skeletal muscle, to (C) brain, to (D) 
various epithelial including MDCK (kidney epithelial cells) shown here; from 
Hager and Bader 2009. 
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(Lin et al, 2007). During murine embryonic development (E12.5) Bves is found in 
muscle, heart, epidermis, digestive and respiratory tracts, and epithelium of the 
developing eye (Smith and Bader 2006; Russ et al, 2010), but Bves knockout 
mice have normal development (Andrée et al, 2002). Similarly, initial studies in 
the rat indicate heart and skeletal muscle enrichments (Parnes et al, 2007). 
Finally, identification of Bves gene in humans indicates enriched expression in 
adult/fetal heart, and skeletal muscle (Reese and Bader 1999), and more recent 
data additionally indicate expression in the cornea, lens and trabecular 
meshwork cells of the eye (Russ et al, 2010). Importantly, Williams et al. (2011) 
demonstrated that intact Bves expression is a metastasis suppressor in human 
colonic epithelium. Thus, Bves is widely expressed early in development in many 
model organisms, continued expression occurs in the adult in a variety of 
Figure 1.9 Bves subcellular localization pattern. Single cells have 
cytoplasmic pools of Bves (red) that translocates to the cell surface at putative 
points of contact, preceding classic junction proteins. Bves then remains at the 
plasma membrane in epithelial sheets. Actin cytoskeleton detected in green; 
from Olser et al. 2005. 
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muscle/epithelial tissues, and this expression must be maintained to prevent 
colorectal, lung and gastric cancers. 
 The Xenopus laevis (X. laevis) model system was utilized in this 
dissertation to determine Bves (named Xbves in this system) function on cell 
surface adhesion during gastrulation. Initial studies identified Xbves as 60-65% 
identical to human Bves (Hitz et al, 2002). Bves is expressed in the heart, and in 
the surface epithelium and involuting cells of gastrulation stage embryos (11.5) 
(Hitz et al, 2002; Ripley et al, 2006). At stage 19, Xbves is found in all three germ 
layers, and specifically is identified in epithelial of the neural tube, developing eye 
and surface ectoderm (Ripley et al, 2006). It is important to note that Morpholino 
interference of Xbves function is an extremely effective knockdown technique as: 
a) Popdc2 and Popdc3 are not expressed in this organism, diminishing 
redundancy issues, and b) knockdown effects can be fully rescued (Ripley et al, 
2006). Morpholino knockdown of Xbves has drastic effects on embryonic 
development: the epithelial movements epiboly and involution are disrupted and 
gastrulation is halted (Ripley et al, 2006).  
 Bves has dynamic subcellular localization depending on cell morphology 
in vivo and in vitro (Wada et al, 2001). In the developing AV junction, Bves 
localizes to intercellular junctions between adjacent epicardial cells, while in 
delaminated subepicardial cells Bves is cytoplasmic (Wada et al, 2001; Osler et 
al, 2005). This phenomenon has also been characterized in human corneal 
epithelial (HCE) sheet biogenesis and EMT, in which Bves has cytoplasmic 
localization when cells are singular, but as cell-cell junctions form Bves precedes 
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classic junction markers (E-cadherin, ZO-1) and is maintained at cell-cell 
interfaces [Figure 1.9; (Ripley et al, 2004; Osler et al, 2005; Russ et al, 2011)]. 
Conversely, after epithelial EMT is stimulated, Bves localization shifts from the 
membrane back to the cytoplasm, along with a concomitant upregulation of 
mesenchymal markers (Wada et al, 2001; Kawaguchi et al, 2008). Additionally, in 
primary cardiac muscle cultures or cardiomyocyte cell lines, Bves translocates 
from the cytoplasm to the intercalated disc at cell-cell junctions (Vasavada et al, 
2004; Smith and Bader 2006), suggesting that this is a global Bves phenomenon. 
 
Bves Regulates Cell-Cell Adhesion 
 Due to lack of homology to other molecules, determining Bves function is 
difficult (Hager and Bader 2009). Bves localizes to the tight junction (TJ), 
colocalizes with canonical TJ transmembrane proteins ZO-1 and Occludin, and 
indirectly interacts with ZO-1 (Osler et al, 2006; Russ et al, 2011). 
Overexpression studies of Bves in non-adherent L-cells conferred adhesive 
properties in culture, decreased epithelial sheet permeability and increased 
Trans Epithelial Resistance [TER; (Wada et al, 2001; Russ et al, 2010; Russ et al, 
2011)], while loss-of-function studies in HCEs and epicardial cells demonstrated 
that Bves is essential for maintenance of epithelial junction integrity and TER 
(Ripley et al, 2004; Osler et al, 2005). Importantly, the Bves C-terminus is 
required for intact localization of occludin, E-cadherin or β-catenin to intercellular 
junctions, suggesting that Bves is required for shuttling cell adhesion molecules 
to the cell surface (Osler et al, 2005; Kawaguchi et al, 2008). Other studies 
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additionally suggest that Bves supports epithelial junction signaling. RhoGEFs 
are activators of the molecular switch enzymes, RhoGTPases, which regulate 
many essential cellular behaviors (Bishop and Hall 2000). RhoA signaling 
elevates cellular contractility and is downregulated when the RhoGEF, GEF-H1, 
is bound to TJs and spatially inhibited (Somlyo and Somlyo 2000; Aijaz et al, 
2005). Russ et al. (2011) demonstrated that RhoA activity is modulated by Bves 
expression level and that GEF-H1 localization depends on Bves expression, 
proposing that Bves strengthens TJ integrity by spatially inhibiting GEF-H1. Thus, 
Bves may function as a supporting structure at cell junctions, rather than 
physically providing adhesion, and may shuttle adhesion proteins to the cell 
surface. 
 
Bves regulates cell migration 
 Bves also regulates cell migration, which was first suggested by chick PE 
explants cultures in which Bves antibody blocked tissue outgrowth (Wada et al, 
Figure 1.10 Bves disruption causes random migration. Bves depletion 
from X. laevis A1-blastomere causes random scatter migration of progeny 
cells (LacZ stain, B-C and E-F); from Ripley et al. 2005. 
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2001). Ripley et al. (2004) demonstrated in HCE-punch wound injury that Bves-
depleted cells migrated faster than controls, but migration was disorganized and 
wound healing impaired. Wound healing was also impaired in murine knockout 
Bves models after skeletal muscle injury (Andrée et al, 2002). During X. laevis 
development, Bves-depleted two-cell embryos exhibited halted gastrulation due 
to deregulated convergence/extension movements in animal caps. Importantly, 
injection of Bves morpholino and a tracer into the A1-blastomere   (32-cell stage) 
initiated rogue movements in the knockdown cells; cells moved randomly 
throughout the embryo and precociously invaded below the surface ectoderm 
[Figure 1.10; (Ripley et al, 2006)]. Lin et al. (2007) demonstrated that pole cells in 
oocytes laid by Drosophila melanogaster expressing antisense Bves RNA failed 
to migrate to their target destination, reflecting results obtained from frog studies. 
Finally, Smith et al. (2008) demonstrated that NIH-3T3 cells expressing Bves C-
terminus inhibited Rho GTPases Rac1 and Cdc42, produce fewer lamellipodial 
protrusions with impaired movement. Collectively, these studies indicate that 
Bves regulates organized migration. The studies presented in Chapter III and IV 
use animal/cell culture models to demonstrate a Bves mechanism that influences 
adhesion and directional migration. These data suggest a unifying model that 
may explain the disparate phenotypes observed above. 
 
Bves is a Metastasis Suppressor 
 Recently, Bves was identified as hypermethylated from a screen 
performed on cancerous versus non-cancerous lung tissue samples (Feng et al, 
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2008). Kim et al. (2010) corroborated these results in gastric cancer where Bves 
and Popdc3 were hypermethylated and RNA expression of Bves and Popdc3 
were 70-87% silenced. Importantly, shRNA knockdown of Popdc3 in gastric 
cancer cell lines promoted invasion and migration, reflecting Bves influence on 
migration discussed above (Kim et al, 2010). A recent study by Williams et al. 
(2011) demonstrated that Bves is hypermethylated and underexpressed in 
human colorectal carcinoma (CRC) tissue and adenomatous polyps. Exogenous 
expression of Bves inhibited migration and invasion in CRC lines and 
growth/metastasis of orthtopic xenografts (Williams et al, 2011). Thus, Bves is 
required to maintain epithelial integrity of epithelial tissues and suppress 
metastasis of specific cancer tissues; understanding Bves molecular function is 
relevant to human physiology and cancer therapeutics. 
 
Bves Function is Elucidated by Binding Partner Interactions 
 In an effort to place Bves in a molecular pathway, yeast-2 hybrid and split-
ubiquitin screens were performed. Previous work has described Bves 
homodimerization and binding of Bves to GEFT [mapped in Figure 1.7; 
(Kawaguchi et al, 2008; Smith et al, 2008)]. This dissertation discusses binding of 
Bves to VAMP3 (Chapter III) and NDRG4 (Chapter IV). With the exception of 
homodimerization, colocalization studies of Bves with binding partners suggest 
that binding may be transient (Hager and Bader 2009). Bves may influence 
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multiple functions through context-dependent temporary binding.  
Kawaguchi et al. (2008) were the first to examine activity of Bves protein. 
Lysine residues 272 and 273, (the KK domain), are essential for Bves homo-
oligomerization (Figure 1.7). L-cell adhesion assays demonstrated that 
expression of Bves KK-mutant plasmids failed to confer adhesion, and plasma 
membrane localization of Bves is lost in KK-mutant expressing cells 
accompanied by loss of junction markers at the cell surface, and TER 
(Kawaguchi et al, 2008). Additionally, loss-of-Bves homodimerization stimulates 
EMT marker expression and, thus, is critical for epithelial sheet maintenance. 
 
Bves and GEFT 
 Bves also directly binds to GEFT in the Popeye domain between residues 
250-300 [Figure 1.7; (Smith et al, 2008)]. GEFT belongs to the RhoGEF family of 
modulators that exchange GDP for GTP to activate RhoGTPase molecular 
Figure 1.11 The RhoGTPase Cycle. RhoGTPase molecules cycle 
between active (bound to GTP) and inactive (bound to GDP). GEF 
proteins exchange GDP for GTP and may localize RhoGTPase to the 
plasma membrane. GAP proteins return RhoGTP to RhoGDP, while GDI 
molecules sequester RhoGDP in the cytoplasm; from Etienne-Manneville 
and Hall 2002. 
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switches and influence a variety of effector proteins and cellular behaviors  
[Figure 1.11; (Schmidt and Hall 2002; Guo et al, 2003). GEFT activates the 
RhoGTPase molecules Cdc42 and Rac1, which are canonical inducers of 
migration through actin polymerization to produce filopodia and lamellipodia, 
respectively (Schmidt and Hall 2002). Bves influences GEFT activation of 
Rac1/Cdc42, cell protrusion formation and migration (Smith et al, 2008). 
Interestingly, RhoGEFs can be spatially regulated and Bves/GEFT colocalize at 
cell borders in muscle tissue (Schmidt and Hall 2002; Smith et al, 2008). While 
actin-based protrusions drive cell migration, they also influence other cellular 
behaviors such as cadherin-mediated intercellular adhesion (Kuroda et al, 1999). 
Indeed, GEFT influences many cellular processes including cAMP-induced 
neurite extension, adipogenesis, myogenesis and lens differentiation through 
Cdc42/Rac1 activity (Bryan et al, 2004; Bryan et al, 2005; Bryan et al, 2006; 
Mitchell et al, 2011). Thus, the Bves/GEFT interaction could globally influence all 
of the developmental and disease phenotypes attributed to Bves. Bves could 
function to both spatially and directly regulate GEFT activity.  
 
Bves and VAMP3 
 Previous studies suggest a theme in which Bves regulates activity of 
diverse molecules via subcellular localization (e.g. TJ/AJ components and spatial 
regulation of RhoGEF activity). How Bves facilitates subcellular movements is 
determined by studies presented in this dissertation. Our data indicate that Bves 
interacts with VAMP3 (cellubrevin, or synaptobrevin 3), a ubiquitous vesicular-
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SNARE transport-mediating molecule (McMahon et al, 1993). This interaction 
provides molecular framework through which Bves could regulate transport of 
many cargoes. VAMP3 functions within the common eukaryotic 
compartmentalization process. 
 Intracellular membrane bound vesicles generate diverse subcellular 
compartments in eukaryotic cells (Alberts 2002). These compartments can 
function in the biosynthetic route to transport de novo produced immature 
proteins from the rough endoplasmic reticulum to the Golgi apparatus for post-
translational modifications, then mature proteins are shuttled to functional 
compartments at the plasma membrane or outside the cell (Proux-Gillardeaux et 
al, 2005). Alternatively, intracellular compartmentalization also mediates 
Figure 1.12 Endocytotic pathways. Internalized receptors and nutrients are 
endocytosed into early endosomes that sort proteins into fast or slow 
recycling compartments, or to late endosome/multivesicular bodies for 
subsequent degredation. Additionally, some multivesicular body/lysosome-
like structures could be targeted for exocytosis; image from Scita and Di Flora 
2010. 
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internalization of nutrients and signaling molecules from the plasma membrane 
and extracellular environment through endocytosis pathways [Figure 1.12; 
(Proux-Gillardeaux et al, 2005; Huotari and Helenius 2011)]. In these pathways 
the plasma membrane invaginates to enclose extracellular particles and 
receptors in early endosomes (Platta and Stenmark 2011). Early endosomes are 
general sorting stations containing the Rab GTPase, Rab5, and its effector, 
EEA1 (Scita and Di Fiore 2010; Platta and Stenmark 2011). Internalized proteins 
are shuttled back to the membrane through either slow or fast recycling 
mechanisms (marked by GTPases Rab11 and Rab4, respectively), or targeted 
for degradation through late endosomes and multivesicular bodies (mediated by 
Figure 1.13 The SNARE complex. SNARE proteins have a highly specialized 
structure consisting of coiled-coil domains that fuse to cognate SNARE 
proteins extending from apposing membranes. SNAREs bring membranes 
together and facilitate fusion. Botulinum neurotoxins target SNARE molecules; 
adapted from Sutton et al. 1998. 
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Rab7) to lysosomes for degradation (marked by LAMP1/2) or exosomes for 
secretion [Figure 1.12; (Scita and Di Fiore 2010; Platta and Stenmark 2011)]. 
Additionally, secretion of lysosome-like multivesicular-derived compartments can 
be targeted for exocytosis in some cellular contexts (Izumi 2007). The general 
framework of endocytosis is resolved. However, endocytotic pathways are cell-
specific and multifunctional, complicating identification of the pathways through 
which genes of interest influence cellular behaviors (Maxfield and McGraw 2004).  
Subcellular shuttling of vesicular compartments entails budding from a 
donor compartment, movement through the cytosol on cytoskeletal tracks and 
SNARE-mediated fusion of the compartment with the receiving membrane 
(Proux-Gillardeaux et al, 2005). Structurally, a single SNARE consists of two α-
helical coils (Scales et al, 2000). Donor v-SNAREs fuse with receptor t-SNAREs 
to bring membranes into close apposition for fusion [Figure 1.13; (Scales et al, 
2000)]. SNAREs have specificity for subcellular compartments and may have  
cognate binding partner SNAREs to ensure specific fusion (Scales et al, 2000).  
 VAMP3 is a v-SNARE enriched in recycling endosomes that participates 
in fusion events of vesicles being shuttled to and from the plasma membrane 
(Borisovska et al, 2005). VAMP3, which is sensitive to inactivation through 
cleavage by Tetanus Toxin (TeNT; Figure 1.13), is a well-described regulator of 
transferrin shuttling; this tool is used to assay VAMP3 function (Daro et al, 1996). 
VAMP3 shuttles a diverse array of molecules, from matrix metalloproteases for 
secretion to myelin transport in oligodendrocytes (Kean et al, 2009; Reefman et 
al, 2010; Feldmann et al, 2011).  Importantly, VAMP3 is required for cell 
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migration, as it mediates delivery of recycled β1-integrin to focal adhesions for 
lamellipodium formation (Proux-Gillardeaux et al, 2005; Skalski and Coppolino 
2005). VAMP3 mediates many cellular behaviors that reflect the functions that 
are also attributed to its binding partner Bves. Thus, the interaction between 
Bves/VAMP3 elucidated in Chapter III provides a mechanistic framework to 
underlie the diverse phenotypes exhibited in Bves-disrupted cellular, 
developmental, and disease models. 
 
Integrin trafficking 
 Integrin heterodimers localize in the plasma membrane where the 
complexes confer adherence to both the underlying surface/neighboring cells 
and transduce cellular signals in response to environmental stimuli (Hynes 2002). 
Figure 1.14 Integrin recycling. Integrin receptors are internalized into early 
endsosomes and either immediately returned to the plasma membrane via fast 
recycling, or, like α5β1 integrin, sorted into a perinuclear recycling 
compartment (PNRC). From the PNRC, Rab11 (and VAMP3) mediate α5β1 
integrin return to the cell surface in the slow recycling pathway; adapted from 
Caswell and Norman 2006. 
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Integrin cycling includes internalization from the plasma membrane and 
redeposition back to the cell surface with an average cycle time of 30 minutes 
(Roberts et al, 2001; Caswell and Norman 2006). The machinery for this cycling 
is integrin specific, and β1-integrins undergo caveolae-dependent internalization 
(Ng et al, 1999). After internalization β1-integrins are shuttled from early 
endosomes to the perinuclear recycling compartment (PNRC) for Rab11-
mediated recycling [Figure 1.14; (Roberts et al, 2001; Roberts et al, 2004)]. 
GTPase proteins/effectors mediate movement from PNRC to Rab11 vesicles (Ng 
et al, 1999; Powelka et al, 2004; Skalski and Coppolino 2005). VAMP3 disruption 
with TeNT treatment delays β1-integrin trafficking in Rab11 vesicles from the 
PNRC to the membrane where it normally fuses by binding to the t-SNARE 
SNAP23 (Veale et al, 2011). Thus, VAMP3 functions within the canonical β1-
integrin recycling mechanism to mediate cell spreading and lamellipodial 
extension (Proux-Gillardeaux et al, 2005). Chapter III of this dissertation details 
Bves regulation of β1-integrin recycling through the established VAMP3 
mechanism.  
 
Fibronectin Assembly and Trafficking 
 Fibronectin, a ubiquitous ECM glycoprotein that exists in a branched 
meshwork around cells, is a major substrate for β1-integrin adherence (Singh et 
al, 2010). Fibronectin has a modular structure with domains allowing for binding 
to other glycoproteins and cell surface molecules simultaneously, and assembly 
is a cell-mediated process where thin fibrils cluster together to form thick bundles 
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(McDonald 1988; Mao and Schwarzbauer 2005; Singh et al, 2010). Fibronectin is 
secreted in a folded conformation, and cells mediate fibrillogenesis primarily 
through binding α5β1-integrin to the RGD (Arg-Gly-Asp) domain on fibronectin 
(Ruoslahti and Obrink 1996). Tethering initiates conformational changes allowing 
fibronectin oligomerization in the N-terminal domain and overall matrix insolubility 
[Fig 1.15; (Sechler et al, 1996; Huveneers et al, 2008)]. Tethering also provides 
resistance to support cell contractility, and subcellular signaling through focal 
adhesion complexes (Singh et al, 2010). The mechanism of fibronectin matrix 
turnover is only now emerging, and occurs through β1-integrin-mediated and 
caveolin-1-dependent endocytosis (Shi and Sottile 2008). It has recently been 
suggested that fibronectin and β1-integrin are internalized and trafficked into 
Figure 1.15 Fibronectin fibrillogenesis. (A) Fibronectin is secreted in a 
folded conformation. (B-D) Integrin proteins tether and change the 
conformation of fibronectin proteins causing oligimerization and insolubility; 
adapted from Singh et al. 2010. 
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lysosomes for either degredation or recycling back to the basal surface of the 
plasma membrane to mediate cell movement (Lobert et al, 2010; Dozynkiewicz 
et al, 2011; Sung et al, 2011). While fibronectin turnover is essential for cell 
adhesion and movement, subcellular regulation of this mechanism requires 
further elucidation. Chapter IV of this dissertation identifies two novel regulators 
of fibronectin recycling and deposition, Bves and NDRG4. 
 
NDRG4 
 The most frequent Bves binding partner identified in split-ubiquitin screens 
was NDRG4. Chapter IV will detail the interaction between Bves and NDRG4 in 
internalization and re-secretion of soluble fibronectin to confer directional 
epicardial cell migration. Elucidating this interaction provides novel information 
about Bves and NDRG4 influence on subcellular trafficking and secretion. 
 NDRG4 (Bdm1 and SMAP8) is a cytoplasmically-localized molecule of 
unknown function that belongs to the NDRG gene family [57-65% amino acid 
identity among family molecules; (Zhou et al, 2001)]. Isoforms of NDRG4 range 
from 339 to 371 amino acids, are highly conserved across species from plants to 
humans, and contain an α/β hydrolase domain predicted to be non-functional 
[Figure 1.16A; (Zhou et al, 2001; Qu et al, 2002; Shaw et al, 2002)]. NDRG4 is 
enriched in heart and brain with minor expression in a variety of other tissues 
such as lung, testis and skeletal muscle (Zhou et al, 2001; Nakada et al, 2002; 
Qu et al, 2002). NDRG4 is expressed in murine pancreatic duct epithelium and 
acinar cells during development, but is downregulated at 21 days 
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(Wang and Hill 2009). In the brain, in situ hybridization and antibody labeling 
demonstrated NDRG4-enriched neurons in many areas during development and 
in the adult, as well as in Purkinje cells in the cerebellum (Okuda et al, 2008; 
Yamamoto et al, 2011). NDRG4 is also enriched in the spinal cord and peripheral 
nerves (Zhou et al, 2001). In the zebrafish, NDRG4 is first expressed in the 
central nervous system at the 10-somite stage, and this expression is enriched 
throughout the nervous system at 72 hpf (Qu et al, 2008). This study was 
additionally the first to demonstrate expression patterns of NDRG4 during heart 
development. NDRG4 is expressed at 24 hpf in the developing heart tube and by 
36 hpf it is expressed in both atrial and ventricular tissues. In epicardial cells, 
NDRG4 is generally cytoplasmic and vesicular, although some protein also 
localizes to cell surfaces (Figure 1.16B). Cellular fractionation of rat brain 
homogenate suggests that NDRG4 is mitochondrial- and endoplamic reticular-
Figure 1.16 NDRG4 conserved structure and subcellular localization. (A) 
NDRG4 (352 AA) belongs to the NDRG protein family. These molecules share 
a conserved α/β hydrolase domain, but the active residues are mutated to 
alanines; modified from Melotte et al. 2010. (B) NDRG4 has mainly a punctate, 
vesicular cytoplasmic localization with some protein found at the cell surface 
(NDRG4 red, ZO-1/dapi blue). 
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enriched and lumenally oriented, as determined through protease protection 
assays (Nakada et al, 2002). Generally, NDRG4 is enriched in heart and brain 
and expression grows progressively stronger from embryonic development to 
adulthood in expressing tissues (Melotte et al, 2010). 
 Gain- and loss-of-function studies demonstrated that NDRG4 influences a 
variety of cellular behaviors. Studies in PC12 neurons indicate that neurite 
protrusion is impair with NDRG4 disruption and, conversely, enhanced with 
overexpression (Ohki et al, 2002). Followup studies demonstrated that MEK/ERK 
signaling cascade activities needed for neuronal differentiation are enhanced 
with NDRG4 overexpression, while activity of Elk-1, a transcription factor target 
of ERK needed for cell growth is attenuated (Hongo et al, 2006). Microtubule 
transport is required for this attenuation, suggesting that subcellular transport of 
cargoes is affected by NDRG4 expression. NDRG4 has also been demonstrated 
to regulate cell proliferation, although the exact effect may be context dependent. 
In rat aortic smooth muscle cell lines (A10) overexpression of NDRG4 reduced 
basal proliferation rate, while overexpression of proliferation stimulated by 
Platelet-Derived Growth Factor (PDGF) was enhanced (Nishimoto et al, 2003). 
Nishimoto et al. (2003) similarly demonstrated enhanced MEK/ERK 
phosphorylation in NDRG4 overexpressing cells. Qu et al. (2008) demonstrated 
during zebrafish development that NDRG4-depletion impairs cardiac myocyte 
proliferation leading to cardiac growth and morphogenesis defects with overall 
weak contractility. Conversely, NDRG4-depleted pancreatic cells fail to repress 
DNA synthesis, a marker of proliferation, during differentiation (Wang and Hill 
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2009). Importantly, overexpression of NDRG4 in A10 cells inhibits cell migration 
(Nishimoto et al, 2003). Finally, NDRG4, like its binding partner Bves, is a tumor 
suppressor in multiple cancer cell types. Melotte et al. (2009) were the first to 
identify hypermethylation of the NDRG4 promoter in colorectal cancer cell lines 
and tissue. This study demonstrated that overexpression of NDRG4 in CRC lines 
inhibited invasion and proliferation, indicating that loss-of-NDRG4 is a biomarker 
for premalignant colorectal tissue (Melotte et al, 2009). Additionally, NDRG4 
expression is elevated in Glioblastoma Multiform (GBM) cells where it is required 
for cell cycle progression and proliferation (Schilling et al, 2009). Thus, NDRG4, 
like Bves, influences varied behaviors in multiple cell, developmental and disease 
models.  
 NDRG4 subcellular protein activity requires elucidation. However, the 
molecular function of the other NDRG family members provides clues as NDRG 
proteins may exhibit redundancy. All of the NDRG family proteins are involved in 
similar cellular processes including differentiation of developing tissues, 
regulated cell proliferation and cellular responses to stress (Melotte et al, 2010). 
Additionally, all NDRG molecules have tumor suppressive functions; Kachhap et 
al. (2007) suggests that NDRG molecules influence later tumor changes, such as 
metastasis, rather than tumor initiation. NDRG1 is the best-studied NDRG 
molecule and is mutated in a form of human Charcot-Marie-Tooth syndrome, the 
degenerative peripheral neuropathy, Hereditary Sensory and Motor Neuropathy-
Lom [CMT4D; (Kalaydjieva et al, 2000)]. NDRG1 expression is elevated in the 
cytoplasm of Schwann cells that ensheath axons of the peripheral nervous 
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system and oligodendrocytes of the central nervous system (Berger et al, 2004; 
Okuda et al, 2008). NDRG1 transfected into COS7s is cytoplasmic, diffuse and 
some colocalization occurs with ubiquitin (Berger et al, 2004). Two murine 
NDRG1-/- models recapitulated CMT4D with axon degeneration due to 
demyelination, and subsequent loss of motor function (Okuda et al, 2004). King 
et al. (2011), using stretcher (str) mutant NDRG1-/- mice, suggested that NDRG1 
influences trafficking of myelin sheath components. NDRG1 interacts through 
yeast-2-hybrid screening with multiple trafficking proteins including Prenylated 
Rab Acceptor 1, a regulator of transport between endosomal compartments 
(Hunter et al, 2005; King et al, 2011). NDRG1 is involved in lipid transport of 
Apolipoprotein binding partners, ApoA-I and II (Hunter et al, 2005). Additionally, 
NDRG1 is a Rab4a effector that regulates shuttling E-Cadherin to/from the 
plasma membrane in prostate cancer cell lines (Kachhap et al, 2007), while the 
Alzheimers Disease associated-NDRG2 regulates secretion of the cytokine IL-10 
(Mitchelmore et al, 2004; Choi et al, 2010). The molecular function of NDRG4 
elucidated here in Chapter IV is consistent with functions ascribed to other 
NDRG family molecules, suggesting that regulation of subcellular trafficking is 
the global function for NDRG proteins. 
 
Summary 
 Epicardial development is a complex process and its coordination requires 
elucidation. Chapter II of this dissertation presents a novel experimental 
mechanism to identify signaling cascade relationships regulating this 
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developmental program. Additionally, Chapters III and IV study epicardial-
enriched Bves protein and reveal two new binding partners, VAMP3 and NDRG4. 
These studies suggest a novel global role for Bves: regulation of cell surface 
trafficking of multiple components. Through this function Bves facilitates cell-cell 
and cell-surface adhesion and supports epithelial integrity and cell movement. 
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CHAPTER II 
 
APPLICATION OF SMALL ORGANIC MOLECULES REVEALS 
COOPERATIVE TGFβ AND BMP REGULATION OF                    
MESOTHELIAL CELL BEHAVIORS 
 
This chapter was published under this title in American Chemical Society 
Chemical Biology on July, 8 2011 (Cross et al. 2011). 
 
Abstract 
Epicardial development is a process during which epithelial sheet 
movement, single cell migration and differentiation are coordinated to generate 
coronary arteries. Signaling cascades regulate the concurrent and complex 
nature of these three events. Through simple and highly reproducible assays, we 
identified small organic molecules that impact signaling pathways regulating 
these epicardial behaviors. Subsequent biochemical analyses confirmed the 
specificity of these reagents and revealed novel targets for the widely used 
Dorsomorphin (DM) and LDN-193189 molecules. Using these newly 
characterized reagents, we show the broad regulation of epicardial cell 
differentiation, sheet movement and single cell migration by Transforming Growth 
Factor β (TGFβ). With the DM analog, DMH1, a highly specific Bone 
Morphogenetic Protein (BMP) inhibitor, we demonstrate the cooperative yet 
exclusive role for BMP signaling in regulation of sheet migration. The action of 
DMH1 reveals that small organic molecules (SOM) can intervene on a single 
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epicardial behavior while leaving other concurrent behaviors intact. All SOM data 
were confirmed by reciprocal experiments using growth factor addition and/or 
application of established non-SOM inhibitors. These compounds can be applied 
to cell lines or native proepicardial tissue. Taken together, these data establish 
the efficacy of chemical intervention for analysis of epicardial behaviors and 
provide novel reagents for analysis of epicardial development and repair.  
 
Introduction 
Mesothelium is the simple squamous lining of the body cavities and 
organs (Wilm 2005).  Mesothelia are important in development, as they are 
essential for blood vessel formation and organogenesis in general (Mikawa and 
Fischman 1992; Dettman et al, 1998; Gittenberger-de Groot et al, 1998; Reese et 
al, 2002). Still, generation of mesothelium is complex and information on 
regulation of its various cell behaviors is only now emerging (Austin et al, 2008; 
Mellgren et al, 2008; Ishii et al, 2010). The epicardium, covering the heart, is the 
best-studied model of mesothelial development (Männer et al, 2001; Wada et al, 
2003). During embryogenesis, the proepicardium arises independently from the 
heart on the sinus venosus (Mikawa et al, 1992; Gittenberger-de Groot et al, 
1998; Reese et al, 2002; Nahirney et al, 2003; Cai et al, 2008). Development and 
differentiation of the proepicardium is dependent on multiple simultaneous cell 
behaviors as it migrates to the naked myocardium, adheres and spreads over the 
heart as an epithelial sheet (Komiyama et al, 1987; Männer et al, 2001). During 
this lateral migration event, selected epicardial cells undergo 
 40 
epithelial/mesenchymal transition, migrate throughout the heart and differentiate 
into many lineages including vascular smooth muscle, fibroblasts, endothelial 
cells, and cardiomyocytes (Mikawa and Gourdie 1996; Dettman et al, 1998; Cai 
et al, 2008; Mellgren et al, 2008; Ishii et al, 2010). Epicardial development is 
likely to require cooperative signaling mechanisms.  
 The approach to understanding complex molecular interplay controlling 
cell behaviors has historically used gene mutation and knockdown studies to 
deactivate gene products (Hood et al, 2004). While these studies have been 
successful, they are not without caveats as they may cause secondary effects on 
the system, and are expensive in terms of time, effort and materials. Additionally, 
knockdown or knockout studies may simultaneously remove all functions 
performed by the gene, including regulation by non-coding microRNAs (Stockwell 
2004; Poliseno et al, 2010). An emerging alternative employs organic chemical 
“perturbagens” that bind to proteins, alter their function, and replace or 
complement gene mutation or knockdown studies (Stockwell 2004). Small 
organic molecules (SOM) have an added advantage: when well-characterized, 
selected compounds have highly-specific activity on discrete residues of their 
target proteins and may affect only one of multiple functions performed by that 
molecule (Stockwell 2004).  
An excellent example of this concept is Dorsomorphin (DM) and its family 
of analogs (Hao et al, 2008; Hao et al, 2010). These structurally-related 
compounds differentially target Bone Morphogenetic Protein (BMP) signaling. 
BMPs are part of the Transforming Growth Factor β (TGFβ) superfamily of 
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growth factors (Chen et al, 2004; Guo and Wang 2009) and have been 
implicated in regulating epicardial behaviors (Schlueter et al, 2006; van Wijk et al, 
2009; Austin et al, 2010; Ishii et al, 2010). TGFβ and BMP signaling occurs 
through stimulation of ligand-specific type-I and type II serine/threonine kinase 
receptors on the effector cell membrane, where they dimerize in response to 
ligand (Giehl and Menke 2006). The receptor complex stimulates signal 
transduction in effector cells via phosphorylation of Smad family mediator 
molecules, which translocate to the nucleus and stimulate transcription of target 
genes (Giehl and Menke 2006).  Identification of SOMs with broad or specific 
inhibitory effects on these pathways would produce versatile tools to study 
intricate developmental processes regulated by concurrent signaling cascade 
mechanisms. 
 Chemical biology is particularly amenable for unraveling the complexity of 
epicardial development, where many signaling cascades coordinately impact cell 
behaviors. In the present study, we conducted SOM screens of epicardial 
differentiation, sheet movement and single cell migration to elucidate signaling 
pathways regulating these independent yet concurrent events. With compounds 
that broadly or specifically intervene on signaling pathways, we show a 
dependence on TGFβ signaling in the regulation of all three activities. Conversely, 
using a newly characterized and highly specific BMP inhibitor, the DM analog 
DMH1, we show that both TGFβ and BMP signal cascades interdependently 
regulate epicardial sheet migration. Intervention with these perturbagens 
demonstrates that a single epicardial behavior can be inhibited while 
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simultaneous cell activities are left intact in both clonal cell lines and native tissue. 
Taken together, these data demonstrate the efficacy of chemical intervention to 
identify cooperative signaling in the regulation of epicardial behaviors. In addition, 
we provide the field with well-characterized reagents for intervention in both 
embryogenesis and wound healing.   
 
Materials and Methods 
 
Quantification 
For the assays described below statistics and percent closure were 
performed in Microsoft Excel.  Error bars represent the standard error of the 
mean; student t-tests were used to determine significance.  All images being 
compared were adjusted equally. 
 
Cell culture, cell and tissue processing, antibodies and 
immunofluorescence analysis 
 
Epicardial cell culture conditions and processing were standard (Wada et 
al, 2003) as was slide preparation (Smith and Bader 2006). Commercially 
available antibodies included: anti-α-SMA, (Sigma 2547, 1:200), anti-ZO-1 
(Zymed 61-7300, 1:200), anti-SM22, (Abcam, ab28811, 1:200), anti-cytokeratin, 
(Abcam, ab9377, 1:200), anti-WT-1, (Abcam, ab52933, 1:100), anti-vimentin, 
(Sigma, V 6630, 1:50) and anti-SM-MHC (Biomedical Technologies BT-562, 
1:200) anti-Phospho-β-catenin (Cell Signaling, 9566, 1:500), Phospho-Smad1/5, 
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Smad5, Smad3, Phospho-Smad3 (Cell Signaling, 9516, 9517, 1:1000 WB, 1:50 
IF), anti-β-Catenin (BD Transduction Laboratories, 610154, 1:500). 
 
SMA expression and wound healing assays 
Initially, 105 epicardial cells were seeded to 4-well glass chamber slides 
(NUNC Lab-Tek 154526) in standard epicardial cell medium (Wada et al, 2003).  
After the 18 hour incubation, the medium was changed to 2% FBS; 2% 
FBS/DMEM, supplemented with TGFβ1, PDGF and EGF (Millipore GF111 & 
GF149, BD Biosciences 354001, respectively) at 10ng mL-1 each, to induce 
epicardial cell differentiation with simultaneous addition of SOMs at the 
concentrations given in Figure 2.2, panel j.  For induction by TGFβ1 alone, 
medium was supplemented with 20ng mL-1 TGFβ1 in 2µM DMSO. The negative 
control consisted of medium with DMSO. For induction by BMP2, 4 and 6 (R&D 
Systems 355-BM, 314-BM-010, 6325-BM, respectively) growth factor was added 
to SFM.  Noggin (R&D Systems 3344-NG) was added at 200ng mL-1 to the 
TGFβ1-supplemented medium.  In all situations, cells were incubated for 48 
hours, until being processed.   
 To assay early differentiation and sheet migration rate, 2.5x105 cells were 
seeded to glass 4-well chamber slides and incubated overnight in standard 
epicardial cell media. After 18 hours incubation, cells were equilibrated in 
mediums.  After six-hours incubation, confluent cell sheets were scratched with a 
200µL pipette tip, incubated for an additional 18 hours and then analyzed for 
SMA expression as above.  Sheet movement was quantified at zero and six 
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hours after wounding.  For ALK2/3 overexpression assays, 5µg of CA-ALK2/3 
plasmids were expressed with the Nucleofector II Device (Amaxa Biosystems) 
using Solution L, program A-020.  2.5x105 cells were added to each well of 4-well 
slide and after 48 hours incubation sheets were wounded and analyzed.  This 
work was conducted at the Vanderbilt CISR. 
 
Smad Phosphorylation Assays   
For analysis by western blot, cells were grown to confluence, serum 
starved and stimulated with TGFβ as above.  Lysates were collected, total 
protein measured, and immunoblotted as previously reported (Smith and Bader 
2006) AP detection of immunoreactive bands was standard (Smith and Bader 
2006). For analysis by IF, cells were seeded, treated and injured as above for 
western blot analysis. Cells were processed for Phospho-Smad1/5 antibody as 
per Cell Signaling (9516). Z-series were captured at VUMC CISR and two 0.6µm 
Z-planes were projected with LSM Image Browser.   
 
IC50 Determination  
Kinase binding and confirmatory in vitro kinase assays were performed by 
KinomeScan at www.kinomescan.com.  
 
RNA collection, cDNA synthesis and Quantitative RT-PCR 
18 hours preceding experimental intervention, 2x105 cells were seeded in 
triplicate to a 6-well plastic culture dish (Falcon 353502).  Next, cells were 
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stimulated with the TGFβ1-induction conditions described above.  After 24 hours 
incubation, cells were lysed (Qiashredder, Qiagen 79654), and RNA was purified 
as described (Shelton and Yutzey 2008).  Specific primers with a melting 
temperature of 59oC were designed from the Rattus norvegicus cDNA database 
using PrimerBlast (NCBI) and are listed in Supplementary Table S4.  QRT-PCR 
was performed on the 7900HT Fast Real-Time PCR System [ABI; (using the 
VUMC DNA resources core)].  Gene expression was compared using TaqMan 
Gene Expression assays: BMP2-Rn01484736_M1, BMP4-Rn00432087_m1, 
BMP6-Rn00432095_m1, GAPDH-Rn99999916_s1, 18s-HS99999901_s1.  Data 
was managed in RQ Manager 1.2 software.  All statistics were performed on the 
DCT values. 
 
Modified Boyden Chamber Migration Assay   
3.0x105 cells per experiment were pelleted for 10 minutes at 1500 RPM in 
a desktop microcentrifuge and resuspended in 400uL of control and experimental 
media described above.  The cells were seeded to the basket of an 8.0µM cell 
culture insert (Millicell P18P01250) and placed in 600µL of the same media in a 
24-well plastic culture dish (Falcon).  Cells were incubated for 4 hours, and 
processed with standard methods (Shelton and Yutzey 2008). Fifteen phase 
images were captured on an Olympus BX60 microscope and Olympus Camera. 
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Chicken Proepicardium Explant Differentiation and Migration Assay   
Gallus gallus 16.5 Proepicaria were dissected from embryos and placed 
on 4-well glass chamber slides coated with 5ug (cm2)-1 Fibronectin (Sigma 
F4759).  Proepicardia were incubated for 24 hours in TGFβ1-induced culture 
conditions (above) and processed for immunochemistry with standard methods 
(Pennisi and Mikawa 2009). Images were captured and processed at VUMC 
EBC. Proepicardial explant size was ascertained with phase-contrast imaging 
and by total-protein content measurement (Figure 2.1).  
 
 
Figure 2.1 PE explants are comparable in size. Two methods were used to 
ensure that equally sized PE explants were used for analysis. First the size of 
select isolates was measured after two hours incubation from phase contrast 
images. Next, total protein in PE isolates was determined as a measure of 
explant size. (a-d) PEs were imaged and measured for total area after two 
hours incubation to allow PEs to settle on the slides. PEs were not statistically 
different in total area after culturing (P>0.05). (e) Total protein content of 
unincubated PEs was also calculated and three groups of PEs were found to 
have similar concentration, with standard deviation of 42.5 µg/mL. For PE 
imaging and total protein content 5 PEs were measured for each condition or 
group, respectively. 
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Results and Discussion 
 
Specific Small Molecules Intervene in Epicardial Smooth Muscle 
Differentiation  
In an effort to establish a broadly applicable approach to analyze 
regulation of specific epicardial cell behaviors, a panel of SOMs was tested for 
effects on early smooth muscle differentiation. Previous work from our laboratory 
and others determined that expression of smooth muscle α-actin (SMA) in 
epicardial cells is a hallmark of epithelial/mesenchymal transition, an initial step 
in smooth muscle differentiation, and can be stimulated by multiple growth 
factors (Wada et al, 2003; Olivey et al, 2005; Mellgren et al, 2008). Treatment of 
epicardial cell lines with a combination of known SMA-stimulating growth factors 
for 48 hours in serum-free medium (hereafter termed medium) evoked a robust 
and highly replicable SMA response (Figure 2.2, panel a versus b). 
Representative results of selected SOMs are presented in Figure 2.2, panels a-i. 
The characteristics and structures of representative molecules are listed in 
Figure 2.2, panels j-k. Most compounds had no or minimal effect on the number 
of cultured cells expressing SMA. One exception was the TGFβ inhibitor, SB-
431542 (Inman et al, 2002), which completely ablated SMA expression (Figure 
2.2, panel c). This is a valuable internal control, as TGFβ is known to stimulate 
SMA expression in epicardium. Interestingly, Dorsomorphin (DM), an inhibitor of 
BMP signaling cascade receptors along with other signaling pathways including 
vascular endothelial growth factor (VEGF) 
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(Zhou et al, 2001; Hao et al, 2008; Hao et al, 2010), also ablated SMA 
expression (Figure 2.2, panel i). This is an unexpected result, as BMP signaling 
is thought to only regulate myocardial differentiation in the heart, but is not a well-
described activator of smooth muscle differentiation (Olivey et al, 2005; Giehl and 
Menke 2006; Schlueter et al, 2006; Svensson 2009; van Wijk et al, 2009). Thus, 
these surprising results raised the possibility that BMP signaling may be involved 
in epicardial cell smooth muscle differentiation. 
Figure 2.2. Dorsomorphin and SB-431542 inhibit epicardial α-smooth 
muscle actin (SMA) expression. (a-b) Epicardial/mesothelial cells (hereafter 
termed ‘epicardial cells’) treated with serum-free medium (hereafter termed 
‘medium’) plus or minus growth factors serve as negative and positive controls 
for SMA expression. (c) Epicardial cells stimulated with growth factors and 
treated with SB-431542 ablated SMA expression. (d-h) Growth factor-
stimulated cells treated with KA4541, BIO, Cyclopamine or XAV had no effect 
on SMA expression. (i) Growth factor-stimulated cells treated with 
Dorsomorphin (DM) also strongly inhibited SMA expression. (j) This 
information panel provides details about the SOMs tested in these studies. (k) 
The structures of the small molecules tested in this study are presented here. 
[(Scale bar=50µm; Footnotes: A-(Inman et al, 2002), B-unpublished data, C-
(Moon et al, 2004) , D-(Chen et al, 2002), E-(Peterson 2009), F-(Yu et al, 
2008), G-(Cuny et al, 2008), H-(Hao et al, 2010) SFM=Medium; GF=Growth 
Factor Medium]. 
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Figure 2.3 Analysis of growth factor regulation of SMA expression in 
epicardial cells. (a,d,g,j) Epicardial cells cultured in low-serum medium did 
not express SMA. (b,e,h,k) Growth factors added to low-serum medium 
induced high levels of epicardial SMA expression. (c,f,m) Epicardial cells 
cultured with growth factors and treated with DM/LDN-193189 significantly 
inhibited SMA expression compared to untreated cells. (i,m) Epicardial cells 
cultured with growth factors and treated with the BMP-specific inhibitor DMH1 
marginally inhibited SMA expression. (l,m) Epicardial cells cultured with growth 
factors and treated with DMH4  were unaffected (from growth factor p=0.237). 
(n-p) Epicardial cells cultured in BMP2, or 4 did not stimulate SMA expression, 
at low or high concentrations. (q-r, t-u) Conversely, TGFβ1 treatment 
stimulated expression of the early differentiation markers, SMA and SM22. s,v) 
TGFβ1–induced SMA and SM22 expression was ablated by addition of DM. 
[n=≥20 images; Scale bar=50µm; (*p<0.01; ~p<0.05) TGFβ=Transforming 
Growth Factor β; BMP=Bone Morphogenetic Protein]. 
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Application of DM Analogs Elucidates Differential Requirements for TGFβ 
and BMP Signaling for Epicardial Differentiation  
We next determined whether the previous results revealed a novel role for 
BMP signaling in epicardial differentiation, an effect of DM on an alternate 
pathway, or both. To examine these possibilities, SMA expression was assayed 
following treatment with 63 structural analogs of DM that have greater selectivity 
for individual pathways than the parent compound (Cuny et al, 2008; Hao et al, 
2010). Treatment of cells with LDN-193189, an inhibitor of BMP and VEGF 
Figure 2.4 BMP2 and 6 do not stimulate SM22 expression. (a) Epicardial 
cell cultures maintained in serum free medium did not express SM22 protein, 
(b) while those treated with TGFβ1 had a strong induction in SM22 expression. 
Conversely, 20ng/mL of (c) BMP2 or (d) BMP6 did not induce SM22 
expression in epicardial cells. 
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pathways (Cuny et al, 2008; Hao et al, 2010), eliminated SMA expression (Figure 
2.3, panels d-f, and m). Conversely DMH1, an extremely selective inhibitor of the 
BMP type-I receptors Activin receptor-like kinases 2 and 3 (ALK2 and ALK3) had 
minimal effect (Figure 2.3, panels g-i, m). Additionally, DMH4, a selective 
inhibitor of VEGF receptor-2 [VEGFR2; (Hao et al, 2010)], had no impact on 
epicardial SMA expression (Figure 2.3, panels j-m). Thus, use of these more 
selective inhibitors suggests that BMP signaling is not responsible for epicardial  
differentiation and that DM and LDN-193189 act on a previously unidentified 
target regulating this behavior. 
To explore these unanticipated results, we conducted the inverse 
experiment adding specific growth factors to epicardial cultures and determining 
their effects on SMA expression. Addition of BMP2 and 4, both canonical 
stimulators of the BMP receptors ALK2/3 (Sieber et al, 2009; Mitchell et al, 2010) 
and highly expressed in epicardial progenitors (Schlueter et al, 2006; Ishii et al, 
2010), had no effect on SMA or SM22 expression at multiple concentrations 
(Figure 2.3, panels n-p, Figure 2.4). TGFβ1 was the only growth factor to induce 
expression of these early smooth muscle differentiation markers in epicardial 
cells (Figure 2.3, panels q-r, t-u), reflecting results obtained from other groups 
(Olivey et al, 2005; Giehl and Menke 2006; Austin et al, 2008). Interestingly and 
consistent with our previous data, this stimulation was completely ablated by 
addition of DM, identical to the inhibitory effects of SB-431542 (Figure 2.3, panels 
s, v). Corroborating our previous results in which the BMP inhibitor, DMH1, had 
little or no effect on TGFβ stimulation of epicardial differentiation (Figure 2.3, 
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Figure 2.5 DMH1, but not Dorsomorphin, specifically inhibits Smad1/5 
activity. (a) The TGFβ responsive Smad3 molecule was activated in the 
presence of TGFβ1 and inhibited with addition of Dorsomorphin, but not DMH1 
(row: P-Smad3). Alternatively the phosphorylation of the BMP-responsive 
Smad1/5 molecules was lost when cells were treated with DM or DMH1 (row: 
P-Smad1/5). Lysates from epicardial cells in all treatments expressed equal 
amounts of Cyclophilin (loading control), Smad1/5, and β-Catenin total 
proteins (rows: Cyclophilin, Smad3, Smad1/5, and βCatenin, respectively). β-
Catenin phosphorylation was unchanged, conferring specific activity to DM 
and DMH1 on Smad transduction molecules (row: P-βCatenin). (b-c) 
Phospho-Smad1/5 nuclear localization was minimal in serum free medium and 
was marginally upregulated by TGFβ1. (f) Alternatively, BMP2 treatment 
greatly increased activated Smad1/5 nuclear localization. (e,g) TGFβ-
stimulated cells wounded, treated with DM and DMH1 did not localize 
Smad1/5 to the nucleus. [n=3 P-Smad3=Phosphorylated Smad3, P-
Smad1/5=Phosphorylated Smad1/5 Protein, P-βCatenin=Phosphorylated 
βCatenin.] 
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panel i). These results support the data presented above, that BMP has no effect 
on this epicardial differentiation and that DM and LDN-193189 may affect this 
particular behavior in epicardial cells via inhibition of TGFβ signaling. 
 
Identification of Novel DM Analog Targets Reveals Differential Regulation 
of Epicardial Receptors  
To precisely determine the signal cascades inhibited by DM and its 
analogs, in vitro kinase inhibitory activities (as assessed by IC50, concentration 
causing 50% inhibition) against potential BMP and TGFβ receptors were 
performed. As expected, all DM analogs tested strongly inhibited ALK1 and ALK2, 
both type-I receptors selective for BMP ligands [Table 1;(Sieber et al, 2009; 
Mitchell et al, 2010)]. Our previous work has shown that DM analogs also 
potently inhibited ALK3, another BMP type-I receptor (Hao et al, 2010). 
Importantly, DMH1 had minimal activity on any of the TGFβ receptors tested  
(Table 1: ALK4, ALK5 and TGFβR2; (Hao et al, 2010)). Conversely and 
unexpectedly, our data revealed for the first time that the widely-used DM and 
LDN-193189 inhibited TGFβR2, a type-II receptor for TGFβ (Giehl and Menke 
2006).  
We next examined whether the apparent differential effects of DM and 
DMH1 on BMP and TGFβ receptors in biochemical analyses extended to 
epicardial cells. Since BMP and TGFβ signaling occur via distinct receptors to 
trigger Smad1/5/8 and Smad2/3 phosphorylation, respectively (Chen et al, 2004; 
Guo and Wang 2009), we utilized pathway-specific Smad phosphorylation to  
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Figure 2.6 DMH1 strongly inhibits epicardial sheet movement, but not SMA 
expression. Epicardial sheet migration rate was assessed by wound healing 
assays with representative images of wounds at six hours in b-f. (a,c) Wounding 
epicardial sheets in the presence of TGFβ1 significantly increased sheet 
migration rate in comparison cells wounded in medium. (a,d-e) Epicardial 
wounds cultured with TGFβ1 and concurrently treated with DM/LDN-193189 
healed at medium-equivalent rates. (a,f) Interestingly, sheets wounded with 
TGFβ1-and the BMP inhibitor, DMH1, healed at a rate significantly slower than 
unstimulated sheets. (g) Epicardial sheets wounded in medium spontaneously 
expressed SMA after an 18-hour incubation. (h) When wounds were cultured 
with TGFβ1, SMA expression was strongly increased. (i-j) Conversly when 
sheets cultured with TGFβ1 and treated with DM/LDN-193189, SMA expression 
was inhibited. (e) DMH1 marginally inhibited TGFβ1-stimulated SMA expression.  
(l, n) Epicardial sheet migration was strongly stimulated by constitutively active 
ALK2/3. (l,o) Migration was modestly inhibited by treatment of constitutively 
active-ALK2/3 cells with DMH1, which differs from the significant inhibition that 
DMH1 exerts on sheet migration in Wildtype cells. [n≥8 wounds; Scale 
bar=50µm; (*p<0.001 from TGFβ1 stimulated cells; ~p<0.001 from untreated 
cells; ^~p<0.001 from untreated CA-ALK2/3); CA-ALK2/3=Constitutively Active-
ALK2/3].   
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determine the inhibitory precision of DM and DMH1 in epicardial cells. TGFβ1 
administration induced Smad3 phosphorylation, and consistent with our in vitro 
kinase assay data, DM, but not DMH1, inhibited TGFβ1-dependent Smad3 
phosphorylation (Figure 2.5, panel a). Conversely, both DM and DMH1 ablated 
Smad1/5 phosphorylation below baseline (Figure 2.5, panel a). Total Smad3, 
Smad1/5, and housekeeping gene (cyclophilin) protein levels were unchanged in 
all conditions. Additionally, the Wnt signaling cascade was unaffected under all 
conditions, further conferring specificity to the DM analogs (Figure 2.5, panel a). 
Immunofluorescence analysis demonstrated that BMP2 stimulated high levels of 
phospho-Smad1/5 nuclear localization, which was completely inhibited by both 
DM and DMH1 (Figure 2.5 f-g and data not shown). TGFβ had minor stimulatory 
effect on nuclear localization, which was also inhibited by DM and DMH1 (Figure 
2.5, panel c-e). Collectively, our data confirm that TGFβ, but not BMP, signaling 
is critical for epicardial cell differentiation and identify new targets of the widely 
used DM and LDN-193189 molecules. With a precise understanding of the 
activities of the DM analogs in epicardial cells it was now possible to examine the 
concurrent regulation of additional behaviors by the two signaling pathways. 
 
Elimination of BMP Signaling Inhibits Epicardial Sheet Movement, but not 
Differentiation  
A more precise understanding of DM and DMH1 activities at the level of 
BMP and TGFβ receptors enabled us to use these reagents to explore whether 
TGFβ and/or BMP signaling regulate epicardial cell behaviors other than SMA  
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expression. Epithelial sheet migration is a function basic to epicardial cells and 
can be analyzed after scratch injury (Gittenberger-de Groot et al, 1998; Reese et 
al, 2002; Ishii et al, 2010). In the presence of TGFβ1, epicardial wounds 
incubated for six hours exhibited significantly increased regrowth rate (Figure 2.6, 
panels a-c). Application of DM and LDN-193189 inhibited sheet migration to 
control rate, indicating that elimination of TGFβ and/or BMP signaling disrupts 
this function (Figure 2.6, panel d-e). Interestingly, DMH1, the exquisitely selective 
BMP inhibitor, intervened in TGFβ-induced sheet migration; having the strongest 
inhibitory effect of all DM analogs (Figure 2.6, panel f compared to a). In fact, 
DMH1 significantly decreased migration rate below the negative control, similar 
to the strong TGFβ inhibitor SB-431542 (Figure 2.7, panels a-c). Because of this 
surprising result, we determined whether activated BMP receptors might 
overcome the requirement for TGFβ1 ligand. Thus, we overexpressed 
constitutively active ALK2/3 and assayed sheet movement in the absence of 
TGFβ1. Overexpression of these receptors strongly enhanced epicardial sheet   
migration, which was again inhibited upon application of DMH1 (Figure 2.6, 
panels l-o). Further in subsequent experiments, we will demonstrate that 
Table 1. In vitro kinase assay 
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exogenous application of BMP ligands can also stimulate sheet movement in the 
absence of TGFβ (Figure 2.11, panel f-g). Thus, activated BMP signaling in the 
absence of TGFβ is sufficient to elicit this response, complementing the strong 
loss-of-migration phenotype observed with DMH1. Because addition of TGFβ is 
the only exogenously applied growth factor in this context, it is possible that an 
endogenous source of BMPs exists or that the BMP targets ALK1-3, may be 
directly activated by TGFβ1 ligand. We perform experiments outlined below which 
resolve this question (Figure 2.11). Taken together, these data illustrate the 
Figure 2.7. SB-431542 treatment strongly inhibits epicardial sheet migration 
and SMA expression at the leading edge, while DMH1 inhibits only sheet 
migration.(a) Treatment of epicardial sheets with SB-431542 strongly inhibited 
wound closure rate when compared to the SFM control. (b) Additionally, all 
wounds failed to close after 18 hours in culture and did not exhibit expression of 
SMA at the leading edge with SB-431542 treatment. (c) Similarly, sheets treated 
with DMH1 frequently failed to close, but maintained SMA expression at the 
leading edge, illustrating a similarity in ALK2/3 and TGFβ regulation of sheet 
migration, but a divergence in regulatory responsibilities of these cascades on 
SMA expression. [(*p≤0.001 from SFM); n=4 wounds.] 
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concurrent requirement for TGFβ and BMP signaling in the regulation of 
epicardial sheet movement.  
Simultaneous with migration of a wounded epithelial sheet is the 
expression of SMA in cells on its leading edge (Darby et al, 1990). Analysis of 
SMA expression during sheet migration afforded us the opportunity to examine 
two distinct epicardial cell behaviors at the same time, and to explore whether 
specific perturbagens reveal differential regulation of these events. Sheets 
Figure 2.8  DMH1 does not ablate single cell migration. (a) Epicardial cells 
cultured in medium have minimal single cell migration in Boyden chamber 
assays. (b,d) Single cell migration is significantly enhanced by stimulation with 
TGFβ1. (c,d) TGFβ1 stimulation was inhibited by DM/LDN-193189 to a 
migration rate equivalent with  medium, (p=0.056). (d) TGFβ1 stimulation was 
only marginally inhibited by DMH1, unlike the TGFβ inhibitor SB-431542, 
which ablated this behavior.  [n=30 images; (*p<0.001 from TGFβ1 ~p<0.001 
from SFM)]. 
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incubated with TGFβ1 exhibited a marked increase in SMA expression, along 
with robust sheet migration (Figure 2.6, panel h). Application of DM, LDN-193189 
or SB-431542, all shown to inhibit TGFβ/Smad2/3 signaling in this system, 
strongly blocked both behaviors (Figure 2.6, panels i-j, Figure 2.7, panel b). 
Interestingly, while DMH1 had the greatest inhibitory effect on sheet migration, 
SMA expression was untouched (Figure 2.6, panel k). These data demonstrate 
that inhibition of TGFβ has broad inhibitory effects on epicardial behaviors, while 
BMP disruption is highly selective for sheet migration. Application of DM and 
DMH1 to epicardial cells allowed the simultaneous analysis of multiple cell 
Figure 2.9. BMP2 and 6 do not stimulate epicardial cell single cell 
migration. (a) Epicardial cells maintained in serum free medium did not 
undergo significant single cell, random migration through filter membranes. 
Addition of  (b) BMP2 or (c) BMP6 was insufficient to stimulate epicardial 
single cell migration. d) Single cell migration of BMP2 and 6 treated epicardial 
cells was quantified and normalized to the negative control. BMP2 treatment 
was statistically similar to untreated epicardial cultures (p=0.777). BMP6 
treatment significantly decreased single cell migration rate compared to the 
negative control [(*p<0.0001); n=45 images from 3 experiments.] 
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behaviors, and revealed specific intervention in only one behavior while leaving 
the other concurrent behaviors intact. 
 
DMH1 does not Ablate Epicardial Single Cell Migration  
Our current data suggest that BMP signaling regulates sheet movement, 
only, in epicardial cells. However, single cell migration is also a critical behavior 
for epicardial-derived cells (Reese et al, 2002) and, as such, we analyzed the 
impact of BMP signaling on this activity. It has been previously noted that TGFβ 
stimulates single cell invasive migration (Dokic and Dettman 2006), thus we used 
TGFβ as an activator of single cell migration and perturbed the behavior with the 
DM analogs. When epicardial cells were stimulated with TGFβ1 a significant 
increase in single cell migration rate occurred compared to controls (Figure 2.8, 
panels a versus b and d). Interestingly, application of DMH1 did not interfere with 
single cell migration (Figure 2.8, panel d). Conversely, DM, LDN-193189 and SB-
431542 all strongly inhibited single cell migration, (Figure 2.8, panels c and d). 
BMP2 and 6 were tested for their influence on single cell migration in the same 
assay and, as expected, did not stimulate this behavior, corroborating the DMH1 
data (Figure 2.9, panels b-d). Taken together, these data indicate that BMP 
signaling specifically regulates epicardial sheet migration, having little influence 
on other behaviors in epicardial cell lines.  
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DMH1 Inhibits Sheet Migration, but not early Differentiation, in 
Proepicardial Explants  
The proepicardium is the source of epicardial cells in the developing 
embryo (Mikawa et al, 1992; Gittenberger-de Groot et al, 1998; Reese et al, 
2002; Nahirney et al, 2003). Several groups have shown that proepicardial 
Figure 2.10 DMH1 inhibits sheet migration, but not SMA expression, in 
proepicardial explants.  HH stage 16 proepicardia were excised from chick 
embryos and incubated for 24 hours. (a,d) Proepicardia incubated in medium 
exhibited a uniformly spread epicardial cell sheet with SMA expression at the 
distal edge and ZO-1, marking epithelial cells, in the interior of the sheet. 
(b,e,g) Proepicardia cultured in TGFβ1 had upregulated SMA expression 
centrally and peripherally in the outgrowths, but TGFβ1 treatment did not 
increase outgrowth migration rate from medium controls. (c,f,g,j) Proepicaria 
stimulated with TGFβ1 and treated by DM/LDN-193189 had reduced epicardial 
sheet migration and SMA expression. (k) Proepicardia stimulated by TGFβ1 
and treated with DMH1 inhibited outgrowth migration, but had enhanced SMA 
expression and diminished zonula occludins-1 protein expression throughout 
the epicardial sheet.  [Measurements assessed per condition=40; Scale 
bars=200µm for A-C and 50µm for D-F; (*p<0.001; n≥5 proepicardia); ZO-
1=Zonula Occludins-1]. 
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explants grown in vitro retain the developmental properties analyzed in this study 
(Reese et al, 2002; Olivey et al, 2005; Pennisi and Mikawa 2009; Ishii et al, 
2010). Thus, it was essential to determine whether SOMs are effective tools to 
modulate specific cell behaviors in native embryonic epicardial tissues. 
Proepicardial explants grown in basal medium spread on fibronectin to form a 
radial outgrowth with the average radius of 904 µm (Figure 2.10, panel a, d, g). 
These outgrowths had membrane localized Zonula Occludins-1 (ZO-1; a 
commonly used epithelial junction marker (Willis and Borok 2007), and SMA 
expressing cells at their periphery. Proepicardial explants incubated in TGFβ1 
had outgrowths of approximately the same size as untreated explants (avg. 
radius=1,003 µm; Figure 2.10, panel g). This similarity was unsurprising given 
the native mobility of embryonic epicardial tissue. However, TGFβ1 evoked 
increased peripheral SMA expression and stimulated expression within the 
epicardial sheet itself (Figure 2.10, panel b, e). In contrast, when proepicardial 
explants were grown in the presence of DM, there was a significant decrease in 
the spread of the epicardial sheet at 24 hours (avg. radius=489 µm; Fig. 2.10, 
panel c, f, g). Similar results occurred with LDN-1923189 treatment (Figure 2.10, 
panel j). Additionally, in DM and LDN-193189 treated explants, SMA expression 
was restricted to the peripheral cells and was greatly diminished in intensity 
compared to TGFβ1-treated cultures. In contrast, treatment of proepicardial 
explants with DMH1 resulted in the greatest inhibition of epithelial sheet 
migration. At the same time, DMH1 treated outgrowths displayed the highest 
level of SMA expression, with abundant numbers of positive cells at the periphery 
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Figure 2.11 Epicardial cells express BMP factors that regulate 
epicardial behaviors. (a) Epicardial cells express a multitude of BMP 
mRNAs when assayed by RT-PCR. (b) Only BMP6 expression level was 
significantly increased after TGFβ1 treatment when assayed by QRT-PCR. 
(c,d,f,g) Epicardial cells treated with TGFβ1 and noggin (200ng/mL) 
inhibited epicardial sheet migration significantly when compared to 
untreated, TGFβ1-stimulated epicardial sheets. (e) Epicardial cells treated 
with BMP2, only, stimulated sheet migration with a rate equivalent to 
TGFβ1 stimulated sheets. (f-h) Similar to BMP2, Epicardial cells stimulated 
with BMP6 in medium did not express SMA when compared to TGFβ1 
stimulated cells. However, BMP6 treatment enhanced sheet migration to a 
rate equivalent to TGFβ1 stimulated sheets. [(p=0.92). n=40 images; Scale 
bar=50µm; *p≤0.001; ^p≤0.001 from TGFβ1 treated]. 
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and within the sheet itself (Figure 2.10, panel k). These data corroborate our 
previous studies using adult epicardial cell lines and suggest that BMP signaling 
is required for epicardial sheet migration while having minimal, or even perhaps a 
permissive effect on SMA expression. The specific inhibition of sheet migration 
from both clonal epicardial cells and native embryonic tissue further 
demonstrates the efficacy of DMH1 in perturbation of a single behavior while 
leaving other functions unaffected. 
 
BMPs are Expressed by Epicardial Cells and Regulate Cellular Behaviors  
The present study suggests that TGFβ and BMP signaling cascades have 
both interdependent and independent roles governing epicardial development. 
While TGFβ and BMP signaling could display some cross-talk amongst 
transduction molecules after receptor activation, the most parsimonious 
explanation of this result is that BMPs are made by epicardial cells, and work 
together with exogenously applied TGFβ to regulate sheet migration. Indeed, 
previous work has shown that both epicardium and compact myocardium 
produce TGFβ ligands and BMPs (van Wijk et al, 2009; Ishii et al, 2010; Olivey 
and Svensson 2010). To determine whether epicardial cells express BMPs, 
cultures were incubated in medium for 24 hours and assessed by RT-PCR. As 
seen in Figure 2.11, panel a, a myriad of BMPs were detected under basal 
conditions. In subsequent studies to quantify BMP expression using QRT-PCR, 
TGFβ1 treatment enhanced expression of BMP6 only (Figure 2.11, panel b).  
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Finally, although epicardial cells make BMP growth factors, it is possible, due to 
effector cross-talk between TGFβ ligand and BMP signal receptors, that BMP 
ligands are not required to stimulate sheet migration. Previous studies indicate 
that while TGFβ and BMP-induced signaling cascades are often independent, 
TGFβ may activate BMP receptors (Olivey et al, 2005; Guo and Wang 2009). To 
test whether BMP itself is a stimulating ligand, the classic BMP extracellular 
sequestering molecule, Noggin (Zimmerman et al, 1996), was used to remove 
any endogenously produced BMP ligands. Wounded epicardial sheets stimulated 
by TGFβ1 and treated with Noggin had a significant reduction in sheet migration 
when compared to TGFβ1 treatment alone (Figure 2.11, panel d, g). This result 
was similar to, but not as pronounced as, the reduction observed with DMH1 
treatment (Compare Figure 2.11, panel g with Figure 2.6, panel a). Thus, Noggin 
and DMH1 both inhibit extracellular stimulation of BMP receptors, but DMH1 has 
greater efficacy and specificity for sheet migration. In a complementary 
experiment, application of the canonical BMP pathway-activating protein, BMP2, 
enhanced epicardial sheet migration rate beyond that observed with endogenous 
levels of BMP (Figure 2.11, panels e, g). This differs from the effect of BMP2 on 
SMA expression, where addition of the growth factor had no stimulatory effect 
(Figure 2.3, panel n). Finally, as TGFβ1 treatment enhanced BMP6 expression, 
this molecule was tested for effects on SMA expression and sheet migration. As 
observed with BMP2 treatment, BMP6 had no effect on smooth muscle 
differentiation (Figure 2.11, panels h-j), but strongly enhanced sheet migration 
(Figure 2.11, panel k), suggesting that BMP2 and 6 have similar stimulatory 
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functions in this system. Interestingly as shown above, BMP2 and 6 have no 
effect on single cell migration (Figure 2.9, panels b-d).  Taken together, these 
data indicate that extracellular BMP growth factors are required to stimulate 
epicardial sheet migration in conjunction with TGFβ.  
 
Conclusion 
Here, we present simple, highly reproducible screens to identify SOM 
perturbagens of epicardial behaviors. Further, we have characterized selected 
compounds to precisely detail their molecular specificity and have identified 
important new targets of the widely used DM and LDN-193189 molecules. With 
these reagents, it was possible to determine their potential intervention in three 
concurrent epicardial behaviors.  Specifically, we demonstrate the broad 
requirement for TGFβ in epicardial differentiation, sheet movement and single 
cell migration, while determining that BMP signaling is essential for only sheet 
movement, with little to no impact on the two other functions. Together, these 
data illustrate that well-characterized analog families of SOMs are valuable tools 
to intervene on specific behaviors in multi-faceted systems. Additionally, we are 
the first to show cooperative regulation of epicardial sheet migration by the TGFβ 
and BMP signaling cascades. Using the DM analog family permitted a co-
analysis of multiple signaling factor contributions to this epicardial behavior. 
During development, cells respond concurrently to a myriad of signals. It is highly 
probable that multiple signal cascades can and do contribute to the regulation of 
a single behavior.  Developing tools like the DM analog family will permit the 
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identification of cooperative regulation of epicardial development, which might 
have been overlooked using less sensitive perturbation techniques.  
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CHAPTER III 
 
IDENTIFICATION OF A NOVEL BVES FUNCTION: 
REGULATION OF VESICULAR TRANSPORT 
 
This chapter was published under this title in EMBO Journal on January 
7th, 2010 (Hager et al, 2010).  
 
Abstract 
Blood vessel/epicardial substance (Bves) is a transmembrane protein that 
influences cell adhesion and motility through unknown mechanisms. We have 
discovered that Bves directly interacts with VAMP3, a SNARE protein that 
facilitates vesicular transport and specifically recycles transferrin and β-1 integrin. 
Two independent assays document that cells expressing a mutated form of Bves 
are severely impaired in the recycling of these molecules, a phenotype consistent 
with disruption of VAMP3 function. Using Morpholino knockdown in Xenopus 
laevis, we demonstrate that elimination of Bves function specifically inhibits 
transferrin receptor recycling, and results in gastrulation defects previously 
reported with impaired integrin-dependent cell movements. Kymographic 
analysis of Bves-depleted primary and cultured cells reveals severe impairment 
of cell spreading and adhesion on fibronectin, indicative of disruption of integrin-
mediated adhesion. Taken together, these data demonstrate that Bves interacts 
with VAMP3 and facilitates receptor recycling both in vitro and during early 
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development. Thus, this study establishes a newly identified role for Bves in 
vesicular transport and reveals a novel, broadly applied mechanism governing 
SNARE protein function. 
 
Introduction 
Vesicular transport is a conserved process where membrane bound 
vesicles transfer material within the cell and to the cell surface. Protein trafficking 
and recycling through vesicles is crucial for a myriad of processes including 
membrane receptor localization and cell motility. Membrane trafficking consists of 
both the endocytic and exocytic pathways that modulate receptors, ligands, and 
molecules that are present on the cell surface. While much is known about this 
process, identification of novel regulators is essential for a comprehensive 
understanding of the role vesicular transport plays in a broad spectrum of cell 
functions. 
There are four essential steps of membrane trafficking: vesicle budding, 
transport, tethering, and fusion (Grosshans et al, 2006; Cai et al, 2007). Coat 
proteins and adaptor proteins select vesicle cargo and facilitate the initial step of 
vesicle budding (Cai et al, 2007; Mellman and Nelson 2008). Rab GTPases and 
motor proteins primarily transport vesicles to the target membrane; however 
there is accumulating evidence that Rab GTPases participate in every aspect of 
protein trafficking from budding to docking. (Segev 2001; Grosshans et al, 2006; 
Pfeffer 2007). Vesicle tethering is carried out by a diverse set of multi-subunit 
proteins (Grosshans et al, 2006). The final step in membrane trafficking is carried 
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out by SNARE proteins, which facilitate fusion of intracellular vesicles to the 
membrane (Brunger 2005; Jahn and Scheller 2006; Leabu 2006). There are 
three families of SNARE proteins: vesicle-associated membrane proteins 
(VAMPs); membrane proteins located on the target membrane (syntaxins); and 
target membrane localized synaptosomal associated proteins (SNAPs) (Brunger 
2005; Jahn and Scheller 2006; Leabu 2006). These proteins interact to form a 
SNARE complex via their coiled-coil SNARE domains (Brunger 2005; Leabu 
2006).  
 Vesicle-associated membrane protein 3 (VAMP3) is a ubiquitously 
expressed vesicular SNARE protein that binds syntaxin 4 in the basolateral 
region of epithelial cells to tether vesicular cargo to the membrane (Fields et al, 
2007). VAMP3 recycles specific receptors to and from the plasma membrane 
through the recycling endosome (RE) (Galli et al, 1994; Breton et al, 2000; 
Polgar et al, 2002; Borisovska et al, 2005). VAMP3 has an established role in the 
recycling of transferrin and low-density lipoprotein receptor (LDLR), and is 
required for specific sorting through Adaptor Protein, 1B (McMahon et al, 1993; 
Fields et al, 2007). Disruption of VAMP3 results in the aberrant localization of 
both transferrin and LDLR. Overall, VAMP3 is necessary for efficient transport of 
cargos, which subsequently act to mediate distinct cellular functions. Several 
studies have shown that VAMP3 is also required for cellular movement through 
the trafficking of β-1 integrins. Disruption of VAMP3 results in reduced migration 
rate in wounded epithelial cells and slower cellular spreading on different 
substrates, as β-1 integrin recycling is impaired (Proux-Gillardeaux et al, 2005; 
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Skalski and Coppolino 2005; Tayeb et al, 2005; Luftman et al, 2009). Integrins 
stabilize lamellar protrusions through interactions with the ECM, and thus must 
be trafficked to the leading edge of the cell during migration (Caswell and 
Norman 2006; Caswell and Norman 2008). In development, integrin-based cell 
motility is imperative for proper morphogenesis. This is evident in gastrulation of 
Xenopus laevis (X. laevis), where integrin adhesion to fibronectin (FN) underlies 
mesodermal migration and subsequent formation of the head and trunk (Ramos 
and DeSimone 1996).  
 Blood vessel/epicardial substance (Bves) is a highly conserved member of 
the Popdc family of proteins (Hager and Bader 2009). Bves exists as a dimerized 
three-pass transmembrane protein with an extracellular glycosylated N-terminus 
and an intracellular self-associating C-terminal tail (Knight et al, 2003; Kawaguchi 
et al, 2008). Within the C-terminus is the highly conserved Popeye domain, 
although no specific function has been linked to this motif (Brand 2005; Osler et 
al, 2006). A wide variety of adherent tissues express Bves including all three 
muscle types and various epithelia (Andrée et al, 2000; Osler and Bader 2004; 
Ripley et al, 2004; Vasavada et al, 2004; McCarthy 2006; Osler et al, 2006; 
Smith and Bader 2006; Torlopp et al, 2006). Bves localizes to the lateral region 
of the plasma membrane of epithelial cells, overlapping the distribution of 
junctional molecules such as E-cadherin, ZO-1, and Occludin (Osler et al, 2005; 
Osler et al, 2006). In smooth, skeletal, and cardiac muscle Bves is observed 
around the circumference of cells (Smith et al, 2008). Intracellular punctate 
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distribution is also observed in both polarized monolayers and unpolarized 
individual cells in vitro. 
 Disruption of Bves leads to a wide range of cell phenotypes in both 
vertebrates and invertebrates, the majority of which remain poorly understood at 
the molecular level. The trans-epithelial resistance of polarized epithelial cells is 
significantly decreased when Bves protein is knocked down, and junctional 
proteins such as E-cadherin, ZO-1, and β-catenin fail to traffic to points of cell-
cell contact (Osler et al, 2005). Although Bves may play a role in localizing or 
stabilizing proteins at the membrane, the mechanism by which Bves functions in 
epithelial biogenesis remains completely unknown.   
Most recently, Bves has been shown to interact with a Rho GEF, Guanine 
Nucleotide Exchange Factor T (GEFT) (Smith et al, 2008). GEFT specifically 
activates Rac1 and Cdc42 to initiate filopodia and lamellipodia extension through 
rearrangement of the actin cortical network (Guo et al, 2003; Bryan et al, 2004; 
Bryan et al, 2006). Disruption of Bves function results in increased cell roundness 
coupled with decreased activity of Rac1 and Cdc42, indicating decreased 
protrusion extension. Bves disruption also results in decreased cell movement, 
which is consistent with decreased Rac1 and Cdc42 activity (Smith et al, 2008). 
However, the exact mechanism by which Bves regulates GEFT remains 
unexplained.  
Finally, Bves has been studied in the context of X. laevis gastrulation, 
where Bves is the only Popdc family member expressed (Ripley et al, 2006; 
Hager and Bader 2009). Frog gastrulation is highly dependent upon cellular 
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migration via integrin recycling (Ramos and DeSimone 1996; Ramos et al, 1996; 
Marsden and DeSimone 2001; Davidson et al, 2006), and protein knockdown 
suggests that Bves is necessary for cell movement (Ripley et al, 2006). Again, no 
prior data demonstrate the precise molecular and cellular mechanism underlying 
Bves function in X. laevis.  
An emerging theme is that vesicular transport may underlie the essential 
biological processes in which Bves is involved: cell-cell adhesion, movement, 
and epithelial biogenesis. However, little is known about the mechanism by which 
Bves functions in these diverse yet fundamental processes. As inhibition of Bves 
function disrupts vital membrane functions and possibly vesicular transport, we 
conducted a split-ubiquitin screen to identify potential protein-protein interactions 
at the cell membrane. Here we report that Bves interacts with the SNARE protein, 
VAMP3, and that disruption or depletion of Bves results in impaired VAMP3-
mediated vesicular transport. From these data, we hypothesize that Bves 
influences VAMP3 function to affect multiple cellular behaviors and suggest that 
a role for Bves in the general process of vesicular transport may explain the 
varied nature of previously reported phenotypes.    
 
Materials and Methods 
For all assays below data was analyzed with Microsoft Excel and error 
bars indicate standard deviation (SD); student t-tests were standard.  
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Antibodies, Constructs, Cell Lines, Tissue Processing, and Protein Harvest  
VAMP3-GFP and VAMP2-GFP were generous gifts from Dr. W Trimble 
(University of Toronto) (Bajno et al, 2000). Rescue RNA that is mutated in the 
MO binding site was used for X. laevis experiments as reported (Ripley et al, 
2006). Rat VAMP3 was cloned into pCMV-3tag-4A, and RNA synthesized with 
mMESSAGE mMACHINE (Ambion). Bves antibodies SB1 and B846 were 
reported (Wada et al, 2001; Smith and Bader 2006). All other antibodies and 
reagents were obtained commercially as follows: Anti-VAMP3 (Novus Biologicals, 
NB300-510 and Santa Cruz, sc-18208, clone N-12); Anti- β-1-FITC (BD 
Pharmingen, clone Ha 2/5 555005); Anti-CD29 (BD Transduction Laboratories, 
clone 18, 610468); Anti-CD29 (BD Transduction Laboratories, clone Ha 2/5, 
555003); Anti-8C8 supernatant (X. laevis β-1 integrin) (Developmental Studies 
Hybridoma Bank); Anti-GFP (Clonetech, JL8); Anti-myc (Sigma, M4439 and 
C3956); Anti-GST (GE Healthcare); and Phalloidin-488 and 568 (Molecular 
Probes). MDCK cells were obtained from ATCC. Tissue processing and western 
blotting followed standard protocols (Ripley et al, 2006). 
 
Split-Ubiquitin Screen  
A split-ubiquitin screen was conducted by Dualsystems (Zurich, 
Switzerland). Full-length mouse Bves was cloned into pCCW-Ste and screened 
against a mouse adult heart library cloned into pDSL-Nx. VAMP3 passed all 
selection tests. 
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GST-pulldown and Co-IP  
Lysates were prepared as follows: COS-7 cells were transfected with 
either VAMP3-GFP alone or both VAMP3-GFP and Bves-myc and confluent 
monolayers harvested by rocking at 4° for one hour in CHAPS buffer (50mM Tris 
HCl pH 8.0, 150mM NaCl, 10mM EDTA, 1% CHAPS) plus protease inhibitors 
(Roche, 11697498001). Lysates were collected and spun down at 18,000 x g for 
30 minutes at 4° C. Co-IPs were conducted using Protein G Magnetic 
Dynabeads and a Dynal MPC Magnet as per manufacturer’s instructions 
(Invitrogen). Bves-GST-Pulldowns of VAMP-GFP proteins were conducted as 
previously published (Smith et al, 2008); western blots were standard. 
 
Generation of Stable Cell Lines  
The extracellular and transmembrane domains of mouse Bves (amino 
acids 1-118; referred to as Bves118) were cloned in frame into pCMV-3myc-4A 
(Stratagene). Bves118 was nucleofected into MDCK cells according to 
manufacturer’s specifications (Amaxa). Three individual clones were selected 
and then maintained in 400µg/mL of G418. RT-PCR and immunofluorescence 
confirmed the expression of stably transfected tagged proteins (Figure 4.18). Cell 
lines expressing wildtype or mutant Tetanus toxin, WT TeNT and mut-TeNT, 
respectively have been described (Proux-Gillardeaux et al, 2005). 
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Transferrin Assays  
MDCK cells: Uptake of Alexa-633 or Alexa-488 labeled transferrin 
(Invitrogen, T23362, T13342) was assessed using flow cytometry. Briefly, cells 
that had been passaged three times were incubated in DMEM and 0.2% BSA for 
2 hours at 37° C and then incubated for 30 minutes with 50ug/mL of labeled 
transferrin at 4° C in the dark. Cells were allowed to internalize labeled transferrin 
at 37°C for the indicated times, and then washed 4X with ice cold PBS on ice. 
Cells were probed for Mean Fluorescence Intensity (MFI) using a BD FACS 
Canto II; data were acquired with Diva 6.0, analyzed with WinList, and are 
reported as the average MFI from four different experiments.  
Animal Caps: Internalization of labeled transferrin-633 (Invitrogen T23362) 
in animal caps was measured in a T-format spectrofluorometer (PTI 
Quantamaster 2000-7SE).  Animal caps were dissected at stage 9-10 in 1X 
Modified Barth’s saline (MBS) and 0.1% BSA and then serum starved in agar-
coated dishes for 2 hours in 1X MBS. Caps were incubated with 50µg/mL of 
transferrin-633 for 30 minutes at 4° C in the dark, and then allowed to uptake 
transferrin-633 for 25 minutes (first five minutes at 37° C; last 20 minutes at room 
temperature with gentle agitation). Caps were washed 5X with cold 1X MBS on 
ice, briefly spun down at 8,000 x g at 4° C, and then 4 caps/well were solubilized 
by vortexing for 15 seconds in 0.2 mL of 0.25% Triton X-100 in PBS. Protein was 
harvested by centrifuging at 15,000 x g for 5 minutes, and the supernatant was 
analyzed for fluorescence (excitation = 488; emission = 633). Protein 
concentration of the animal caps was determined using a BCA assay (Thermo 
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Scientific 23227) and fluorescent units/µg of protein determined. For side by side 
comparison of control and experimental models, Bves MO, Bves MOR, VAMP3 
MO and VAMP3 MOR data are reported as a percentage of the control (COMO). 
 
Scratch Assay  
A scratch assay was performed and scored for the amount of internalized 
β-1 integrin according to Proux-Gillardeaux et al. For scratch assays that directly 
compared TeNT cells and Bves118 cells, CD29 was conjugated to Alexa-564 
(Molecular Probes) and conducted in triplicate. 
 
Cell Spreading Assay in MDCK Cells  
Cell spreading was defined as the increase of cell area over time prior to 
polarized cell movement. One day before cell spreading analysis, cells were 
plated at single cell density so that they would be contact naïve at the time of the 
assay. On the day of image acquisition, cells were trypsinized and plated at 
single cell density on MatTek dishes (MatTek Corporation) coated with 25µg/mL 
of FN Sigma (F4759). Attached yet rounded cells were chosen 45 minutes after 
plating and DIC images acquired with a temperature and CO2-controlled 
WeatherStation as part of a DeltaVision platform (Precision Control). Images 
were obtained with an Olympus IX71 inverted microscope and a CoolSNAP-HQ2 
CCD camera using the 40X objective at intervals of one minute for one hour. 
Image deconvolution was carried out with the SoftWorx software. Metamorph 6.0 
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was used to determine cell area and construct kymographs from DIC images 
every tenth minute. 
 
X. laevis Embryos  
Female X. laevis were obtained from Nasco, primed, and fertilized by 
standard methods (Ripley et al, 2006). Images of appropriately staged embryos 
(Nieuwkoop and Faber 1994) were captured with Magnafire (Olympus America 
Diagnostics). 
 
Microinjection and Morpholino Treatment  
Embryos were microinjected with 5nL into both cells at stage 2; embryos 
were injected in 5% Ficoll in 1X Steinberg’s Solution (SS), then switched to 0.1X 
SS before gastrulation. Bves MO, VAMP3 MO, or COMO were injected into sister 
embryos along with mGFP or mRFP (1.5ng) as a tracer at a concentration of 
20ng (stage 35-42 analysis only) or 40ng/embryo (Gene Tools, LLC) (Wallingford 
et al, 2000; Ripley et al, 2006). For transferrin assays, 100pg of Rescue RNA 
(described above) was co-injected along with Bves MO or VAMP3 MO. Xbves 
Rescue RNA has been reported previously (Ripley et al, 2006) and is mutated in 
the MO binding sequence, thus not recognized by Bves MO. The most 
successful MO for knockdown of X. laevis VAMP3 was designed against the 5’ 
UTR, approximately 20 base pairs upstream from the ATG site: 
GGACACCGGTCCGACTTTACTC (Gene Tools, LLC). Note this sequence is 
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perfectly conserved with Xenpus tropicalis, but has no conservation with rat 
VAMP3 (EST databases). 
 
SEM  
Embryos were fixed and processed for SEM with standard methods and 
HM was dissected out (the overlying BCR was peeled away from this region to 
expose cells that are attached to FN) with eyebrow knives. SEM images were 
quantified as follows: cells were chosen from random fields from ten different 
embryos and measured for cellular overlap and polarity using the leading edge 
as a reference point. Overlap was defined as the number of overlapping cell 
bodies or lamellipodia for each selected cell. Polarity was determined by defining 
the length/width axis (longest axis of the cell intersected perpendicularly by the 
widest part of the cell), measuring the deviation of this axis from a set point, and 
then averaging the standard deviations from the defined point. 
 
X. laevis Microdissections, Adhesion Assays, and Spreading Assays 
Microdissections of X. laevis embryos were carried out according to (Ren 
et al, 2006). Explants were disassociated in Ca2+ Mg2+ free MBS and single cells 
were plated in MBS on slides (for adhesion assays; LabTek) or on Mat Tek 
dishes (for spreading assays) coated with 200µg/mL of FN (Sigma F4759). 
Explants from several embryos (control or experimental) were pooled and plated 
for either adhesion or spreading assays. 
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Adhesion assays on FN were conducted and scored as described (Ramos 
et al, 1996). Cells were cultured for two hours, washed three times in MBS to 
remove non-adhered cells, fixed in PFA overnight at 4° C, labeled with Phalloidin, 
and imaged with a Zeiss Inverted LSM 510 Confocal Microscope using a 40X 
objective. Round cells are attached to the plate and spherical, while spread cells 
are elongated and had two or more lamellipodia as previously defined (Ramos et 
al, 1996). 
For spreading analysis, time-lapse images were obtained with the 
DeltaVision platform. Movies of mGFP or mRFP labeled cells were imaged over 
a 35 minute timeframe with fluorescent and DIC images being collected every 
minute. The point of cell/matrix interaction was used as the focal point in 
obtaining these images. Quantification of lamellipodia and cell spreading are as 
follows: for at least 12 different cells, the average number of lamellipodia (defined 
here as 10 µm extensions devoid of yolk granules with distinct matrix attachment 
sites) was determined for ten time points at three minute intervals over the period 
of culture for both control and experimental groups. Metamorph 6.0 was used to 
analyze every third frame to determine the cell area and construct kymographs.  
 
Results 
Bves interacts with VAMP3  
Given the protein distribution of Bves, and previously reported phenotypes, 
we conducted a split-ubiquitin screen to detect Bves-interacting membrane 
proteins with characterized functions in cell movement (Dünnwald et al, 1999). 
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VAMP3, a SNARE protein that facilitates the fusion of apposing membranes 
during vesicular transport (McMahon et al, 1993), was identified as a binding 
partner in this screen. Importantly, VAMP3 transports membrane proteins, and is 
required for the vesicular transport underlying cell motility (Galli et al, 1994; 
Proux-Gillardeaux et al, 2005; Skalski and Coppolino 2005; Tayeb et al, 2005). 
As Bves is also required for cell motility, and VAMP3 has a known function in this 
process, we chose to probe this interaction further.  
 To confirm this result, we determined if Bves and VAMP3 proteins interact 
biochemically using co-immunoprecipitation (co-IP) and GST-pulldown assays. 
As seen in Figure 3.1A, VAMP3 was precipitated with Bves. Additionally, GST-
pulldown assays demonstrated a specific interaction between Bves and VAMP3, 
localized to the intracellular C-terminal Popeye domain (Figure 3.1B). 
Figure 3.1 Bves and VAMP3 interact. For Co-IP (A), COS-7 cells were 
transfected with tagged proteins: VAMP3-GFP alone, or VAMP3-GFP and full 
length Bves-myc. Cell lysates were pulled down with myc and blotted for 
GFP. In GST pulldown assays (B), the C-terminus of Bves fused to GST 
(GST-CT) was sufficient to pulldown transfected VAMP3-GFP from COS-7 
cell lysate. Loading controls (lysate in A and LC in B) are shown for 
comparison. 
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Interestingly, Bves also interacts with VAMP2 via GST-pulldown (Figure 3.2) 
VAMP2 and VAMP3 are highly homologous, with only one amino acid difference 
in their SNARE binding domain (McMahon et al, 1993), suggesting a conserved 
interaction between Bves and SNARE proteins. Taken together, these data 
confirm the direct interaction of Bves through its cytoplasmic tail with VAMP3. 
 
Bves and VAMP3 co-localize  
Bves and VAMP3 exhibit similar dynamic distributions that are both at the 
cell periphery and in intracellular compartments (Osler et al, 2005; Hager and 
Bader 2009). Co-localization in Madin-Darby Canine Kidney (MDCK) cells of 
endogenous Bves (Figure 3.3A) and exogenously expressed VAMP3-GFP 
(Figure 3.3B) is readily observed both at the cell periphery and in intracellular 
vesicles (merge in Figure 3.3C, arrows). While overlap is extensive, it is not 
complete, as some intracellular vesicles labeled with Bves are not co-labeled 
with VAMP3. Examining endogenous localization in confluent epithelial sheets, 
Figure 3.2 GST pulldown demonstrates Bves and VAMP2-GFP interact 
biochemically. Loading control (Lane 1) detects the mobility of VAMP2 by 
immunoblotting. GST alone does not interact with VAMP2 above background 
(Lane 2). The C-terminus of Bves fused to GST was sufficient to pulldown 
transfected VAMP2-GFP from COS-7 cell lysate (Lane 3), demonstrating this 
intracellular portion of the protein binds VAMP2-GFP, in addition to VAMP3-
GFP. Lane 1. VAMP2-GFP Loading Control ; Lane 2. GST/VAMP2-GFP; Lane 
3. GST-CT/VAMP2-GFP. 
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Bves (Figure 3.3D) and VAMP3 (Figure 3.3E) co-localized in the lateral portion of 
MDCK cells and staining is also observed in intracellular vesicles (merge in 
Figure 3.3F, arrows). These data confirm that overlap of these two proteins is 
consistent with their previously reported endogenous distribution profile (Osler et 
al, 2005; Fields et al, 2007). Disruption of VAMP3 function (detailed below) 
resulted in a significant decrease in the presence of Bves at the cell membrane 
(Figure 3.4) while expression of a truncated Bves lacking the VAMP3 binding 
domain (also detailed below) produced only minor changes in protein distribution. 
While VAMP3 is ubiquitously expressed across all non-neuronal tissue 
types, Bves is present at high levels in muscle as well as in other adherent or 
excitable tissues (McMahon et al, 1993; Hager and Bader 2009). Thus, we 
characterized endogenous protein distribution in mouse heart and skeletal 
muscle to probe for colocalization. Significant co-localization was observed in 
Figure 3.3 Bves and VAMP3 co-localize in MDCK cells. Both endogenous 
Bves (A) and transfected VAMP3-GFP (B) are observed at the membrane and 
in vesicles. The endogenous distribution of both proteins also demonstrates 
this same localization pattern (Bves, D; VAMP3, E), and Bves and VAMP3 co-
localize at both of these subcellular locations (arrows, C, F). Scale bars are 
5µm. 
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both muscle types, although overlap was not absolute (Figure 3.5). Co-
localization was seen primarily at the circumference of the myocytes, with certain 
muscle cells demonstrating more intense labeling (Figure 3.5C, G, white arrows). 
Intensity profiles (Figure 3.5D, H) of both Bves and VAMP3 signal demonstrate 
the high degree of co-localization (Figure 3.5C, G; red arrows indicate area of 
intensity profile). As Bves and VAMP3 both interact and co-localize, we next 
focused on functional assays to determine the potential importance of this 
interaction.  
Figure 3.4 Bves localization in TeNT cell lines. In mut-TeNT cells, which 
express VAMP3-GFP (C), Bves (red) localization is seen intracellularly and at 
the membrane in confluent epithelial sheets (A, arrows). However, 
whenVAMP3-GFP is cleaved by wildtype Tetanus toxin (D), Bves localization 
is reduced at the membrane, although intracellular labeling is still visible (B).  
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Transferrin recycling is attenuated in cells with disrupted Bves function 
VAMP3 is required for recycling of transferrin, as cleavage of VAMP3 
disrupts vesicular transport of this receptor (McMahon et al, 1993; Galli et al, 
1994). To identify the potential role of Bves in VAMP3-dependent recycling using 
a standard transferrin uptake assay, we developed an MDCK cell line that stably 
expresses only the first 118 amino acids of Bves (Bves118). Bves118 lacks the 
intracellular VAMP3-binding domain and contains only the short extracellular and 
transmembrane domains. Transferrin endocytosis was analyzed at 5, 10, and 20 
minutes (Figure 3.6A), and the mean fluorescence intensity (MFI) was analyzed 
in MDCK and Bves118 cells. At 5 minutes internalization, average MFI (which 
directly correlates to the amount of endocytosed transferrin) for MDCK cells was 
46.53, whereas Bves118 cells had an average MFI of 16.41, demonstrating 
decreased uptake of labeled transferrin. This trend continued at 10 and 20 
minutes internalization with Bves118 cells having severely decreased 
Figure 3.5 Endogenous Bves and VAMP3 co-localize in muscle. Bves (A, 
E) and VAMP3 (B, F) are seen at the cell periphery in adult cardiac (A-C) and 
skeletal muscle (E-G). Areas of intense co-localization are denoted by the 
white arrows (C, G). Red arrows indicate the area of the fluorescent intensity 
profile for cardiac (D) and skeletal muscle (H). Scale bars are 20µm.  
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internalization of labeled transferrin relative to MDCK cells (5 minutes: p <0.001; 
10 minutes: p <0.003; 20 minutes: p <0.0036). Disruption of transferrin kinetics 
was also demonstrated by a recycling assay, as labeled transferrin was 
exocytosed from Bves118 cells more slowly compared to controls (Figure 3.7). 
This phenotype is consistent with disrupted VAMP3 function and supports the 
hypothesis that Bves-VAMP3 interaction is necessary for VAMP3-mediated 
vesicular transport.  
To corroborate and extend these studies with an in vivo model and directly 
compare the effects of transferrin recycling between Bves- and VAMP3-depleted 
embryos, we used a Morpholino (MO) knockdown and rescue strategy in X. 
laevis (Ripley et al, 2006). Embryos were injected with Bves MO, VAMP3 MO, or 
Control MO (COMO); alternatively, sister embryos were co-injected with Bves 
Figure 3.6 Transferrin uptake is attenuated when Bves is disrupted.  
(A) MDCK and Bves118 cells internalized labeled transferrin for 5, 10, or 20 
minutes. Transferrin uptake, as measured by the MFI, was significantly 
decreased in Bves118 cells at all time points. (B) When normalized with 
Control values (100%), Bves MO and VAMP3 (V3) MO treated caps were 
impaired in internalization of labeled transferrin/µg of total protein. Transferrin 
uptake is restored when Bves MO or V3 MO are co-injected with rescue Bves 
(Bves MOR) or VAMP3 (V3 MOR) RNAs, demonstrating that this phenotype is 
specific to depletion of the respective proteins.  
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MO or VAMP3 MO and their respective rescue RNAs (Bves MOR, VAMP3 MOR). 
Isolated animal caps, which express the transferrin receptor (NCBI, EST 
databases), were allowed to endocytose transferrin-633 for 25 minutes and the 
fluorescent intensity (FI)/µg of animal cap protein was determined. As seen in 
Figure 3.6B, recycling of labeled transferrin in Bves MO and VAMP3 MO treated 
animal caps is severely reduced relative to COMO treated caps. When 
normalized against COMO treated caps (100%), Bves MO treated animal caps 
display only 57.2±5.06% of FI/µg, demonstrating that recycling of labeled 
transferrin is inhibited when Bves is depleted (Table 2). Similarly, VAMP3 MO 
treated caps internalize 60.4±9.9% of labeled transferrin relative to COMO (Table 
2). This reduction in recycling of labeled transferrin in animal caps is completely 
dependent upon knockdown of Bves or VAMP3, as these phenotypes are 
Figure 3.7 Transferrin Recycling in Bves118 cells. MDCK or Bves118 cells 
were serum starved for three hours in DMEM plus 0.2% BSA at 37° C, and 
then allowed to uptake Transferrin-633 (25µg/mL) for 60 minutes at 37° C. 
Cells were then washed 4X on ice with cold PBS with 0.1% BSA and 
incubated in DMEM plus 0.2% BSA with 5mg/mL of unlabeled APO transferrin 
for 20 minutes at 37° C. After the twenty minute chase with unlabeled 
transferrin, cells were probed for MFI using a MACSQuant flow cytometer 
(Miltenyi Biotech). It was found that Bves118 cells had a higher MFI (94.1±33) 
than MDCK cells 75.3±28, indicating that exocytosis of transferrin, a process 
mediated by VAMP3, was impaired in cells expressing mutated Bves.  
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rescued in caps co-injected with Bves rescue RNA along with Bves MO, or 
VAMP3 rescue RNA along with VAMP3 MO (Bves MOR: 96.8±4.57% and 
VAMP3 MOR: 94.9±12.14% of FI/µg relative to COMO treated caps; Table 2). 
Taken together, these two independent methods demonstrate that recycling of 
transferrin is attenuated after Bves disruption, suggesting that VAMP3-mediated 
transport is dependent on Bves function.  
 
VAMP3-mediated recycling of β-1 integrin is impaired in cells expressing 
mutated Bves  
VAMP3 function is necessary for the recycling of β-1 integrin during cell 
movement (Proux-Gillardeaux et al, 2005; Skalski and Coppolino 2005; Tayeb et 
al, 2005; Luftman et al, 2009). Proux-Gillardeaux et al. have reported an in vitro 
scratch assay that directly tests VAMP3-mediated recycling of β-1 integrins by 
quantifying its recycling over time; we adapted this method by using β-1 integrin 
labeled with FITC.  In wildtype MDCK cells, 59.6 ±5% of cells at the free edge of 
the wound were positive for labeled integrin (Figure 3.8A-C; Table 3). Bves118 
cells showed a dramatic decrease in endocytosed FITC-labeled integrins (Figure 
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3.8D-F). Note the limited number of Bves118 cells with internalized FITC-labeled 
integrin (35.5±5%) as compared to wildtype MDCK cells (Figure 3.8G; Table 3, p 
<0.0001) even though β-1 integrin protein levels remain the same (Figure 3.8H). 
Figure 3.8 Cells stably expressing mutated Bves have decreased integrin 
recycling. A wounded monolayer of MDCK cells (A-C) internalized FITC 
labeled β-1 integrin antibody (panel A, arrows: intracellular labeling) as cells 
migrated to close the wound. β-1 integrin recycling is visualized by the 
presence of FITC-labeled protein in intracellular compartments. In Bves118 
cells, integrin recycling was attenuated (D-F), as seen by decreased 
intracellular punctate labeling, although integrin expression levels of Bves118 
cells are consistent with MDCK cells (H). This decrease in integrin 
internalization is also seen when directly compared to WT TeNT and mut-
TeNT cells (G; SI Fig 6). Cells marked with an asterisk (C, F), were counted as 
integrin positive in quantification (G, Table 3). Scale bars are 20µm.  
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To confirm that disruption of Bves does in fact phenocopy disruption of VAMP3, 
we repeated this assay using β-1 integrin antibody (CD29, clone Ha 2/5) 
Figure 3.9 Integrin internalization in cells expressing mutated Bves and 
VAMP3. As demonstrated in Figure 4.8, Bves118 cells have decreased 
internalization of β-1 integrin-FITC when induced to migrate. To verify this 
result, we directly compared Bves118 cells uptake of β-1 integrin-Alexa-564 
with cells without VAMP3. As Tetanus toxin selectively cleaves VAMP1-3 
(McMahon et al., 2003), Proux-Gillardeaux et al., 2005 utilized this property to 
create cell lines without VAMP3, which we used here. In our hands, 62.4±16% 
of MDCK cells expressing VAMP3-GFP and mutated and inactive form 
Tetanus toxin (mut-TeNT were positive for internalized β-1 integrin; visualized 
by the punctate intracellular labeling of VAMP3-GFP, panel D). Note that the 
mutated toxin serves as a positive control as VAMP3 remains intact. In 
contrast, MDCK cells expressing VAMP3-GFP and wild type Tetanus toxin 
(WT TeNT) display a diffuse intracellular labeling due to the of cleavage of 
VAMP3-GFP (panel E). When expressing the WT TeNT, only 40.8±2% of cells 
were positive for internalized β-1 integrin (B). This decrease in integrin 
internalization was reported previously in Proux-Gillardeaux et al., 2005. In a 
side-by-side comparison, 37.8±7% of Bves118 cells were positive for 
intracellular integrin labeling (panel C), demonstrating that β-1 integrin 
internalization is attenuated in Bves118 cells, with similar internalization rates 
as cells without VAMP3. Data is quantified in Table II.  
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conjugated to Alexa-564, and directly compared cells expressing wildtype 
Tetanus toxin (WT-TeNT, which effectively cleaves VAMP3, rendering it unable 
to transport integrin) with Bves118 cells. Using the exact cell line in which 
disrupted integrin recycling upon VAMP3 knockdown was first reported (Proux-
Gillardeaux et al, 2005), along with the control cell line that expresses mutant 
inactive Tetanus neurotoxin (mut-TeNT), we determined that in a side-by-side 
comparison, 37.8±7 % of Bves118 cells and 40.8±2% WT TeNT cells internalized 
labeled integrins, while 62.4±16% of mut-TeNT cells were positive for integrin 
internalization (Figure 3.8G; Figure 3.9). Additionally, internalized β-1 integrin co-
localized with both Bves and VAMP3 antibodies (Figure 3.10), supporting a role 
for Bves and VAMP3 in recycling of integrins. These data demonstrate that 
disruption of Bves and VAMP3 result in similar phenotypes and further supports 
the hypothesis that intact Bves function is required for proper VAMP3-mediated 
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recycling of different molecules.  
Expression of mutated Bves or TeNT disrupts cell spreading  
As Bves118 and WT TeNT cells have impaired integrin uptake during cell 
movement, we determined if another integrin dependent function, cell spreading, 
was also disrupted. Cells were plated on FN at single cell density and allowed to 
adhere for 45 minutes prior to time-lapse analysis. At time 0, all four cell types, 
MDCK (Figure 3.11A), Bves118 (Figure 3.11C), mut-TeNT (Figure 3.11E), and 
Figure 3.10 Co-localization of Bves, VAMP3 and β-1 integrin. Confluent 
MDCK cells were wounded via scratch and allowed to internalize β-1 integrin-
FITC (B) as described in the methods. Antibody labeling of Bves (A) and 
VAMP3 (C) revealed these proteins co-localize with endocytosed integrins in 
individual vesicles as seen in the merged image (D, white vesicles). For better 
visualization, corresponding magnified views of panels A, B, and C of the area 
outlined in D are seen in panels a, b, c, and d. The white box surrounds three 
separate vesicles, all of which are positive for Bves, VAMP3, and β-1 integrin.  
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WT TeNT (Figure 3.11G) displayed similar areas and it was evident that cell 
protrusions were beginning to form. However, after one hour of image acquisition, 
MDCK and mut-TeNT cells (Figure 3.11A, E; Time 60) greatly increased cellular 
areas (Figure 3.11J, Table 4), 73% and 87% respectively, while Bves118 and 
WT TeNT cells (Figure 3.11C, G; Time 60) only increased cell areas by 16% and 
Figure 3.11 Cell Spreading is attenuated with disruption of Bves or 
VAMP3 function. Time-lapse analysis indicates that cell spreading, or the 
increase of area prior to polarized cell movement, is decreased in Bves118 
cells (C) compared to MDCK cells (A). Similarly, WT TeNT (G) cells have less 
cell spreading than mut-TeNT cells (E). Kymographs of cell spreading over 
time demonstrate the difference in the degree of cell spreading between 
control and experimental groups (MDCK, panel B vs Bves118, panel D; and 
mut-TeNT, panel F vs WT TeNT, panel H). Note the similarity in cell areas (I) 
and percent increase of cell area (J) between experimental groups and control 
groups as determined from composite kymographs (B, D, F, H). Scale bars 
are 20µm.  
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13%, respectively (Figure 3.11J; Table 4). Kymographs of cell spreading over 
time reveal significant differences in cell spreading between MDCK cells (Figure 
3.11B) and Bves118 cells (Figure 3.11D); as well as between mut-TeNT cells 
(Figure 3.11F) and WT TeNT cells (Figure 3.11H; Table 4). It should be noted 
that in a direct comparison of the area of cell spreading (Figure 3.11I), both 
experimental cell lines have similar areas of cell spreading (Bves: 363µm2; and 
VAMP3: 318µm2), which are significantly reduced from the areas observed in 
both control cell lines (MDCK: 2,337µm2; and mut-TeNT: 2,401µm2). Individual 
frames of composite kymographs seen in Figure 3.11B, D, F and H are given in 
Figure 3.12. These data, which are corroborated using the X. laevis system (see 
below), demonstrate that cell spreading is significantly impaired in cells with 
mutated Bves or VAMP3, suggesting that interaction of these two proteins is 
important for integrin-mediated processes.  
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Morphological defects are observed in Bves- and VAMP3-depleted X. laevis 
embryos  
Having established that Bves is required for VAMP3-mediated vesicular 
transport in vitro, we next determined the in vivo significance of this interaction. 
Gastrulating X. laevis embryos undergo extensive integrin-dependent cellular 
Figure 3.12 Individual frames of time-lapse imaging seen in Figure 4.11. As 
seen in Figure 4.11, Bves118 and WT TeNT cells have decreased cell 
spreading on FN. Cell tracings from different time points demonstrate that 
although cell area is similar in all four cell lines at the onset of image acquisition 
(panels A-D, Time 0), during the period of analysis, MDCK and mut-TeNT cell 
lines increase their cellular area more quickly than Bves118 and WT TeNT cell 
lines (panels A-D, Time 60). Individual cell tracings throughout time are shown 
here and are displayed as a composite in Figure 4.11, panels B, D, F, and H.  
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rearrangement, hence this is an advantageous system in which to analyze Bves 
function in development (Keller 1980; DeSimone et al, 2005). Bves-depleted  
Figure 3.13 Bves depletion in X. laevis embryos. Blastopore closure in 
embryos injected with Bves MO was dramatically decreased (B) in comparison 
to embryos injected with COMO (A). The blastopore is outlined in the bottom 
embryo in panels A and B for better visualization. Anterior defects are observed 
in Bves-depleted stage 35 embryos (C), characterized by disrupted eye 
morphogenesis and ectodermal outgrowths (arrows). Histological staining 
demonstrates the BCR has failed to intercalate properly, and remains thickened 
(E, arrow), whereas the BCR of control embryos has thinned (D, arrow). Also, 
the involuting HM has become detached from the BCR in Bves depleted 
embryos (E, asterisk). Integrin levels in Bves MO treated embryos (and in 
VAMP3 treated embryos) are similar to COMO treated embryos (F). In SEM 
analysis of HM, COMO injected embryos display a distinct pattern of tightly 
overlapped and polarized cells (G, I, white line indicates direction of polarity), 
whereas Bves MO injected embryos lack directionality, have increased spaces 
between cells, and exhibit irregular cell shapes (H, J; quantified in Table 5). 
Panels I and J show magnified views of the boxed areas in panels G and H, 
respectively. 
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Figure 3.14: Depletion of VAMP3 in X. laevis. Embryos were injected with 
40 ng of VAMP3 MO at stage two and then fixed at different time points. In 
stage 11.5 embryos, blastopore closure was delayed in 50% of embryos 
(Panel B, D; 2,3), while the remaining 50% of embryos had normal 
blastopore closure (Panel B, D; 1) relative to COMO injected embryos (Panel 
A). This represents a similar, yet less severe phenotype in relation to Bves 
MO injected embryos (see Figure 4.13B). It is interesting that similar defects 
are seen at this stage in both Bves- and VAMP3-depleted embryos, as this is 
when integrin-mediated adhesion is very important for migration across the 
blastocoel roof, which results in blastopore closure (Marsden et al., 2001). It 
should be noted that delayed blastopore closure can result from a range of 
defects, however, it generally is an indicator of impaired cell movement. 
Knockdown of VAMP3 in X. laevis embryos resulted in a range of 
phenotypes in tadpoles. The most severe embryos (Panel C; 4) displayed 
substantial edema, a curved body, and a drastically shortened anterior-
posterior (AP) axis (16% of embryos; panel E, 4), while roughly half of the 
embryos (panel C; 2, 3) had a less extensive manifestation of this phenotype 
(49.4% of embryos, phenotypes 2 & 3; panel E, 2, 3). Approximately one 
third of embryos (34.7%; panel E, 1) were indistinguishable from COMO 
injected controls (panel C; 1). 
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embryos (via aforementioned MO knockdown) exhibited delayed closure of the 
blastopore during gastrulation, which is indicative of disrupted cellular movement 
[Figure 3.13B; (Johnson et al, 1993; Ramos and DeSimone 1996; Ramos et al, 
1996; Marsden and DeSimone 2001; Marsden and DeSimone 2003)]. Similarly, 
embryos injected with VAMP3 MO, displayed a delay in blastopore closure 
(Figure 3.14B), although this phenotype was less penetrant when compared to 
the Bves phenotype. It is interesting that similar defects are seen at this stage, as 
this is when integrin-mediated adhesion is important for migration across the 
blastocoel roof (BCR), which results in blastopore closure (Marsden and 
DeSimone 2001). The BCR intercalates to become two to three cell layers thick 
in COMO injected embryos (Figure 3.13D, arrow), but remained thickened in 
Bves-depleted embryos upon histological analysis [Figure 3.13E, arrow; (Keller 
1980)]. Additionally, the involuting mesoderm is disassociated from the BCR in 
Bves-depleted embryos, suggesting decreased cell-matrix adhesion (Figure 
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3.13E, asterisk). Interestingly, X. laevis embryos injected in one of two cells with 
a lower dose of Bves MO (20ng), display anterior defects, characterized by 
disrupted morphogenesis of head structures and ectodermal outgrowths on the 
injected side (Figure 3.13C, arrows). These phenotypes are completely 
dependent upon inhibition of Bves function as total rescue is achieved by co-
injecting Bves MO with 100 pg of X. laevis Bves mRNA (Figure 3.15). Conversely, 
VAMP3 MO treated embryos did not display overt defects in the anterior region 
at the tadpole stage and generally had a less severe phenotype compared to 
Bves MO treated embryos that was characterized by a shorter Anterior-Posterior 
(AP) axis and moderate to severe edema (Figure 3.14).  
In X. laevis, anterior structures are the progeny of the involuting head 
mesoderm (HM), thus, we further analyzed the this population of cells [region 
Figure 3.15 Bves Morpholino (MO) specifically knocks down Bves 
function. Embryos were injected into 2/2 cells with mGFP, 20ng of Bves MO, 
and 100pg of Xbves Rescue RNA that is mutated in the MO binding site. 
Stage 41 embryos (A) developed normally, with no gross defects in 
development, thus demonstrating full rescue. Embryos had membrane GFP 
labeling in the majority of cells (B), indicating the injected constructs diffused 
to each cell. This rescue data confirms Bves MO is specific, and off target 
effects are minimal.  
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denoted by the asterisk in Figure 3.13E; (Kumano and Smith 2002)]. Involuting 
HM utilizes integrin adhesion to migrate along a FN gradient that is distributed on 
the BCR (Smith et al, 1990). These cells are directionally polarized towards the 
Figure 3.16 Bves- and VAMP3-depleted cells display decreased cell 
adhesion on FN. HM cells stained with Phalloidin-568 from COMO injected 
embryos (A) display distinctly spread morphologies on FN, while Bves-
depleted cells (B) are round. Analysis over time (in minutes) indicates that as 
an mRFP labeled COMO treated cell moves (C, Time 0-30), it maintains a 
spread phenotype, extending several lamellipodia. Conversely, mGFP labeled 
Bves- (E, Time 0-30) or VAMP3- (G, Time 0-30) depleted cells are unable to 
maintain substrate adhesion and become rounded. Kymographs (D, F, H) 
depict cell morphology over time, underlining the distinct differences in cell 
shape, lamellipodia number, and cell area, which are quantified in graphs I, J, 
and K. Scale bars are 100µm (A, B) and 20µm (C, E, and G).  
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leading edge and extend lamellipodia (Winklbauer and Nagel 1991). Scanning 
electron microscopy (SEM) and quantitative morphometrics of this region 
revealed significant changes in cell polarity and overlap in experimental embryos 
when compared to controls (Table 5). SEM of Bves-depleted embryos 
determined that the anterior population of HM was severely disorganized (Figure 
3.13H, J) with fewer overlaps, large spaces between cells, and no detectable 
polarity of cell orientation (Figure 3.13H, J; Table 5). In contrast, control embryos 
displayed a ‘shingle-like’ pattern of overlapping cells that are all situated in a 
similar direction relative to the leading edge of the involuting mesoderm [Figure 
3.13G, I; (Winklbauer and Nagel 1991)]. Taken together, these data suggest that 
gastrulation movements have been disrupted in both Bves MO and VAMP3 MO 
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treated embryos, and that Bves function is necessary for proper orientation, cell 
contact, and morphology of HM during involution. Previous studies show that 
inhibition of integrin function results in overt defects in cellular movement, similar 
to those seen in Bves-depleted embryos [Figure 3.13; (Ramos and DeSimone 
1996; Marsden and DeSimone 2001; Na et al, 2003)].   
 
Bves-depletion results in decreased X. laevis cell spreading on FN  
Integrins are required for migration of the involuting HM over a FN 
gradient during gastrulation of X. laevis (Marsden and DeSimone 2001). As 
integrins are recycled by VAMP3, we next determined if this was potentially an 
integrin-dependent phenotype (Proux-Gillardeaux et al, 2005; Skalski and 
Coppolino 2005; Tayeb et al, 2005; Luftman et al, 2009). By plating primary 
disassociated HM cells on FN, we found that COMO cells had defined 
lamellipodia and displayed spread morphology in vitro (Figure 3.16A), as defined 
by previous published studies (Ramos and DeSimone 1996). Conversely, Bves-
depleted cells exhibited distinctly decreased cellular spreading on FN (Figure 
3.16B), with smaller cell protrusions. Previous reports have demonstrated 
disruption of integrin function results in round or spherical cells, phenocopying 
Bves depletion (Ramos and DeSimone 1996). This decrease in spread 
morphology was not due to a decrease in integrin expression levels, as Bves MO 
injected embryos expressed the same level of integrin protein as COMO treated 
embryos (Figure 3.13F). The majority of Bves-depleted cells remain rounded 
(79.2±6%), with few filopodia anchoring them to FN (Figure 3.16B, arrows; Table 
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6a). Conversely, 73.6±4% of control cells were spread in morphology. This result 
was significant: p < 0.0002.  
We next used live cell imaging to determine if Bves-depleted cells 
displayed impaired cell spreading, morphology, or movement over time; 
additionally, we extended this study to examine the effect of VAMP3 MO on HM 
Figure 3.17: Kymographs of HM cells. Figure 4.16 demonstrates that cell 
adhesion to a FN substrate in Bves- and VAMP3-depleted X. laevis primary 
head mesoderm cells is disrupted over time. Individual cell tracings displayed 
here from COMO (panel A), Bves MO (panel B), and VAMP3 MO (panel C) 
demonstrate that lamellipodia protrusions and cell area are decreased in 
Bves- and VAMP3-depleted cells over time (Time 0-60; quantified in Table V). 
Overall, Bves or VAMP3 MO treated cells have distinctly different cell 
morphology, characterized by rounded or spherical cells which indicates 
decreased integrin-mediated cell adhesion, while COMO treated cells maintain 
cellular protrusions, as well as spread morphology.  
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cell morphology. HM cells injected with COMO, Bves MO, or VAMP3 MO 
displaying spread morphologies were chosen at the onset of image capture and 
were visualized by previously co-injected membrane GFP (mGFP, 
experimentals) or RFP [mRFP, control; (Wallingford et al, 2000)]. The behavior of 
individual cells was recorded over time and subjected to kymographic analysis 
for cell spreading and morphology. Both control and experimental cells display a 
heavily yolk-laden appearance (Figure 3.16C, E, G) and no cell in any group 
exhibited “directional” migration over the course of study. Time-lapse analysis 
demonstrated COMO injected cells (Figure 3.16C) displayed on average 
4.45±2.3 lamellipodia per cell, while Bves or VAMP3 MO treated cells had only 
0.98±1.5 and 1.7±1.7 lamellipodia/cell (Figure 3.16J, Table 6b). As previously 
reported (Ramos and DeSimone 1996), when integrins are non-functional, 
cultured HM cells remain round in appearance. This was clearly observed in both 
Bves- and VAMP3-depleted cells (Figure 3.16E and G). In a controlled side-by-
side comparison of cells plated on the same FN coated dish, Bves-depleted cells 
(labeled with mGFP) became rounded over time while COMO treated cells 
(labeled with mRFP), remained spread. Additionally, both Bves- and VAMP3-
depleted cells often exhibited large and very transient bleb-like protrusions that 
harbored yolk granules (Figure 3.16E, G, arrows); in control cells (Figure 3.16C), 
yolk granules indicate the stable boundary between the cell body and cell 
protrusion (Selchow and Winklbauer 1997). These membrane blebs, known as 
circus movements in early development (Johnson 1976) were short-lived, and 
are generally thought to be associated with decreased adhesion or breakdown of 
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the actin-cytoskeleton network (Shook and Keller 2003; Fackler and Grosse 
2008) Kymographs of the area of attachment reveal Bves- and VAMP3-depleted 
cells had a significantly smaller area of interaction with the substrate (Figure 
3.16D, F, H, K; see Figure 3.17 for individual frames), when compared to the 
COMO injected cells. These statistically significant results (Table 6c) 
demonstrate that cell adhesion and process extension, processes regulated by 
integrins (Holly et al, 2000; Caswell and Norman 2006), are impaired in Bves- 
and VAMP3-depleted cells. These data, which are corroborated by our current 
findings with MDCK cells, further support a role for Bves in cell movement 
through VAMP3-mediated recycling of integrins. 
 
Discussion 
In this study we present data that link Bves to the fundamental cellular 
process of vesicular transport. Bves has been previously reported to regulate cell 
Figure 3.18 Stable Bves118 expression in MDCK cells is confirmed by 
RT-PCR. After selection in G418, stably transfected lines were assayed for 
RNA transcripts. Briefly, MDCK cell lysate was harvested using Trizol, and 
cDNA was made using Superscript II RT. PCR was carried out with the 
following primers: the forward primer began at pCMV-3Tag-4 vector nucleotide 
584 (AAC CGT CAG ATC CGC TA) and the reverse primer began at 
nucleotide 943 (CTG GCA ACT AGA AGG CAC), thus spanning the multiple 
cloning site.  Bves118 is 354 nucleotides, yielding a PCR product of 713 
nucleotides as seen in lane 6. Lanes 1, 3-5 are negative controls, Lane 2 is a 
positive control.  
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movement and cell-cell adhesion, although these functions were unexplained at 
the molecular level. Here we describe a mechanism that may elucidate the role 
Bves plays in these processes through its interaction with the vesicular transport 
protein, VAMP3. Our findings demonstrate that the intracellular domain of Bves 
interacts directly with VAMP3 and that these proteins co-localize in a variety of 
cell types. Furthermore, stable expression of a mutant form of Bves or elimination 
of Bves protein function results in a remarkably similar disruption in transport of 
two independent molecules, transferrin and β-1 integrin, both of which are 
trafficked by VAMP3 (Galli et al, 1994; Proux-Gillardeaux et al, 2005). These 
findings are corroborated in X. laevis embryos, where Bves depletion (as well as 
depletion of VAMP3) results in impaired transferrin recycling in animal caps and 
morphological defects consistent with the disruption of integrins. Furthermore, in 
both model systems, cells with inhibited Bves function have disrupted cell 
adhesion or spreading, consistent with VAMP3-dependent trafficking of integrins. 
Based on these data, we propose that Bves is essential for VAMP3 function in 
vesicular transport, and is specifically required for the recycling of VAMP3-
mediated receptors. Thus, we propose that Bves functions in broad cellular 
processes regulated by vesicular transport, explaining previously reported 
phenotypes unresolved at the molecular level. 
 
Bves as a novel regulator of vesicular transport  
Bves is essential for proper cell movement, although the exact role Bves 
played in this process was previously unknown (Ripley et al, 2006; Smith et al, 
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2008). We propose that, through interaction with VAMP3, Bves is necessary for 
the vesicular transport of the adhesion molecule, β-1 integrin, as attenuated 
integrin recycling is observed during cell migration when Bves is disrupted. This 
retardation in integrin recycling exactly phenocopies VAMP3 disruption and 
directly links Bves disruption to impaired integrin recycling. These data are 
corroborated by attenuated cell spreading or adhesion (processes dependent 
upon integrin integrity) observed with Bves inhibition. Furthermore, impaired 
recycling of integrins is a potential mechanism explaining the gastrulation 
phenotype observed in the embryo. 
VAMP3 transports transferrin, hence, the rate of transferrin uptake is a 
general indicator of the integrity of VAMP3 trafficking (Galli et al, 1994). With 
Bves disruption, either by expression of a mutated protein or protein depletion, 
endocytosis of transferrin decreases over time and phenocopies VAMP3 
inhibition. These data, along with decreased recycling of β-1 integrin, 
demonstrate that Bves is important for VAMP3-mediated vesicular transport of 
receptors. 
Bves is important for the generation and maintenance of epithelial junction 
integrity (Osler et al, 2005). In the process of epithelial biogenesis, cell-cell 
adhesion is initiated as specific proteins are trafficked to the forming adherens 
junctions (Bryant and Stow 2004; Yap et al, 2007). This process is disrupted 
upon Bves depletion, as the canonical adherens junction molecule, E-cadherin, is 
not localized to points of cell-cell contact (Osler et al, 2005). Cadherin-based cell 
adhesion is a dynamic process with E-cadherin constantly being replenished at 
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the cell surface via vesicular transport (Bryant and Stow 2004; Yap et al, 2007). 
Defects in the vesicular transport of E-cadherin could lead to disrupted cell 
adhesion or signaling, which results in pathogenic states such as metastatic 
cancer (Hirohashi 1998). Recently, it has been shown that efficient delivery of E-
cadherin in both polarized and unpolarized cells is dependent upon functional 
Rab11 positive REs (Desclozeaux et al, 2008). Disruption of either Rab11 (a Rab 
GTPase and known player in vesicular transport) or the RE results in apical 
delivery of proteins. VAMP3 is a well-known member of the RE (Skalski and 
Coppolino 2005; Fields et al, 2007) and thus it is plausible to hypothesize that 
VAMP3-mediated vesicle fusion may be important for the recycling of E-cadherin, 
and mislocalization of E-cadherin upon Bves depletion may be explained by 
disrupted VAMP3-mediated vesicular transport. Thus, the current data and 
previous results suggest that Bves may influence vesicular transport in a broad 
array of cell functions. 
 
Bves in cell adhesion, spreading, and movement  
We provide conclusive evidence that Bves-depleted embryos have 
disrupted cell movements during gastrulation.  X. laevis gastrulation is a well-
studied system where integrin-dependent cell adhesion and movement are 
critical for development (Marsden and DeSimone 2003; Davidson et al, 2006). 
We report that HM cells in Bves-depleted embryos fail to orient properly and, 
when isolated, display rounded morphology and impaired process extension 
when plated on FN. Additionally, these cells display transient membrane blebs, 
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which have been associated with decreased cell adhesion during development 
(Shook and Keller 2003), and indicate localized breakdown of the actin-
cytoskeletal network (Fackler and Grosse 2008). Evidence of this breakdown is 
seen in Bves-depleted cells as yolk granules, which are usually confined to the 
cell body, extend into lamellipodia (Selchow and Winklbauer 1997). The 
decreased integrin-mediated cell-substrate adhesion, coupled with actin-
cytoskeletal network breakdown found in these cells is not surprising. Bves 
depletion influences Rac and Cdc42 activity (Smith et al, 2008), both of which are 
molecules that are important for actin polymerization and communicate with 
integrins during cell movement (DeMali et al, 2003). Additionally, actin 
polymerization has a well documented role in the endocytic pathway (Lanzetti 
2007). Overall, these gastrulation-stage phenotypes are consistent with disrupted 
integrin function, as integrins are responsible for cell adhesion and spreading on 
FN (Marsden and DeSimone 2001). As VAMP3 is known to recycle integrins, our 
data suggest VAMP3 interaction with Bves is necessary for proper integrin-
dependent movements during early X. laevis development. 
In turn, several previous reports have linked Bves to the regulation of cell 
movement. For example, germ cell migration in the developing Drosophila 
embryo is impaired with mutation of Dmbves (Lin et al, 2007), while 
Bves/Popdc1-null mice exhibit impaired skeletal muscle regeneration due to the 
inhibition of myoblast movement (Andrée et al, 2002). Previous work from our 
own group has demonstrated impaired movement and regulation of cell shape in 
vitro and in developing organisms (Ripley et al, 2004; Ripley et al, 2006; Smith et 
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al, 2008). Still, until the identification of Bves-VAMP3 interaction, a molecular 
mechanism underlying these phenotypes was unresolved. Interestingly, the Bves 
gene is hypermethylated in specific cancer types (Feng et al, 2008), suggesting 
silencing of this gene may coincide with down-regulation of cell-cell adhesion. 
Thus, the role of Bves in the modulation of SNARE function may have broad 
impact on development and disease. 
 
Bves as a moderator of diverse cellular pathways  
In addition to interacting with VAMP3, we show that Bves interacts with 
VAMP2. It has been reported that VAMP2 and VAMP3 are promiscuous during 
development and in vitro, substituting for each other when one molecule is 
absent (Bhattacharya et al, 2002; Deak et al, 2006). This comes as no surprise, 
as rat VAMP2 and VAMP3 are highly homologous, differing by only one amino 
acid in their SNARE binding domain (McMahon et al, 1993). Bves interaction with 
VAMP2, and the potential overlapping function between different VAMP 
homologues, may explain the milder phenotype observed in VAMP3-depleted X. 
laevis embryos, and may suggest a broader role for Bves in influencing VAMP-
mediated vesicular transport. Additionally, VAMP2 is expressed in muscle 
satellite cells and is up-regulated during skeletal muscle regeneration (Tajika et 
al, 2007); interestingly, this process is delayed in Bves knockout mice (Andrée et 
al, 2002). Finally, Bves is highly expressed in the brain, tissue where VAMP1 and 
2 are also enriched, although Bves has never been studied in this context (Hager 
and Bader 2009). It would be interesting to determine if Bves interacts with 
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VAMP1, and if interaction with VAMP1 or 2 had any functional significance in the 
nervous system. Overall, Bves interaction with VAMP2 may suggest a broader 
role for Bves in a variety of tissue types that utilize SNARE machinery. 
Current and recent studies have shown that Bves interacts with two 
proteins, VAMP3 and GEFT, that function through downstream targets to 
regulate convergent cellular processes (Smith et al, 2008). In light of the present 
data, it is intriguing to consider the overlapping cell operations in which GEFT 
and VAMP3 are involved. Although the direct functions of VAMP3 and GEFT 
within the cell are very different, they are nonetheless involved in a common 
pathway. GEFT activates Rho GTPases, which in turn regulate cell adhesion, cell 
motility, polarity, gene expression, and membrane trafficking (Etienne-Manneville 
and Hall 2002). VAMP3, through regulation of protein trafficking, modulates cell 
motility, polarity, and gene expression (Schwartz and Shattil 2000). Indeed, 
several studies have even implicated Rho GTPase activity in the regulation of 
vesicular transport (Ridley 2001; Symons and Rusk 2003), and integrins have 
been shown to recruit Rho GTPases necessary for modulation of the actin 
network (Holly et al, 2000; Caswell and Norman 2008). However, the interplay 
between integrin signaling and Rho GTPase function is not entirely understood. 
We hypothesize that through interaction with VAMP3 and GEFT, Bves may 
provide crosstalk to achieve cellular synchrony in these essential cell processes. 
Taken together, our data suggest that Bves may play an unexpected role in a 
broad spectrum of cellular functions regulated by vesicular transport. 
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CHAPTER IV 
 
BVES AND NDRG4 REGULATE EPICARDIAL CELL MIGRATION THROUGH 
AUTOCRINE EXTRACELLULAR MATRIX DEPOSITION 
 
This chapter is currently in submission. 
 
Abstract 
Here, we demonstrate a novel interaction between Bves and NDRG4 that 
is essential for directionally persistent cell migration. This activity is dependent on 
another novel function for these proteins identified in this study; namely, vesicular 
trafficking of internalized soluble fibronectin through late endosomal/lysosomal 
compartments for deposition into the extracellular matrix. This endocytic/recycling 
mechanism was recently discovered in cancer cells. Loss of Bves and NDRG4 
function disrupts directional movement and decreases matrix secretion from 
epicardial cells. Revealing the relationship between matrix deposition and 
directed cell movement has important implications for heart development, as 
directed epicardial cell motility is essential for coronary vessel morphogenesis. 
Together with prior studies, the present data demonstrate that Bves traffics not 
only cell-cell and cell-matrix adhesion molecules but also their matrix substrates 
to the cell surface for adhesive and migratory events. With previously reported 
functions, our data suggest that Bves is a global regulator of cell-
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microenvironmental interactions in a diverse set of migratory cell behaviors 
impacting development, repair and disease. 
 
Introduction 
Blood vessel epicardial substance (Bves) was first identified in epicardial 
tissue and later recognized for its dynamic distribution in a multitude of cell types 
(Reese et al, 1999; Andrée et al, 2000; DiAngelo et al, 2001; Wada et al, 2001; 
Ripley et al, 2004; Vasavada et al, 2004; Smith and Bader 2006; Kawaguchi et al, 
2008; Russ et al, 2010). Bves (Popdc1) is the prototypical member of the Popdc 
family, which share a conserved Popeye Domain, but do not contain homologous 
domains with other protein families (Andrée et al, 2000). Loss of Bves function in 
epithelial cells results in disruption of sheet integrity and defects in epithelial 
morphogenesis (Osler et al, 2005; Ripley et al, 2006; Kawaguchi et al, 2008). A 
reoccurring theme seen with disruption of Bves is randomization of cell 
movement. For example, in normal Xenopus laevis development, individual A1 
blastomeres, early embryonic cells, give rise to progeny that migrate in a highly 
patterned manner incorporating into anterior head and somitic structures. With 
morpholino knockdown of Bves in these same blastomeres, migration of resulting 
progeny is completely randomized with cells moving throughout the embryo 
(Ripley et al, 2006). Similarly, Drosophila melanogaster larvae expressing 
antisense Bves have aberrant pole cell migration (Lin et al, 2007). An in vitro 
model of wound repair demonstrates that Bves-depleted human corneal epithelial 
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cells move more rapidly than controls but in a disorganized manner resulting in 
impaired epithelial sheet closure (Ripley et al, 2004). Bves-disrupted cells have 
impaired lamellipodial formation and loss of adhesion (Smith et al, 2008; Hager et 
al, 2010). Finally, Bves is a recently-identified tumor suppressor of gastric and 
colorectal cancers with Bves mutations associating with epithelial-to-
mesenchymal transition and metastatic behaviors (Kim et al, 2010; Williams et al, 
2011). Thus, Bves regulates cell movement in a variety of settings, although the 
underlying mechanism is poorly understood.  
 Bves itself is not an adhesion molecule but is important for intracellular 
trafficking of adhesion molecules, such as E-Cadherin, Occludin and ZO-1, and 
stability of junctional complexes (Osler et al, 2005; Russ et al, 2011). Additionally, 
Bves is critical for the trafficking of β1-integrin to the cell surface and subsequent 
lamellipodial extension through interaction with the SNARE protein Vamp3 
(Hager et al, 2010). Together, previous reports suggest that Bves has an 
important role in trafficking integral membrane proteins to the cell surface for cell-
cell and cell-matrix adhesion. 
 In ongoing interaction screens to identify Bves binding partners and 
determine protein function, the most frequent hit was N-myc Downstream 
Regulatory Gene 4 (NDRG4), a cytoplasmically-localized protein whose 
expression, similar to Bves, is enriched in heart tissue (Zhou et al, 2001; Qu et al, 
2002; Qu et al, 2008). This interaction was of interest, as other NDRG family 
members have been implicated in trafficking adhesion molecules to the cell 
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surface (Okuda et al, 2004; Berger et al, 2006; Kachhap et al, 2007; Choi et al, 
2010). Additionally NDRG4, like Bves, is a colorectal cancer tumor suppressor 
that regulates cell migration, morphology and differentiation (Zhou et al, 2001; 
Nishimoto et al, 2003; Melotte et al, 2009; Schilling et al, 2009; Kim et al, 2010; 
Williams et al, 2011). Furthermore, NDRG4 depletion impairs neurite extension, 
mirroring the loss of lamellipodia observed in Bves-depleted cells (Ohki et al, 
2002).  
 Here, we demonstrate that Bves/NDRG4 interaction, through a unique 
binding domain, is critical for directionally persistent cell migration. Further, we 
identify another novel function for these proteins; namely, trafficking of 
internalized fibronectin for deposition into the extracellular matrix.  Endocytosis 
and resecretion of internalized fibronectin from a late endosomal/lysosomal 
secretory compartment was recently shown to promote the motility of cancer cells 
(Sung et al, 2011). We show that this mechanism is essential for directionally 
persistent movement of epicardial cells and that fibronectin resecretion is 
dependent on Bves and NDRG4 function. This has broader implications for heart 
morphogenesis and coronary vessel development. Together with previous 
studies, the present data demonstrate that Bves traffics not only cell-cell and cell-
matrix adhesion molecules but also their matrix substrates to the cell surface for 
adhesive and migratory events critical in development, cancer and repair.  
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Materials and Methods 
All experiments performed with murine models followed IACAC guidelines. 
 
Quantification 
For the assays described below statistics were performed in Microsoft 
Excel 2011.  The error bars represent the standard error of the mean; standard 
student t-tests were used to determine significance.  All compared images were 
equivalently adjusted in Adobe Photoshop CS5. For intensity profile quantification, 
the ImageJ Straighten program was used to follow structures at a width of five 
pixels, these pixels were averaged for fluorescence intensity and each channel 
was plotted together in Excel versus distance (µm). Progressive paths of 
epicardial cells after gene manipulation were gathered using ImageJ Manual 
Tracking and were compiled in Photoshop. 
 
Cell Culture, Antibodies, Immunocytochemistry and Immunohistochemistry   
EMC maintenance and processing was standard (Wada et al, 2003). The 
dilutions and manufacturers of the antibodies were: anti-Bves SB3 (1:1000) 
(Smith and Bader 2006), anti-NDRG4 91:500, Novus, H00065009-M01), anti-
Fibronectin (1:100, Santa Cruz, SC-9068), anti-GAPDH (1:500, Abcam, ab290), 
anti-GFP (1:500, Clonetech, 632375), anti-Myc (1:200, Clonetech, 631206), 
Rab4a/b (1:200, Abcam, ab13252), Rab11a (1:500, Gift from James Goldenring), 
EEA1 (1:200, BD Transduction, 610457), Lamp1 (1:100, BD Transduction, 
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555798), Lamp2 (1:100, Abcam, ab18538), Rab27a (1:200 Abcam ab55667), 
Alexa Fluor-488, 568, and 647 1:500 (Molecular probes), DAPI, 1:10000. Zenon 
IgG labeling kits were used for direct labeling (Molecular Probes).  Slide 
preparation for immunocytochemistry was standard (Smith and Bader 2006). For 
immunohistochemistry, 10µm slices of E14.5 murine hearts were cryosectioned 
onto charged slides.  Tissue processing followed standard methodologies (Osler 
et al, 2005; Smith and Bader 2006).  Images were captured with Leica TCS-SP5 
confocal microscope (Leica Microsystems), Zeiss LSM150 inverted confocal 
microscopes, and the DeltaVision Platform (Precision Control).  All microscopy 
was done in conjunction with VUMC CISR and EBC. 
 
Split-Ubiquitin Screen 
A split ubiquitin screen of murine Bves (NM_024285) against a mouse 
heart library was performed as previously described (Hager et al, 2010). Murine 
NDRG4 transcript A (NM_001195006.1) was cloned into the pPR3-N vector and 
passed all nutrient drop-out selection tests against Bves. 
 
Co-IP, GST pulldown and Native IP 
For Co-IP, Bves, cloned into the pCMV-myc-3tag-4A vector (Stratagene), 
and NDRG4, cloned into the pEGFP-C1 vector (BD Biosciences), were 
exogenously expressed in COS-7 monkey kidney cells (ATCC) with 
Lipofectamine 2000 (Invitrogen).  Lysates were harvested as previously 
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described (Hager et al, 2010) and CoIPs performed per manufacturerʼs 
instructions using Profound c-Myc Tag IP/Co-IP Application Set (Pierce). Bves-
GST truncation pulldowns of NDRG4-GFP expressed in COS7 cells were 
performed as previously described (Smith et al, 2008).  For Native-IP, lysates 
from three 10cm plates of EMCs were pooled in M-PER Mammalian Protein 
Extraction Reagent (Pierce).  20µg Bves SB3 antibody was crosslinked using 
BS3 to protein G Magnetic Dynabeads (Invitrogen) as per manufacturerʼs protocol.  
Dynabeads were washed in PBS-T pH 7.4 and 250 uL of EMC lysate was 
applied and rocked at 4oC for two hours. Binding partners were eluted per 
manufacturerʼs protocol and probed with NDRG4 antibodies via western blotting, 
which was exposed with standard alkaline phosphatase methodology (Hager et 
al, 2010). 
 
SPOTs Analysis 
A SPOTs membrane designed to the Bves C-terminus (residues 115-358) 
was synthesized (Sigma Genosys) with each 13-mer SPOT having 10 amino acid 
overlap with neighboring SPOTs.  NDRG4-EGFP or EGP vector control lysates 
were exogenously expressed in COS7 cells, and lysates were collected using 
MPER buffer as described above. Standard BCA assays (Thermo Scientific) 
determined total protein concentration, and lysates were incubated with both 
monoclonal and polyclonal GFP antibodies to enhance signal, overnight at 4oC.  
The SPOTs membrane was prepped and incubated in lysate as previously 
 120 
described (Kawaguchi et al, 2008). Antibody binding was visualized using 
standard chemiluminescence methodology, and the membrane was regenerated 
using DiMethylFormamide (DMF) as previously described (Kramer and 
Schneider-Mergener 1998). The DNA sequence of an ~120 base pair region of 
Bves (BC132044.1; residues 292 to 330) was cloned into the pCMV-3tag-4a 
vector (Agilent Technologies #240198) with standard methods (Hager et al, 
2010) and in-frame ligation was confirmed via PCR, restriction enzyme dropout of 
the insert and sequencing (in conjunction with the Vanderbilt University DNA 
Sequencing Facility). Overexpression of 10µg of two separate clones was 
performed with nucleofection as described below.  Expression efficiency and 
proper localization, colocalization was ascertained by analyzing images gather 
with the Delta Vision platform, and confocal microscopes. 
 
Modified Boyden Chamber Migration Assay 
3.0x105 EMCs per experiment were pelleted for 10 minutes at 1500 RPM 
in a desktop microcentrifuge and resuspended in 400uL of 10% FBS plus P/S in 
DMEM.  The cells were seeded to the basket of an 8.0µM cell culture insert 
(Millicell) and placed in 600µL of the same media in a 24-well plastic culture dish 
(Falcon).  Cells were incubated for 4 hours, and processed with standard 
methods (Cross et al, 2011). Phase images were captured on an Olympus BX60 
microscope and Olympus Camera. 
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siRNA Knockdown and Rescue   
Oligos were designed against the 3ʼ UTR of Bves and NDRG4 (Sigma 
Custom Oligos; sequences listed in Table 7). Nucleofection using the 
Nucleofector II Device (Lonza) was optimized in EMCs with a Cell Line 
Optimization Kit (Lonza VCO-1001N). Briefly, 5x 105 EMCs in solution L using 
program A-033 had the highest transfection efficiency of pMAX-GFP DNA 
(>70%) and highest viability (>80%). Using this protocol, three pooled Bves 
and/or NDRG4 siRNA oligos were applied to EMCs at 100nM each, as were 
standard control oligos (Sigma SIC001).  
Cells were incubated for 48 hours in standard conditions and collected as 
outlined above and protein concentration was normalized to expression of the 
housekeeping gene cyclophilin via western blot. Rescue constructs of Bves and 
NDRG4 pCMV-Myc-3tag-4 vector (Stratagene) lacked the siRNA target 
sequences and were stably expressed in EMCs via nucleofection, followed by 3 
weeks of G418 treatment.  Cells were clonally sorted at the Nashville VA Medical 
Table 7. Bves and NDRG4 knockdown constructs 
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Center Flow Cytometry Core, expanded, and then assayed with a Boyden 
Chamber, as above.   
 
Live Imaging Assays and Analysis 
EMCs siRNA depleted for Standard Control, Bves and/or NDRG4 plasmid 
as described above were incubated for 24 hours in standard medium then split to 
glass-bottom 35mm dishes (MatTek) either uncoated or coated in 10µg/cm2 
Fibronectin (Sigma F4759) at 5,000 cells per dish, and incubated for another 24 
hours.  To monitor cell movements, DIC images were acquired with the 
DeltaVision Platform in a temperature, humidity and CO2 controlled weather 
station. Images were taken every 60 seconds with autofocus every 30th image.  
The movies were analyzed for distance, velocity and directional persistence 
using ImageJ Cell Tracker software.  These data were collected in conjunction 
with VUMC EBC. 
 
Cell-Free ECM Assays 
Control or Bves/NDRG4 knockdown EMCs were seeded at 1x106 on 
MatTek dishes or 5x105/well of a 4 well glass chamber slide (NUNC Lab-Tek) 
and grown to confluence (48 hours).  A cell-free ECM was prepared by applying 
20mM ammonium hydroxide to the cells with vigorous rocking for five minutes.  
The cellular debris was washed away with one application of water and three of 
PBS for five minutes each, again, with vigorous rocking. As a measure of 
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properly produced ECM, directional persistence was compared between control 
cells in complete medium, Bves and NDRG4 knockdown cells in complete 
medium, and control cells in fibronectin depleted medium, as a negative control, 
using the live-cell directional persistence assay described above. 
 
Fibronectin Medium Depletion and fibronectin internalization/deposition 
assays   
To deplete medium of fibronectin, FBS was purified over a disposable 
column using Gelatin Sepharose 4B beads (GE Healthcare) according to the 
manufacturerʼs protocol and assayed for FN depletion via western blot.  Gene-
depleted cells maintained on glass MatTek dishes were fibronectin starved for 24 
hours, DyLight 550 NHS Ester (Thermo Scientific)-, or Sulfo-NHS-LC-LC-Biotin-
labeled fibronectin at 10 ug/mL for times specified in the text and as previously 
described (Sung et al, 2011). Cells were washed twice with complete medium 
and 3 times with PBS for five minutes each, and then cells were processed for 
immunofluorescence as above.  For DiI labeling experiments, EMCs seeded at 
very low confluence on glass or 10µg/cm2 Fibronectin were covered with 200 µL 
Fast DiI (Molecular Probes; 5µL DiI per 1mL 10% FBS DMEM), incubated for 35 
minutes at 37oC, fixed with Formalin for 25 minutes and processed for antibody 
labeling as discussed above. For biotin labeled deposition experiments, confluent 
fibronectin starved cell sheets on 35mm plastic dishes (Corning) were fed biotin-
FN for 48 hours, a cell-free ECM assay was performed, as below, and 
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conjugated to Streptavadin-HRP overnight at 4oC (Thermo Scientific). The plates 
were washed with TBST pH 8.0 four times for 10 minutes each. Cells were 
exposed to TMB substrate (Pierce) for 25 minutes.  Reactions were stopped with 
2M sulfuric acid and absorbance read per manufactureʼs protocol. 
 
Results 
Bves and NDRG4 Bind Directly Through a Novel Interaction Domain 
In an effort to determine Bves function, molecular binding partners were 
identified with a split ubiquitin two-hybrid screen (Iyer et al, 2005) designed for 
membrane-associated proteins in the heart using Bves as bait. Initial results 
identified a direct interaction between Bves and NDRG4, the most common target 
from this screen. The interaction passed quadruple dropout stringency selection 
tests (Figure 4.1A), and was further confirmed as myc-tagged full length Bves 
(Bves-myc) coimmunoprecipitated GFP-tagged NDRG4 (NDRG4-GFP; Figure 
4.1B) from Cos7 cell lysates. To further define this interaction domain, a series of 
Bves C-Terminus truncation constructs spanning intracellular sequences of the 
protein were produced (BCT; diagrammed in Figure 4.1C). Only the full-length 
construct (amino acids 115-358) interacted with NDRG4 while all other constructs 
(spanning amino acid residues 115 to 150, 218, 250, 275 and 300 of Bves, 
respectively) failed to pulldown NDRG4-GFP (Figure 4.1D).  
SPOTs analysis was performed to determine the minimal Bves residues 
sufficient to interact with NDRG4. As diagrammed in Figure 4.1E, 13-mer 
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Figure 4.1 NDRG4 Protein Directly Interacts with Bves Residues 307-316. 
(A) Bves protein directly interacts with NDRG4 by split-ubiquitin quadruple 
drop-out selection test; n=3 assays. (B) Exogenously expressed Bves-Myc 
protein pulls down NDRG4-GFP from COS7 lysate above background lysate 
lacking Bves-Myc expression; n=3 assays. (C) A diagram of the Bves structure 
depicts the functional intracellular C-terminal domain (BCT) spanning residues 
115-357. (D) Bacterial produced BCT-GST truncations indicate that only the 
full length BCT is sufficient to pull down NDRG4-GFP from COS7 lysate, 
unlike constructs truncated at residue 150, 218, 250, 275, or 300 ; n=3 assays. 
(E) SPOTs Assay: 13-mer synthesized peptides, from amino acid 115 to the 
end of the Bves protein, are fused to a cellulose membrane, with 10 amino 
acid consecutive overlap. (F) GFP-NDRG4 lysate binds to three Bves peptides 
on the cellulose membrane. The Bves-SPOTs blot overlaid on the cellulose 
membrane indicates that NDRG4-GFP binds to peptides 63-65. The Bves 
residues essential for binding NDRG4-GFP are: 307-316; HHFLRGSSST.  
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peptides of BCT were fused to a cellulose membrane with 10 amino acid overlap 
between adjacent peptides and probed with Cos7 lysate containing NDRG4-GFP. 
Interestingly, NDRG4-GFP bound strongly to peptides 63 through 65, which 
corresponded with residues 307 to 316 of the Bves protein (Figure 4.1F, 
Bves/NDRG4-Minimal Binding Domain). Importantly, SPOTs analysis matched 
our truncation pulldown experiments where Bves/NDRG4 interaction was 
observed only with inclusion of residues 300-358 (Figure 4.1D). These data 
identify a novel protein-protein interaction site within Bves that is outside of the 
conserved Popeye domain previously identified for Bves/Bves dimerization 
activity (Kawaguchi et al, 2008). 
 
Bves and NDRG4 Colocalize and Interact in Mammalian Epicardial Cells 
As Bves and NDRG4 are both enriched in the heart (Qu et al, 2002; Hager 
and Bader 2009), distribution patterns of the two gene products in embryonic 
murine cardiac tissue were determined. Bves and NDRG4 colocalized in cardiac 
myocytes and the epicardium in E14.5 hearts (Figure 4.2A, inset and intensity 
plot). As Bves has different subcellular localization in cells depending whether 
they are freely migrating or present in epithelial sheets (Wada et al, 2001; Osler 
et al, 2005), we determined the subcellular localization of Bves and NDRG4 
under varying conditions. Epicardial cells plated at low confluence are motile, 
with a mesenchymal morphology (Wada et al, 2003). In this setting, Bves and 
NDRG4 colocalized at the cell cortex and in extended cell processes  (Figure 
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Figure 4.2 Bves and NDRG4 colocalize and interact in mammalian 
epicardial cells. Bves expression is visualized by green labeling, NDRG4 is 
red; all optical slices are 1 Airy Unit. (A) In murine E14.5 ventricle tissue, 
Bves and NDRG4 colocalize in cardiomyocytes (merge) and epicardial cells 
(inset; confocal images of transverse sections). Colocalization is quantified by 
ImageJ intensity profiling (box and graph). M: myocardium, E: epicardium; 
scale is 75µm. (B) Mesenchymal-shaped epicardial cells at low confluence 
exhibit Bves and NDRG4 colocalization in plasma membrane protrusions 
(merge and inset); colocalization in the box quantified in the intensity profile; 
scale is 10µm. (C) High magnification of Bves/NDRG4 subcellular position 
indicates that proteins have punctate, vesicular colocalization (white arrows in 
digital zoom demarcate colocalization); scale is 10µm. (D) Epicardial cells at 
high confluence do not contain areas of Bves and NDRG4 colocalization 
(inset shows cell borders); scale is 10µm. (E) Epicardial cell lysate run over a 
column cross-linked to Bves antibody pulls down and enriches for NDRG4 
protein above background (PBS-Tween 20: no Bves antibody); n=3 
pulldowns. 
 
 128 
4.2B, inset and intensity profile), at points of cell contact (data not shown), and 
on intracellular vesicular structures  (Figure 4.2C, digital zoom and white arrows). 
Still, in other regions of the cell, non-overlapping distribution of these proteins 
was also apparent and these two proteins failed to colocalize in established 
epicardial sheets (Figure 4.2D, inset). Interestingly, in confluent cells, NDRG4 
localization was primarily vesicular whereas Bves localized to the cell cortex and 
plasma membrane. Additionally, co-immunoprecipitation demonstrated that Bves 
and NDRG4 interact in epicardial cells (Figure 4.2E). Taken together, these data 
indicate that Bves and NDRG4 interact in epicardial cells of mobile morphology, 
suggesting that they may function together in a capacity related to cell migration.  
 
Bves and NDRG4 Interaction Regulates Epicardial Cell Movement  
To ascertain whether cell motility was altered in epicardial cells with loss of 
Bves and/or NDRG4 protein, nucleofection of siRNA oligonucleotides was 
optimized in epicardial cells to disrupt protein expression. Pooling three siRNAs 
designed against the 3ʼ UTRs of Bves and NDRG4 most strongly depleted 
epicardial cells of the respective proteins compared to standard control (SC) 
siRNA treatment (Figure 4.3A; siRNA sequences in Materials and Methods).  
With successful depletion of protein levels, we assayed whether loss of 
Bves and/or NDRG4 affected epicardial cell migration with a modified Boyden 
Chamber system in which serum chemoattractant was placed on both sides of 
the filter to promote random motility. Consistent with previous reports on both 
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Figure 4.3 The Bves and NDRG4 interaction regulates epicardial cell movement. 
(A) Bves or NDRG4 siRNA oligos applied to epicardial cells via nucleofection 
knockdown protein levels of respective genes. Co-knockdown with Bves and NDRG4 
oligos depleted expression of both proteins; n=3 blots. (B) siRNA depletion of Bves or 
NDRG4 elevates single cell migration through a modified Boyden Chamber which is 
rescued by overexpression of each respective gene; n=5 separate assays; *p≤0.0003 
from standard control (SC) treated samples, **p≤0.05 from SC. (C) The structure of the 
Bves/NDRG4 minimal binding domain (Bv/N4-MBD) construct contains the Bves 
residues that bind to NDRG4 fused to a 3-myc tag, the construct should compete for 
binding with native NDRG4 protein. (D) Overexpression of the Bv/N4-MBD plasmid has 
robust cytoplasmic, punctate and membrane localization in epicardial cells, reminiscent 
of native NDRG4 protein localization. (E) Overexpression of two separate Bv/N4-MBD 
clones significantly elevate single cell migration, while vector control cell migration was 
unchanged compared to wildtype; n=55 images from 3 experiments *p≤0.0001 from 
vector treated cells, NS=not significant compared to vector. (F) Overexpression of the 
Bv/N4-MBD construct (green) colocalizes with native NDRG4 protein (red) in multiple 
planes as calculated by single pixel analysis and demarcated by white pixels. (G) The 
overlapping pixels from each Z-plane are displayed in the bottom panel; 0.5µm optical 
slices. 
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proteins (Nishimoto et al, 2003; Ripley et al, 2006), depletion of Bves or NDRG4 
significantly increased the movement of cells in this assay (Figure 4.3B). 
Expression of a cloned RNA lacking the 3ʼUTR oligonucleotide target sequences 
decreased the enhanced migration exerted by Bves and NDRG4 siRNA, rescuing 
the phenotype (Figure 4.3B).   
To determine whether interaction of Bves and NDRG4 directly regulated 
this process, the minimal binding domain of Bves for NDRG4 (see Figure 4.1E) 
Figure 4.4 Bves/NDRG4-myc tagged dominant negative competes for 
NDRG4-GFP binding to Bves. (A) Co-overexpression of BvN4-DN with GFP-
vector or GFP-NDRG4 plasmids indicate that BvN4-DN is sufficient to 
pulldown NDRG4 above vector background; cyclophilin housekeeping gene is 
a loading control; top GFP-NDRG4 band runs at the expected molecular 
weight for NDRG4 plus a GFP tag of ~26kDa. (B) Two separate BvN4-DN 
constructs were sufficient to interfere with endogenous Bves and NDRG4 
interaction in epicardial cells.   
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was expressed in epicardial cells to interfere with native interaction (diagrammed 
in Figure 4.3C). Subcellular localization of the myc-tagged minimal binding 
domain (Bv/N4-MBD) was consistent with native Bves and NDRG4 localization in 
that it was cytoplasmic and primarily localized to vesicles (Figure 4.3D). Further, 
in apical, central and basal z-planes, Bv/N4-MBD and NDRG4 proteins 
colocalized in epicardial cells, as determined by single pixel analysis (Figure 4.3F 
cells, 4.3G single pixel colocalization per designated plane). Interaction of Bv/N4-
MBD and NDRG4 proteins was confirmed by pulldown methods (Figure 4.4A), 
demonstrating that this domain binds NDRG4 in cells. Conversely, interference of 
endogenous Bves/NDRG4 protein interaction with overexpression of the binding 
domain was visualized by the absence of NDRG4 protein with Bves pulldown 
analysis (Figure 4.4B). Together these data demonstrate that the Bv/N4-MBD of 
Bves for NDRG4 interferes with Bves/NDRG4 interaction, and thus is a dominant 
negative peptide against this interaction. Using Bves/NDRG4-MBD constructs, 
modified Boyden Chamber analysis of random cell migration was conducted to 
measure migration rate in serum. In these experiments, overexpression of two 
different Bv/N4-MBD constructs significantly increased transwell migration rate 
compared to controls (Figure 4.3E), mirroring the gene depletion studies.  
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Figure 4.5 Bves and NDRG4 coregulate epicardial cell directional persistence 
and fibronectin trafficking. (A) Epicardial cells treated with SC siRNA and 
plated at low density on glass dishes move a short distance with high 
directionality over the timecourse. In these representative images, the nuclear 
path of movement is demarcated by the green line (ImageJ manual tracking). 
(B) Bves/NDRG4 siRNA-depleted epicardial cells have deregulated 
movement, as cells tracked over the timecourse (purple line) appear to travel 
further, without directionality compared to controls. Cells also retain large 
cytoplasmic vacuoles (yellow arrow). (C) Manual tracking quantification 
indicates that Bves- and/or NDRG4-depletion conditions exhibit accelerated 
cell movement speed and increased distance traveled, which is highly 
statistically significant; n≥40 cells per condition; *p≤0.0001. (D) Bves and/or 
NDRG4-depleted cells had highly significantly impaired directional 
persistence, (a ratio of the total displacement over the distance traveled, (with 
1 being highly directional and 0 being random); n≥40 cells per condition; 
*p≤0.0001. (E) An overlay of representative tracks of epicardial cells illustrates 
the impaired directionality and randomized movement exhibited by Bves- 
and/or NDRG4-depleted cells (10 tracks per condition). 
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Bves and NDRG4 Coregulate Epicardial Cell Directional Persistence and 
Fibronectin Trafficking 
Disruption of Bves or NDRG4 leads to an increase in random cell motility 
in vitro and Bves-depletion causes a defect in cell homing in whole organisms 
(Andrée et al, 2002; Nishimoto et al, 2003; Ripley et al, 2006; Lin et al, 2007; 
Melotte et al, 2009). Still, the molecular and cellular mechanisms underlying 
Figure 4.6 Bves or NDRG4-depleted epicardial cells have impaired 
movement on glass but not fibronectin. (A) Bves or NDRG4 depleted 
epicardial cells appear to move long distances and have poor directional 
persistence compared to controls as tracked by ImageJ manual tracking and 
demarcated by the yellow and red lines, respectively (Figure 4). (B) Plating 
Bves or NDRG4 depleted epicardial cells on an evenly disbursed fibronectin 
matrix rescues directional persistence defects on a glass surface (A). 
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randomized movement are poorly understood. To determine the specific motility 
defect impaired with loss of function, epicardial cells were treated with Bves 
and/or NDRG4, or SC siRNA, plated on glass in complete medium, and imaged 
for two hours at a frame rate of one/min. Distance traveled, velocity and 
directional persistence were quantitated using Image J. Interestingly, Bves-, 
NDRG4- or co-depleted cells had strikingly poor directional persistence (Figure  
4.5D) calculated by dividing the total displacement traveled by the distance 
traveled. Directional persistence is measured on a scale of 0 to 1 where 0 is 
random movement and 1 is movement in a straight line (Harms et al, 2005). Also, 
depleted cells exhibited faster paced movement and longer path lengths as 
compared to controls, mirroring in vivo results [Figure 4.5A-C, Figure 4.6A, 
Supplemental Movies 1-4; tracking lines follow cell nuclei; (Ripley et al, 2006)]. 
An overlay of the progressive paths of 10 representative cells illustrates that 
disruption of Bves and/or NDRG4 function randomizes and accelerates cell 
movement (Figure 4.5E).  
In addition to impaired cell movements, time-lapse DIC imaging 
demonstrated that Bves- and/or NDRG4-depleted cells accumulated large 
cytoplasmic vacuoles (Figure 4.5B, yellow arrow) that originated at the plasma 
membrane and rapidly traveled toward the cell nucleus (Supplemental Movies 1-
4). Since vesicular enlargement is generally associated with membrane 
trafficking defects, this finding suggested that Bves and NDRG4 are necessary 
for regulated vesicular transport. Two recent studies demonstrated that endocytic 
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Figure 4.7 Bves/NDRG4-depleted cells contain large fibronectin positive 
objects in late endosomal/lysosomal and recycling endosome 
compartments. (A) Epicardial cells marked with DiI (Red; to mark the 
membranes) and labeled with Fibronectin antibody indicate that Bves- and/or 
NDRG4-depleted epicardial cells retain vesicles of cytoplasmic fibronectin. (B) 
Fibronectin positive objects were identified and measured using ImageJ 
thresholding and particle analysis (top original image, bottom overlay of 
included particles). (C) Quantification with ImageJ indicates that there are 
significantly more fibronectin positive objects that are larger with stronger 
fluorescence intensity compared to controls; *p≤0.001 n≥50 cells/condition. (D) 
Bves/NDRG4-depleted epicardial cells labeled for Fibronectin (green) and 
Lamp2 (red) indicate that cytoplasmic fibronectin traffics in late 
endosomal/lysosomal compartments; scale bar is 5µm, optical slices are 1 
Airy Unit. (E) Bves/NDRG4-depleted epicardial cells labeled with a Fibronectin 
antibody (green) and Rab11a (red) indicate that fibronectin also traffics 
through recycling endosomes; scale bar is 10µm.  
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trafficking of exogenous fibronectin present in the environment regulates cell 
movement (Lobert et al, 2010; Sung et al, 2011). Given prior data and our current 
phenotype of randomized cell movement and large intracellular vesicles, we 
tested whether fibronectin accumulates intracellularly in Bves- and/or NDRG4-
depleted cells. As shown in Figure 4.7A, immunofluorescence confocal 
microscopy revealed that large fibronectin-positive structures are indeed present 
in the cytoplasm of these cells. Quantification by object analysis in ImageJ 
revealed that Bves and/or NDRG4-depleted cells exhibited a 2-3-fold increase in 
the number, mean area, and intensity of fibronectin-positive structures, compared 
with controls (Figure 4.7B-C). Colocalization of these structures with LAMP2 
demonstrated fibronectin accumulation within late endosomal/lysosomal 
compartments (Figure 4.7D), as previously reported (Sung et al, 2011). In 
addition, there was colocalization of fibronectin in small Rab11a-positive 
endosomes (Figure 4.7D-E). Together, these data suggest that disruption of 
Bves and NDRG4 function impairs endocytic trafficking of fibronectin.  
 
Fibronectin Substrate Rescues Bves and NDRG4 Migration and Trafficking 
Defects 
We have previously shown that a cytoskeletal protein, cortactin, facilitates 
resecretion of internalized fibronectin from a late endosomal/lysosomal 
compartment to promote adhesion assembly, lamellipodial stability and effective 
cell migration (Sung et al, 2011). In this previous study, migration defects in 
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cortactin-depleted cells were fully rescued when cells were plated on substrates 
coated with high concentrations of exogenous ECM, making this an ideal assay 
to determine whether genes such as Bves and NDRG4 regulate autocrine ECM 
secretion. 
Figure 4.8 Fibronectin substrate rescues Bves and NDRG4 migration 
and trafficking defects. (A) Control epicardial cells on an evenly-
distributed fibronectin matrix exhibit a high amount of directional movement 
over the timecourse. (B) Bves/NDRG4 co-depleted epicardial cells plated 
as described in (A) also exhibit a high level of directionality over the 
timecourse. (C) ImageJ manual tracking analysis indicates that migration 
distance and velocity are partially restored on fibronectin substrate; 
*p≤0.05, n≥44 cells/condition, NS=not significant compared to SC. (D) 
Strikingly, Bves-depleted cell directionality is fully rescued, and NDRG4/co-
depleted cells have significantly better directionality than controls; *p≤0.05, 
n≥44 cells/condition, NS=not significant compared to SC. (E) 
Representative tracks of ten cells per condition plated on fibronectin 
illustrate that directional persistence defects are rescued on fibronectin 
substrate. 
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Bves-, NDRG4- and co-depleted cells were plated on glass coverslips coated 
with 10 µg/ml fibronectin and assayed by live imaging as in Figure 4. Interestingly, 
Bves and/or NDRG4-depleted cells now migrated with directional persistence 
when plated on fibronectin substrate (Figure 4.8D-E, Figure 4.6 and 
Supplemental Movies 5-8). Image quantification analysis demonstrated that 
presence of a fibronectin matrix fully rescued directional persistence or improved 
it beyond control level (Figure 4.8C, compare to data in Fig 4.5C). In contrast to 
the full rescue of all phenotypes in Bves-depleted cells, distance and velocity 
measurements in NDRG4-depleted and co-depleted cells were only partially 
rescued by plating on exogenous fibronectin (Figure 4.8C, compare to Fig 4.5C), 
suggesting that NDRG4 may have additional functions in cell motility. Overall, 
exogenously applied fibronectin matrix rescued movement, suggesting that Bves 
and NDRG4 might regulate autocrine-ECM deposition to facilitate directional 
movement when cells lack substrate. 
 
Bves and NDRG4 Coregulate Autocrine ECM Deposition 
Our data suggest that Bves and NDRG4 regulate cell movement through 
deposition of ECM. To test the functionality of ECM produced by control and 
Bves/NDRG4-depleted cells, we isolated autocrine-produced cell-free ECM from 
each of the cell types by removing confluent cell monolayers with 20 mM 
ammonium hydroxide (Sung et al, 2011). Fresh Bves/NDRG4-depleted or control 
cells were then plated on these cell-free matrices and monitored for two hours.  
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Figure 4.9 Bves and NDRG4 coregulate fibronectin deposition. ECM 
deposition is probed using a cell-free ECM assay, which removes cells 
but retains the ECM. Migration of newly-plated cells is then assessed on the 
previously-produced ECM to test the functionality of the matrix. (A) On control-
produced extracellular matrix, control and gene-depleted epicardial cells move 
directionally. Conversely, on Bves/NDRG4-depleted ECM, control cells move 
directionally, but Bves/NDRG4-depleted cells have poor directional persistence; 
n>50 cells; *p≤0.0001. (B) When control epicardial cells were fed medium-
lacking fibronectin, cells only moved directionally on control ECM. Unlike in (A), 
control epicardial cells failed to overcome poorly produced ECM, when 
fibronectin was unavailable in the medium; n≥50 cells, *p≤0.001. (C) Biotin-
labeled fibronectin deposition assays indicate that Bves/NDRG4-depleted cells 
have impaired fibronectin deposition onto a surface compared to controls; n=7 
assays. (D) Fibronectin-free medium supplemented with DyLight-550 labeled 
fibronectin (DyLight-FN) is internalized by epicardial cells after one hour. 
Endogenous Bves colocalizes with DyLight-FN on vesicular structures; optical 
slices are 1 Airy Unit, scale is 10µm. (E) Internalized DyLight-FN also 
colocalizes with endogenous NDRG4 on vesicular structures; scale is 10µm. 
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On ECM produced by control cells, newly-plated epicardial cells moved 
directionally whether cells were treated with SC or Bves/NDRG4 siRNA  
(Figur4.9A, Supplemental Movies 9-10). This is similar to results obtained from    
cells plated on exogenous fibronectin substrates (see Figure 4.8B). In contrast, 
only control cells moved in a directionally persistent manner on ECM produced 
by Bves/NDRG4 depleted cells (Figure 4.9A, Supplemental Movies 11-12), while 
Bves/NDRG4-depleted cells moved randomly, phenocopying their behavior on 
glass (see Figure 4.5B).  
 In this previous experiment, soluble fibronectin was present in the medium 
in both experimental conditions. Thus, a possible explanation for the efficient 
migration of control cells on matrix produced by Bves/NDRG4-depleted cells is 
that they can dynamically internalize and resecrete fibronectin present in the 
medium for use as a motility substrate. To test this hypothesis, cells were 
replated on matrix deposited by control or Bves/NDRG4-depleted cells. Motility 
assays were then performed in medium depleted of fibronectin [prepared as 
described by: (Danen 2002; Sung et al, 2011)]. As expected, control cells moved 
in a directionally persistent manner on matrix produced by control cells, as 
dynamic ECM secretion of internalized fibronectin was unnecessary on a well-
formed matrix (Figure 4.9B). Conversely, in the absence of soluble fibronectin, 
control cells were unable to migrate persistently when plated on matrix produced 
by Bves/NDRG4-depleted cells (Figure 4.9B, Supplemental Movies 13 & 14). 
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Thus, the presence of fibronectin in the medium is required for control cells to 
overcome deficiencies in matrix produced by Bves/NDRG4-depleted cells 
(compare Figures 4.9B and 4.9A). These data demonstrate that fibronectin 
internalization and resecretion may be necessary for persistent cellular 
movement of epicardial cells and that loss of cellular Bves and NDRG4 function  
disrupts this process.  
To directly test whether Bves and NDRG4 regulate fibronectin 
internalization and/or deposition, biotin-labeled fibronectin was added to the 
medium of control and Bves/NDRG4-depleted epicardial cell sheets after 24 
hours of culture in fibronectin-free medium. After 18 hours, cells were removed 
from the plate with ammonium hydroxide and the amount of biotin-labeled 
fibronectin present in the resulting autocrine-secreted ECM was quantified by 
streptavidin-HRP ELISA (see Materials and Methods for details). Absorbance 
measurement demonstrated that Bves/NDRG4-depleted epicardial cells 
deposited four-fold less fibronectin than controls (Figure 4.9C). To directly 
visualize whether epicardial cells internalized fibronectin, DyLight 550 labeled 
fibronectin was added to cell grown in fibronectin-depleted medium for one hour 
(Figure 4.9D-E). Under these conditions, internalized DyLight 550 fibronectin 
localized to vesicular compartments that co-label with Bves and NDRG4 (Figure 
4.9D-E, respectively). Taken together, these studies demonstrate that 
internalization of soluble fibronectin into vesicles proceeds in the absence of 
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Bves and NDRG4, but re-secretion of this ECM component is dependent on their 
function to promote directionally persistent migration. 
 
Discussion 
In this study we identified an interaction between Bves and a novel binding 
partner, NDRG4 and demonstrated that the two proteins function together to 
promote directionally persistent cell movement. We find that Bves and NDRG4 
are important for resecretion of fibronectin into the ECM from a late 
endosomal/lysosomal compartment. Our data further indicate that fibronectin 
secretion is critical for persistent epicardial cell migration. Thus, in the absence of 
NDRG4 or Bves, cell motility is randomized when cells are forced to autocrine 
secrete ECM. This phenotype can be rescued on exogenously applied fibronectin 
and matrix produced by control cells. Taken together, we propose that Bves is a 
pivotal regulator of cell migration and adhesion by coordinating subcellular 
trafficking of intra- and extracellular proteins, and that this function has broad 
implications for development, repair and cancer.   
 
The Interacting Partners Bves and NDRG4 Regulate Overlapping Cellular 
and Developmental Behaviors 
Using multiple methodologies, we show that Bves and NDRG4 physically 
interact. The identification of this interaction was of immediate interest as 
previous studies demonstrated that loss of Bves and NDRG4 function result in 
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similar cellular phenotypes. For example, morpholino Bves knockdown impairs 
lamellipodial formation in Xenopus head mesoderm and NIH-3T3 cells (Smith et 
al, 2008; Hager et al, 2010), while expression of antisense NDRG4 RNA inhibits 
neurite outgrowth in PC12 neuronal cell lines (Ohki et al, 2002). Additionally, 
Bves and NDRG4 are hypermethylated and downregulated in multiple cancer cell 
types (Feng et al, 2008; Melotte et al, 2009; Schilling et al, 2009; Kim et al, 2010; 
Williams et al, 2011) and overexpression of either gene inhibits migration in 
related cancers, suggesting that the genes may suppress metastasis (Melotte et 
al, 2009; Williams et al, 2011). These overlapping phenotypes suggest that the 
Bves/NDRG4 interaction is important for morphogenesis, repair and tumor 
suppression. 
Previous in vivo and in vitro gene perturbation studies indicate that cell 
movement is disorganized with loss of Bves function (Ripley et al, 2004; Ripley et 
al, 2006), but the molecular mechanism underlying these phenotypes has not 
been determined. Here, using a clonal epicardial cell line, we quantified Bves 
influence on directional migration for the first time, and demonstrate that NDRG4 
depletion, like its binding partner Bves, randomizes cell movement. This loss of 
directional persistence may explain the errors in morphogenesis and wound 
healing previously reported above.  
While NDRG4 regulates cell migration in cancer and other cell lines (Nishimoto et 
al, 2003; Melotte et al, 2009; Wang and Hill 2009), the current study is the first 
illustration of the mechanism by which NDRG4 influences this behavior. Although 
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NDRG4 has not been previously shown to regulate vesicular trafficking, previous 
studies on the related family member, NDRG1, have shown that it directs E-
Cadherin recycling, as well as myelin sheath maintenance and APO AI/AII lipid 
trafficking in Schwann cells (Hunter et al, 2005; Berger et al, 2006; Kachhap et al, 
2007; King et al, 2011). Also, NDRG2 is necessary for IL-10 secretion (Choi et al, 
2010). The present data provide a possible molecular explanation for these 
phenotypes through NDRG association with Bves. The collective data suggest a 
global mechanism through which NDRG molecules impact a broad array of 
cellular behaviors perturbed in multiple cancer types (Melotte et al, 2010).   
 
ECM Secretion Enhances Directional Persistence and may Promote In Vivo 
Morphogenesis Events 
Our study demonstrates that fibronectin matrix produced by control cells or 
simple application of purified protein supports directionally persistent epicardial 
cell movement. Consistent with our findings, Harms et al. reported that fibronectin 
substrate confers directionally persistent movement in CHO cells (Harms et al, 
2005). One possible explanation for the requirement of ECM in promoting 
persistent motility could be that spontaneous cell polarization facilitating cell 
migration is frequently unstable but can be stabilized by adhesion formation at 
the leading edge of cells. Consistent with this idea, Bves inhibition results in 
lamellipodial and cell polarization defects (Hager and Bader 2009; Hager et al, 
2010).  At lower matrix concentrations or in a complex ECM environment (e.g. in 
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vivo), direct deposition of ECM at the leading edge of cells might be the most 
efficient mechanism to stabilize newly formed lamellipodia and thus strengthen 
cell polarization. 
Bves and NDRG4 are Essential for Autocrine ECM Deposition 
Bves/NDRG4-dependent fibronectin deposition proceeds through a newly 
identified trafficking mechanism in which exogenous soluble fibronectin is 
endocytosed, processed through recycling in late endosomes/lysosomes, and 
resecreted onto an underlying matrix (Sung et al, 2011). The initial uptake of 
fibronectin appears to be uninhibited with loss of Bves or NDRG4 function. 
Indeed, large fibronectin and LAMP2 double-positive late endosomal 
compartments as well as smaller fibronectin and Rab11 double-positive recycling 
endosomal compartments are found in the cytoplasm of Bves- and/or NDRG4-
depleted cells. The accumulation of fibronectin in those compartments suggests 
that Bves and NDRG4 may function downstream of internalization to promote 
fibronectin secretion from either late or recycling endosomes (Sung et al, 2011). 
Clearly, loss of Bves and NDRG4 results in a reduction in biotin-labeled 
fibronectin moving from the medium to the insoluble matrix. 
Interestingly, we previously found that Bves binds VAMP3, an endosomal 
v-SNARE that regulates recycling endosome fusion at the plasma membrane for 
integrin and protease secretion (Proux-Gillardeaux et al, 2005; Hager et al, 2010), 
and that this interaction was important for β1-integrin trafficking (Hager et al, 
2010).  That finding raises the possibility that fibronectin and its receptors are 
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recycled in the same endosomal vesicles to promote efficient cell motility. Of note, 
Lobert et al. recently showed that fibronectin binding leads to trafficking of α5β1-
integrin into late endosomes, suggesting that they are cotrafficked during the 
initial part of the pathway (Lobert et al, 2010). In our studies on cortactin, we also 
found that fibronectin trafficked through a late endosomal/lysosomal 
compartment before exocytosis.  An important future direction will be to 
determine the exact role of VAMP3 in BVES/NDRG4-mediated fibronectin 
secretion. 
The present study demonstrates that Bves and NDRG4 regulate autocrine 
ECM production in epicardial cells. While it is known that epicardium makes 
fibronectin which is abundant in the subepicardial space, and that adhesion of 
integrin receptors to substrates is critical for coronary artery formation (Manasek 
1969; Kalman et al, 1995; Kwee et al, 1995; Yang et al, 1995; Sengbusch et al, 
2002; Nahirney et al, 2003), the current study is the first report of a subcellular 
trafficking mechanism that regulates this process. During embryonic epicardial 
development, dynamic ECM secretion could support de novo fibronectin 
deposition during epicardial sheet migration and also provide a substrate for 
myocardial adhesion. Furthermore, combined with the previous data in cancer 
cells, our finding that fibronectin secretion regulates persistent motility of 
epicardial cells suggests that autocrine ECM secretion is likely to regulate 
migration in both developmental systems and disease processes.  
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Summary 
The present data are the first to indicate that Bves, through an interaction 
with NDRG4, regulates exocytosis of macromolecules to the extracellular matrix. 
The number and variation in subcellular events regulated by Bves in 
developmental, reparative, and disease processes is now emerging. It is possible 
that the trafficking compartment regulated by Bves and its binding partners 
NDRG4 and VAMP3 shuttles diverse contents depending on cellular context. 
Thus, we propose a central or unifying theme for its function, namely that Bves is 
a pivotal interacting protein in the trafficking of diverse molecules for cell 
movement and adhesion.  
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CHAPTER V 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Conclusions 
 
Summary 
 This dissertation presents experiments developed to identify and elucidate 
regulators of epicardial cell behaviors. First, the present chapter will discuss the 
findings of Chapter II and the implications of chemical genetic screening to 
epicardial research. Second, studies performed in Chapter IV identified a novel 
epicardial cell behavior, autocrine ECM deposition, and two regulators of this 
mechanism. The relevance of these findings to heart development and repair will 
be discussed. Third, Chapter III revealed that Bves/VAMP3 interaction regulates 
cell adhesion through β1-integrin and, possibly, general recycling endosome 
trafficking. As Chapter IV identified a Bves/NDRG4 interaction that regulates 
directional migration through autocrine ECM deposition mechanism, these 
findings suggest that Bves globally regulates cellular trafficking to facilitate 
adhesion and migration. Thus, this chapter will discuss how studies defining 
Bves binding interactions have illuminated the understanding of Bves molecular 
activity. Finally, taking the previous studies collectively, a working model of Bves 
global function will be proposed.   
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Chemical Genetic Screens Elucidate Coordination of Epicardial Behaviors 
Proepicardial contribution to coronary vasculature has been observed for 
several decades and is well described (Manasek 1976; Mikawa and Gourdie 
1996; Lepilina et al, 2006). Many molecules have been identified that extrinsically 
regulate specific phases of epicardial development and it is clear that the process 
employs overlapping signaling mechanisms to regulate multiple behaviors 
(Olivey and Svensson 2010). Still, how epicardial cells coordinate these signaling 
mechanisms and subsequent behaviors is largely unknown. One possible reason 
for this deficit is that most of the studies previously addressing signaling during 
epicardial development have been approached in a linear fashion, often 
observing the contribution of single pathways to single behaviors [see Figure 1.4; 
(Olivey and Svensson 2010)]. While these studies are important for initial 
identification of signals involved in this process, the scope is only a narrow 
window of the entire coordinated program; very few detailed cell biological 
studies examine the regulation of concurrent epicardial behaviors. Chapter II 
augments previous literature by developing in vitro and ex vivo methodologies to 
examine effects of signaling cascade players on multiple epicardial behaviors 
concurrently, as well as determine the simultaneous influence of multiple signal 
cascades on a single cellular process.  
As proof-of-principle, the present studies resolve a cooperative interaction 
between TGFβ and BMP signaling in which the hormones coregulate epicardial 
sheet migration, while other behaviors occurring in unison, including single cell 
migration, only require TGFβ signaling (process diagrammed in Figure 5.1). As 
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discussed in detail in the introduction, TGFβ signaling has previously been 
determined to stimulate EMT, migration and early differentiation of epicardial 
cells in culture (Olivey and Svensson 2010). Additionally, TGFβ1&3 regulate in 
vivo murine coronary vessel formation as: Tgfβr3 null mice produce fewer 
vessels, ALK5 stimulation promotes EMT, and Alk5 null murine epicardia fail to 
adhere to the myocardium and produce small coronary vessels (Zwijsen et al, 
2001; Compton et al, 2007; Sridurongrit et al, 2008). Hence, our data are 
Figure 5.1 TGFβ and BMP signaling cooperatively regulate epicardial 
sheet movement. Epicardial cells move as sheets to cover the developing 
heart. During this movement BMP signals are elaborated into the extracellular 
space. TGFβ and BMP signal cascades then cooperatively regulate sheet 
movement. Two tools, Dorsomorphin (DM) and DMH1 can broadly or 
specifically inhibit these pathways. 
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consistent with previous findings in which TGFβ signaling is a general regulator 
of many epicardial behaviors in vitro and in vivo. Alternatively, BMP signaling, 
while widely expressed throughout the sinus venosus, developing PE and heart, 
has primarily been identified to stimulate only PE specification and sheet 
migration (Schlueter et al, 2006; van Wijk et al, 2009; Ishii et al, 2010).  
Although these hormones have been individually identified to influence 
epicardial development; few studies suggest that BMP and TGFβ signaling 
cooperatively regulate epicardial development, and this conclusion has only been 
indirectly implied. For example, Inhibitory-Smad6 null mice upregulate BMP-
specific Smads 1/5/8, which contributed to impaired coronary vessel formation, 
similar to the phenotype observed in Alk5 null mice (Imamura et al, 1997). These 
data imply that TGFβ and BMP signaling cooperatively co-regulate epicardial 
development, but neither definitively identify this relationship or elucidate 
when/how TGFβ and BMP are coordinated. The studies presented here directly 
examine, at high resolution, simultaneous regulation of single epicardial 
behaviors by TGFβ and BMP signal cascades, as well as the effect of TGFβ or 
BMP singling on multiple concurrent behaviors. The cooperative regulatory 
relationship observed in vitro was also applicable to ex vivo studies, underscoring 
the relevance of data observed in vitro to organism development. Taken together, 
the present data provide novel experimental methodologies for the field to either 
investigate a range of behaviors and pathways or isolate single elements. 
To date, regulators of epicardial development have emerged through 
classic gain- and loss-of-function mutation studies as well as stimulation by 
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specific growth factors (Olivey and Svensson 2010). The growing field of 
chemical genetics uses small organic molecule treatments, rather than mutations, 
to influence protein behaviors in cellular and developmental systems (Stockwell 
2004). Small organic molecules tools are valuable for studying complex 
developmental programs because synthesized molecules can be controlled to 
specifically influence individual functions of target proteins, while leaving other 
behaviors intact (Stockwell 2004). Additionally, these chemicals are inexpensive 
to create, and vast chemical libraries allow for unbiased screening of cellular and 
developmental behaviors to identify novel players that regulate the process under 
examination (Stockwell 2004). The studies outlined here are the first to utilize a 
directed chemical genetic screen to establish simple readouts of epicardial 
behaviors, and as a result determined that Dorsomorphin (DM) inhibits TGFβ and 
BMP signaling while DMH1 specifically inhibits BMP (Figure 5.1). These 
experiments could become a standard for pathway characterization and 
discovery in the epicardium, as the small organic molecule screening 
methodologies presented here have readouts that are highly amenable to future 
unbiased, high-throughput screening. Such future studies could be essential to 
broadly describe, and eventually mimic, epicardial development during injury 
repair. 
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Epicardial Cell Cultures Robustly Recycle and Redeposit Soluble 
Fibronectin 
 In early electron microscopy studies identifying the extracardiac origin of 
the epicardium, a “floccent” material was observed in epicardial cell cytoplasm 
that was later identified to be fibronectin (Manasek 1969; Manasek 1976). In 
mice, fibronectin is expressed on the basal surface of PE cells and in patches on 
the apical sheath covering the naked myocardium (Kalman et al, 1995). 
Fibronectin expression fluctuates throughout development but is highly enriched 
in the subepicardial space (Tidball 1992; Bouchey et al, 1996). While fibronectin 
global null mice are embryonic lethal prior to PE formation, the fibronectin plasma 
membrane binding partner, α4β1-integrin, and another myocardial expressed 
fibrillar substrate, VCAM-1, are critical for epicardial sheet migration to the heart, 
adherence and coronary vessel formation (George et al, 1993; Kwee et al, 1995; 
Yang et al, 1995; Sengbusch et al, 2002).  Even before reaching the heart, PE 
villi interact with extracellular matrix present in the pericardial cavity to initiate 
sheet migration (Nahirney et al, 2003). Interestingly, several combinations of α 
and β integrins adhere to and catalyze fibronectin fibrillogenesis in epicardial 
cells, and disruption of α4β1 integrin impairs fibronectin incorporation into a 
subepicardial matrix (Pae et al, 2008). Thus, the field has demonstrated that 
epicardial cells make fibronectin, and that adhesion to this substrate is an 
essential epicardial process for development, yet no research to date has 
determined how epicardial cells facilitate subepicardial fibronectin enrichment 
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and subsequent adhesion.  
In the present studies, epicardial cell culture models are effective tools to 
recapitulate developmental behaviors. With these tools, we identified a behavior 
novel to epicardial cells: internalization of soluble exogenous fibronectin for re-
deposition onto an underlying surface and subsequent directional movement. 
While this behavior has not yet been described in vivo, these cell biological 
assays are critical to bridge the information gap between the presence of 
subcellular fibronectin in epicardium (Manasek 1976) and the essential role for 
integrin substrates in epicardial adhesion and directed migration [Figure 5.2; 
Figure 5.2 Fibronectin deposition is essential for epicardial development. 
(A) An extracellular matrix bridge between the PE and developing heart 
adheres to PE cells and is required for sheet migration to the heart (Nahirney 
2003). PE cells contain fibronectin (Manasek 1969) and could produce the 
ECM bridge. (B) Fibronectin is also abundant in the subepicardial space 
(subepicardium). Both the epicardium and the myocardium contribute to this 
layer. Epicardial contributions to both sheet movement and adhesion could 
occur using autocrine ECM deposition (Chapter IV). Images adapted from 
Winter and Gittenberger-de Groot 2007. 
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(Kwee et al, 1995; Yang et al, 1995; Sengbusch et al, 2002; Merki et al, 2005; 
Pae et al, 2008)]. Our experiments address the important question: what 
mechanism facilitates deposition and enrichment of ECM substrates in the 
subepicardium and throughout the heart? Manipulation of such a mechanism 
may become critically important as mounting evidence suggests that EPDCs 
secrete proteins after MI to condition a niche in which injured cardiac tissue could 
either undergo fibrosis or regenerate (Poss et al, 2002; Zhou et al, 2011). 
 
Bves and NDRG4 Interact in Epicardial Cells  
 Bves was first discovered through subtractive screening of the developing 
heart (Reese et al, 1999; Andrée et al, 2000). Polyclonal antibody labeling 
techniques determined that Bves has highly enriched expression in the chick PE, 
migrating PE villi, surface epicardial sheet, in the cytoplasm of subepicardial 
EPDCs, and around the developing coronary arteries (Reese and Bader 1999; 
Wada et al, 2001) In cell lines and in vivo, Bves exhibits plasma membrane 
localization in epicardial sheets, while after epicardial delamination Bves 
localization shifts to the cytoplasm (Wada et al, 2001; Osler et al, 2005). Bves 
colocalizes with adherens junction markers and functions to sustain epicardial 
sheet integrity, while blocking Bves function impairs ex vivo PE outgrowth and 
migration (Wada et al, 2001; Osler et al, 2005). Collectively, these studies 
suggest that Bves influences both cell-cell and cell-matrix adhesion in epicardial 
tissue, yet Bves protein function remains unidentified in the epicardium. Likewise, 
while NDRG4 is enriched in heart tissue and regulates cardiomyocyte 
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proliferation, expression of NDRG4 or a function for this protein in epicardial cells 
has not been identified (Qu et al, 2002; Qu et al, 2008). 
Cell biology assays allowed the identification of Bves and NDRG4 
interaction in epicardial cells. Protein-depletion and dominant negative 
interference of the interaction demonstrated that, as suggested by antibody 
labeling and prior loss-of-function studies (Nishimoto et al, 2003; Hager and 
Bader 2009; Melotte et al, 2010), Bves and NDRG4 regulate epicardial cell 
migration. Cell tracking and image analyses of Bves- and NDRG4-depleted 
epicardial cell migration indicated that these proteins influence epicardial 
directional persistence by regulating trafficking of internalized fibronectin for 
deposition. While identifying a novel epicardial cell process, the present data also 
provide two regulators of this behavior. Indeed, these data are the first to 
describe a function for Bves in epicardial tissue, despite its identification as 
dynamically expressed therein over ten years ago. Furthermore, the data 
presented in this dissertation link NDRG4 to a novel molecular pathway and thus 
provide a framework for future studies on this protein in developmental and 
disease systems.  
 
Bves Facilitates Diverse Behaviors Through Binding Partner Interactions  
Despite the well-described roles for Bves in epithelial sheet maintenance 
and cell migration, establishing molecular function of Bves, which shares no 
known homologous domains, has been difficult. Initially, it was suggested that 
Bves is a novel transmembrane adhesion protein, functioning similar to occludin 
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and E-Cadherin but subsequent biochemistry refuted this theory, as the putative 
adhesive domain was, in fact, intracellular (Wada et al, 2001; Knight et al, 2003). 
Furthermore, Bves was subsequently demonstrated to have broader affects, as 
regulated migration also requires Bves (Ripley et al, 2006). Bves is enriched in 
heart tissue, but is expressed at low levels in most other cell types and thus few 
clues to function could be derived from expression patterns. Similarly, subcellular 
Bves expression is both cytoplasmic and plasma membrane localized, with 
intensity in either domain dependent upon cell morphology and/or adhesive 
properties (from a sheet to a single mobile unit). Many signal cascades and 
protein players localize in these domains and are associated with such large-
scale cellular alterations, and hence these data failed to provide a definitive 
protein function for Bves.   
Studies on Bves regulation of epithelial sheet maintenance began to 
define a function for this protein. Osler et al. (2006) demonstrated that Bves is 
required for localization of junction proteins to the cell surface, which confers 
sheet integrity. Additionally, Bves C-terminus was sufficient to pulldown 
complexes that include ZO-1 protein. These data were corroborated by recent 
studies demonstrating that aberrant expression of Bves C-terminus interferes 
with pulldowns of ZO-1 complexes, and also interferes with activity of tight 
junction-dependent RhoA signaling through mislocalization of GEF-H1 (Russ et 
al, 2010; Russ et al, 2011). Importantly, cells expressing Bves mutated at the KK 
residues essential for dimerization failed to localize junction molecules to the cell 
surface. Collectively, these data suggest that Bves supports epithelial integrity 
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and intercellular adhesion by shuttling proteins to intercellular junctions, yet the 
molecular pathway through which Bves moves these proteins was entirely 
unknown. To elucidate Bves function at higher resolution required two-hybrid 
screening to identify direct binding partners.  
Initial screens identified interaction between Bves and GEFT, an activator 
of the RhoGTPases Rac1 and Cdc42 (Guo et al, 2003; Smith and Bader 2006). 
RhoGEF and RhoGTPase molecules control myriad behaviors, are well-
described local regulators of lamellipodial extension as well as intercellular 
adhesion, and thus participate in many subcellular pathways regulating diverse 
cellular behaviors (Nobes and Hall 1995; Kuroda et al, 1999). Smith et al. (2008) 
demonstrated that overexpression of Bves-C terminus inhibited Rac1 and Cdc42 
activity as well as lamellipodial extension and migration, and that Bves interaction 
within the Dbl Homology domain of GEFT, [the segment that binds to the target 
RhoGTPase nucleotide binding pocket to stimulate GDP release (Rossman et al, 
2002)]. These data suggest that Bves could physically inhibit GEFT binding and 
thus regulate activation of downstream RhoGTPase targets. Additionally, Rac1 
and Cdc42 activities are regulated based on GEF localization at plasma 
membrane active sites, the site of Bves and GEFT colocalization, suggesting that 
Bves regulates GEFT via localization (Etienne-Manneville and Hall 2002; Smith 
et al, 2008). Finally, as RhoGTPase signaling and GEFT activity regulate many 
behaviors from neurite extension to myogenesis, Bves-GEFT interaction provides 
the first data to suggest that Bves could operate through a single mechanism to 
regulate disparate cellular functions. However, further identification of other direct 
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binding partners is required to illuminate the global pathway through which Bves 
operates. 
Using split-ubiquitin two-hybrid screening we demonstrated that Bves 
directly binds to VAMP3 (Chapter III), an endosomal v-SNARE that regulates 
recycling of multiple subcellular factors including transferrin and notably, β1-
integrin. We demonstrated that Bves influences recycling of two VAMP3 cargos 
and that Bves simultaneously colocalizes with internalized β1-integrin and 
VAMP3 (Chapter III). We further demonstrated that VAMP3-dependent cell 
spreading and lamellipodial formation are impaired in vitro and in Xenopus laevis 
head mesoderm cells, which may explain the drastic morphological defects 
exhibited with Bves disruption in previous studies (Wada et al, 2001; Osler et al, 
2005). These data indicate that β1 integrin turnover requires Bves and are the 
first to demonstrate a subcellular pathway through which Bves influences cell-
surface adhesion. Additionally, a Bves/VAMP3 interaction could explain how 
Bves loss-of-function affects diverse cellular behaviors. It has been demonstrated 
that VAMP3 facilitates a range of subcellular trafficking events, from delivering 
endomembranes to protruding pseudopods (Bajno et al, 2000), to secretion of 
matrix metalloproteases in fibrosarcoma cells (Kean et al, 2009), to transport of 
myelin in oligodendrocytes (Feldmann et al, 2011). As Bves regulates recycling 
of multiple VAMP3-dependent cargoes, the data suggest that Bves is a general 
mediator of cell surface trafficking and in this capacity regulates a variety of 
cellular behaviors.  
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VAMP3 shuttles vesicles to and from the cell surface where it binds with t-
SNARE molecules on the receiving membrane to form trans-SNARE complexes 
and draw the membranes into proximity for fusion (Hu et al, 2007). To execute 
these binding events SNARE proteins have highly specialized structures 
containing transmembrane residues and a long α-helical domain that binds with 
compatible SNARE molecules to form end-to-end oriented helical bundles (see 
Figure 1.13). This orientation draws the transmembrane domains close together, 
allowing for membrane fusion and delivery of cargos such as transferrin 
receptors and β1-integrin (Leabu 2006). As SNARE molecules are highly 
specialized, they may rely upon other molecules for targeting to sites of activity 
(Leabu 2006). Bves colocalizes with both VAMP3 and its cargo β1-integrin on 
vesicles and also on the cell surface, making it a candidate regulator of VAMP3 
localization. Bves could bind VAMP3 on the vesicular membrane and then 
dimerize with existing Bves on the plasma membrane to pull VAMP3 into 
proximity with t-SNARE molecules. Additionally, Bves already localized on the 
plasma membrane could directly bind to VAMP3. Using multiple cooperative 
binding events could tether VAMP3 at the targeted docking site while leaving it 
free to interact with t-SNARE molecules. The role of VAMP3-Bves interaction in 
the general Bves mechanism will be discussed in detail below. 
Data presented in this dissertation additionally elucidate an interaction 
between Bves and NDRG4 (Chapter IV). Bves and NDRG4 interact in the C-
terminus of Bves at residues 207-216 that are part of a novel domain outside of 
the conserved Popeye sequence (see Figure 1.7). The Bves/NDRG4 interaction 
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was the most frequent hit in the split-ubiquitin screen of the heart library from 
which it was identified, suggesting the importance of this interaction in heart 
tissue. Additionally, manipulation of Bves or NDRG4 expression exhibited similar 
cellular phenotypes, alluding to a common function for these proteins (Hager and 
Bader 2009; Melotte et al, 2010). As NDRG4 has not been linked to a subcellular 
pathway, the interaction with Bves provides the first molecular underpinnings for 
the influence of NDRG4 on cellular behaviors. Also, being involved with recycling 
endosome trafficking could explain how NDRG4 regulates diverse behaviors cell-
specifically (Melotte et al, 2010); cells use many of the same subcellular 
trafficking components to context-dependently interact with the environment 
(Ulrich and Heisenberg 2009; Scita and Di Fiore 2010). Thus, the interaction with 
Bves illuminates the subcellular function of NDRG4.  
Some clues to NDRG4 function in the Bves mechanism can be gleaned 
from studies performed on other NDRG family proteins. The NDRG family are 
highly conserved cytoplasmic proteins that contain an α/β hydrolase domain, but 
are missing the expected catalytic motifs to function in this capacity [see Figure 
1.16; (Shaw et al, 2002; Bhaduri et al, 2003)]. Despite this, the NDRG proteins 
regulate many overlapping behaviors, supporting the important and redundant 
subcellular function of these proteins. For example, all NDRG proteins are critical 
for tumor suppression in normal epithelia, and gain- or loss-of-function of any 
NDRG4 protein affects a variety of cellular behaviors from proliferation, to 
migration, to maintenance of differentiation (Melotte et al, 2010). Interestingly, a 
pattern has recently emerged that could unify NDRG protein function. NDRG1 
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regulates trafficking of myelin and apolipoproteins I/II to the cell surface in 
Schwann cells (Berger et al, 2004; Hunter et al, 2005; King et al, 2011). These 
data together explain how NDRG1 mutation causes the demyelinating 
neuropathy, hereditary motor and sensory neuropathy-Lom (HMSNL). Similarly, 
NDRG2 regulates secretion of IL-10 from differentiated dendrite cell models 
(Choi et al, 2010).  Importantly, like Bves, NDRG1 also regulates recycling of E-
Cadherin to and from intercellular junctions (Kachhap et al, 2007). This study 
also elucidates how NDRG proteins functionally participate in subcellular 
trafficking. In addition to defining NDRG1 regulation of E-Cadherin, Kachhap et al  
(2008) illustrated that NDRG1 is a peripheral membrane protein bound to 
phosphotidylinositol 4-phosphate that additionally associates with membrane 
bound Rab4a-GTPase. NDRG1 fails to bind Rab4a-GDP and, like Bves, it 
influences recycling kinetics of the canonical recycling endosome cargo, 
transferrin (Kachhap et al, 2007). These data reveal that NDRG1 proteins are 
RabGTPase effectors that facilitate recycling endosome transport. As all NDRG 
proteins similarly influence subcellular behaviors and exhibit redundancy, we 
speculate that NDRG4 is also a Rho or RabGTPase effector. In this way, through 
interaction with Bves, NDRG4 also influences subcellular trafficking and 
migration.  
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Bves may Orient Effector Proteins to Facilitate Subcellular Cargo Delivery 
of Adhesion Components 
When considering the collective data on interacting partners and pathways 
associated with Bves, a working model of Bves function begins to resolve. In our 
recent studies we have defined interactions between Bves and GEFT, VAMP3, 
NDRG4 and Bves itself, and found that these interactions regulate similar cellular 
behaviors in multiple experimental models. This suggests that the proteins are 
players functioning together in a joint mechanism to facilitate common cellular 
effects. Indeed, Bves regulation of both β1-integrin and fibronectin, presented 
here, is supported by recent studies in which co-internalization of β1-integrin and 
fibronectin is essential for regulated cellular movement (Lobert et al, 2010; 
Dozynkiewicz et al, 2011). Bves colocalizes with vesicles labeled with both β1-
integrin and VAMP3, and thus β1-integrin and fibronectin could be trafficked 
together in VAMP3 labeled vesicles (Chapter III). As discussed above, VAMP3 
may use binding partners to facilitate targeting (Leabu 2006), and Bves may be 
the targeting molecule available to bind to VAMP3 both on the vesicles and from 
the plasma membrane, as well as perform Bves homodimerization between 
vesicular and plasma membrane Bves. The sum of these binding events could 
tether vesicles at docking sites and pull them toward targets, while leaving 
VAMP3 available for its specialized function (Figure 5.3). Additionally and 
importantly, our description of NDRG4 and Bves regulation of fibronectin 
deposition (Chapter IV) mirrors a recent study in which internalized fibronectin is 
resecreted from late endosome/lysosomal compartments to facilitate migration in 
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cancer cells (Sung et al, 2011). These authors demonstrated that cortactin, a 
regulator of the actin-nucleating factor, Arp2/3, is essential for autocrine ECM 
deposition. Overexpression of the Arp2/3-interacting and actin-binding domains 
of cortactin exclusively rescued motility defects caused by cortactin depletion, 
Figure 5.3 Working Model: Bves orients binding partners to facilitate 
endosome fusion. Endosomes utilize F-actin polymerization for movement 
to the plasma membrane (Ridley 2006). Branched actin polymerization 
requires cortactin binding to F-actin and the Arp2/3 complex (Sung 2011). 
First, Bves positions GEFT at the plasma membrane where it activates 
Rac1/Cdc42-GDP to Rac2/Cdc42-GTP (Smith 2008). Bves may also position 
NDRG4 for binding to activated Rac1/Cdc42-GTP. Rac1/Cdc42 would 
activate the WAVE complex to mediate Arp2/3-cortactin nucleation of 
branched actin polymerization. These events would move endosomes 
toward the plasma membrane. Next, at the plasma membrane, Bves bound 
to v-SNARE proteins VAMP2/3 could bind to Bves and SNARE proteins on 
the plasma membrane. These interactions would bring SNARE complexes in 
close apposition while leaving the SNARE residues available for membrane 
fusion. Fusion of these vesicles could deliver cell-cell or cell-substrate 
adhesion molecules to the plasma membrane for cell migration or 
intercellular adhesion.  Bves functions as a scaffold to localize these players. 
 166 
suggesting that actin polymerization is essential for fibronectin deposition (Sung 
et al, 2011). It is well understood that movement of vesicles to the membrane 
requires RhoGTPase-stimulated actin polymerization (Ridley 2001), and Sung et 
al. (2011) suggest that cortactin facilitates this process. As a transmembrane 
protein, Bves is trafficked to the plasma membrane along with its binding partner 
GEFT. GEFT could be positioned by Bves to stimulate RhoGTPase activity for 
cortactin-mediated branched actin polymerization through WAVE activation of 
Arp2/3 nucleating factors (Figure 5.3). This could facilitate movement of vesicles 
to the plasma membrane. Finally, as discussed above, NDRG4 may be a Rho- or 
RabGTPase binding effector that stimulates actin polymerization (Kachhap et al, 
2007). NDRG4 colocalizes with Bves on vesicles but also in the cell cortex at 
points of protrusion. NDRG4 binding to Bves is within the residues of Bves that 
could extend the furthest into the cell cytoplasm, and Bves may present NDRG4 
as a substrate for RabGTPase or RhoGTPase, (activated by GEFT bound to 
Bves closer to the membrane) to actin polymerization (Figure 5.3).  Additionally, 
NDRG1 regulation of both E-Cadherin and transferrin, two other Bves-recycled 
cargoes suggests that this mechanism could universally apply to all Bves 
cargoes and NDRG proteins (Figure 5.3). Thus, we propose that Bves is a 
plasma membrane scaffolding molecule that moves players to docking sites at 
the cell surface. Bves positions these players to participate in a complex that 
facilitates vesicle fusion and cargo delivery (Figure 5.3). In this way Bves is a 
pivotal regulator of cell cortex, plasma membrane and secretory trafficking to 
promote cell-cell and/or cell-surface adhesion.  
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Future Directions 
 
Bves and NDRG4 Global Function in the Mouse 
NDRG4 and Bves Regulate Murine Gut Development 
 The studies outlined in Chapter III elucidate Bves and NDRG4 function in 
adult epicardial cell lines. To solidify the relevance of these findings these studies 
must be extended to animal models systems. In murine development this has 
been hindered by the occurrence of compensation from other protein family 
members. For example, Bves knockout mice develop normally, but exhibit 
impaired skeletal muscle regrowth after injury (Andrée et al, 2000). In these 
studies, experimental intervention provoked defects, suggesting that deficiencies 
are present in Bves depleted animals but low level Bves expression or 
compensation may be sufficient to assuage developmental phenotypes. Likewise, 
NDRG4 phenotypes may be tempered by compensation-based phenotype 
rescue, as murine models with complete NDRG1 deficiency have intensified 
phenotypes compared to NDRG1 hypomorphic mutant mice (Okuda et al, 2004; 
King et al, 2011). Similarly, NDRG4-/- murine models exhibit delayed 
development but overall appear structurally normal (Figure 5.4B). Thus, we 
attempted to exacerbate NDRG4 and Bves developmental phenotypes by 
breeding an NDRG4-/-; Bves-/- mouse.  
The double knockout mice exhibit a striking phenotype in which mice are 
smaller and most die around 24 days old (Figure 5.4D). Interestingly, the cause 
of death appears to be a necrotic gut, which does not occur in the  
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single knockout littermates (Figure 5.4C). This phenotype is of particular interest 
as both NDRG4 and Bves are colorectal cancer tumor suppressor proteins 
(Melotte et al, 2009; Williams et al, 2011). Thus, future studies in this model 
system are warranted to describe the defects and determine the cause of death.  
First, the adult and embryonic gut must be analyzed by H&E staining for 
gross morphological defects. With this technique, the structures of the villi will be 
examined to determine whether the subcellular junctions between the villi remain 
intact. These studies will be coupled with antibody labeling of frozen sections 
with tight and adherens junction markers, as well as markers of gut cell types 
(e.g. PAS staining for goblet cells). Additionally, fibronectin is abundantly 
expressed in the basement membrane of intestinal epithelia and α5β1 integrin 
protects intestinal epithelial cells from apoptosis (Quaroni et al, 1978; Lee and 
Juliano 2000). Thus, impaired fibronectin and β1-integrin distribution and 
aberrant apoptosis could explain the disintegration of NDRG4-/-; Bves-/- murine 
intestines and will be compared to single knockout and heterozygote littermates 
using antibody labeling techniques and TUNEL stains. Finally, NDRG4-depleted 
mice exhibit neural phenotypes including impaired spatial learning defects 
(Yamamoto et al, 2011), thus it is important to inspect the development of 
Auerbach’s plexus using a neural stain such as Holmes silver nitrate. Data 
gathered from these studies will suggest followup functional studies to be 
performed in intestinal epithelial cell lines (e.g. Caco2 cells) or isolated primary 
cells, which could include the fibronectin and integrin trafficking/deposition and 
adhesion assays performed in this dissertation. Together these studies solidify 
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Figure 5.4 NDRG4-/-; Bves-/- murine models have developmental defects. 
(A) Bves or (B) NDRG4 single knockdown murine heart and gut 
development occurs without obvious defects. (C) NDRG4-/-; Bves-/- murine 
models exhibit smaller hearts and necrotic guts at 24 days of age. (D) 
NDRG4-/-; Bves-/- mice are smaller overall and many die around 24 days of 
age. 
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the relevance of Bves and NDRG4 during embryonic development, and 
additionally elucidate the specific mechanism through which Bves and NDRG4 
could influence both organism development and colorectal cancer. 
 
NDRG4 and Bves in Murine Heart Development and Epicardial Migration 
 As illustrated in Figure 5.4, NDRG4-/-; Bves-/- murine models also exhibit 
smaller hearts. This phenotype could be due to the overall smaller size of the 
mice from nutritional defects caused by a necrotic gut. However, the data 
presented in this dissertation demonstrate that Bves and NDRG4 coregulate 
epicardial cell migration and could influence myriad heart developmental 
processes from PE protrusion to epicardial sheet adhesion to coronary vessel 
formation. Indeed, a preliminary study suggests that NDRG4-/- isolated epicardial 
cells migrate further and faster with impaired directional persistence than 
NDRG4+/- littermates (Figure 5.5). While these data require substantiation, they 
suggest that impaired epicardial movement could contribute to the small heart 
phenotype observed in NDRG4-/-; Bves-/- adult mice. Defects in heart function 
could also contribute to mortality around 24 days of age.  
 Thus, NDRG4-/-; Bves-/- knockout hearts will be compared to single 
knockout and heterozygous littermates with H&E staining to determine gross 
morphological differences during development and as an adult, such as 
cardiomyocyte thickness and number/size of coronary vessels. The PE and 
epicardium will be visually compared with immunostaining or in situ hybridization 
for markers such as WT1 or Tbx18. Also, fibronectin deposition, which fluctuates 
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during development but is highly enriched in the subepicardial space (Tidball 
1992), will be compared with antibody labeling of cryosections. Similarly, 
localization and expression of β1-integrin will be compared. Developmental 
timepoints will be collected to evaluate progression of PE cells to and over the 
heart. Additionally, as demonstrated in the preliminary study, isolated embryonic 
NDRG4-/-; Bves-/- epicardial single cellular migration will be examined as well as 
Figure 5.5 NDRG-/- epicardial cells migrate faster with poor directional 
persistence compared to NDRG4+/- littermates. NDRG4-/- and NDRG4+/- 
murine epicardial cell migration was monitored for one hour. NDRG4-/- 
migration was faster with poor directionality compared to NDRG4+/- littermates. 
These data reflect studies performed in cell lines in Chapter IV. 
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β1 integrin recycling and fibronectin deposition. Ex vivo epicardial sheet 
expansion and fibronectin deposition could also be compared, as performed in 
Chapters II and IV. Preliminary studies and previous work predict that NDRG4-/-; 
Bves-/--depleted murine epicardia would exhibit impaired fibronectin deposition, 
de-regulated integrin localization and overall disorganized movement. As a 
consequence of migration defects it would be expected that murine models 
present with impaired coronary vessel formation and possibly thin cardiomyocyte 
wall thickness, as previously demonstrated in integrin and VCAM-1 depletion 
models (Kwee et al, 1995; Yang et al, 1995; Sengbusch et al, 2002). Additionally, 
these models could be used to test function of Bves/NDRG4 in the epicardial 
response to induced Myocardial Infarction. It would be anticipated that NDRG4-/-; 
Bves-/- murine models exhibit impaired healing and fibrotic scar formation, as 
EPDC fibroblasts contribute to the healing process, as discussed in Chapter I 
(Zhou et al, 2011). Taken together, these studies would elucidate the role of 
Bves and NDRG4 during in vivo epicardial development and would solidify the 
relevance of our findings in Chapter IV.   
 The murine models may fail to exhibit heart phenotypes due to 
redundancy. In this case, alternative experiments would be performed to assess 
Bves and NDRG4 influence on Xenopus laevis (X. laevis) heart development. X. 
laevis is a common model for studies on heart development (Warkman and Krieg 
2007), and many gene depletion and reconstitution techniques are optimized in 
this system. While redundancy could still be an issue, as all NDRG family genes 
are expressed in this organism (NCBI), lack of Bves redundancy may provide a 
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more accurate phenotype and present novel findings regarding Bves and 
NDRG4 effect on heart development. Also, X. laevis is very useful for mosaic 
analysis of gene function to avoid embryonic lethality, and would provide a 
valuable in vivo model system to microinjection of Bves/NDRG4 minimal binding 
domain plasmids (Chapter IV) and test the relevance of Bves/NDRG4 interaction 
during overall embryonic development. For example, overexpression of the 
Bves/NDRG4 dominant negative in A1 blastomeres and subsequent LacZ tracing 
would determine whether this interaction contributes to organized cellular 
movement and overall morphologic development previously attributed to Bves 
alone (Ripley et al, 2006). The successful completion of these studies would 
highlight the relevance of the Bves/NDRG4 interaction during heart and overall 
embryonic development. 
 
Bves and NDRG4 Globally Regulate Trafficking  
The data presented here demonstrate that Bves and NDRG4 traffic 
fibronectin for epicardial cell substrate deposition. However, studies on both Bves 
and NDRG family proteins suggest that these molecules are global regulators of 
cell surface trafficking and, as such, will participate in trafficking of many 
subcellular components in a variety of tissues. Figure 5.5 presents preliminary 
data suggesting that Bves and NDRG4 participate in autocrine ECM deposition in 
vivo. NDRG4 is expressed in the heart, but is also expressed in embryos missing 
cardiac tissue (Figure 5.6A; H-heart; E-whole embryo), suggesting that NDRG4, 
possibly through interaction with Bves, could perform a global function. In cross 
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section of E14.5 murine ventricular tissue, Bves and NDRG4 are highly 
expressed and, similar to epicardial tissue, colocalized at subcellular puncta 
(Figure 5.6B). Previous work indicates that Bves localization in cardiomyocytes 
shifts from the cytoplasm to the plasma membrane junctions (intercalated discs), 
suggesting a trafficking function in these cells (Smith and Bader 2006). Our 
preliminary data visually support this hypothesis and suggest that the 
Bves/NDRG4-regulated trafficking mechanism is additionally functioning in 
Figure 5.6 NDRG4 is highly enriched in heart tissue and colocalizes with 
Bves in puncta in cardiomyocyte tissue. (A) NDRG4 mRNA is expressed in 
murine heart tissue and other parts of the embryo; E-embryo, H-Heart , E-H 
embryo without heart. (B) In wildtype E14.5 murine ventricular cardiomyocytes, 
Bves and NDRG4 colocalize in vesicular structures. 
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cardiomyocytes. Based on these previous studies and our preliminary data, it 
would be of interest to determine whether intercalated disc formation is affected 
by Bves and NDRG4 depletion. Initial studies would label transverse sections 
through murine ventricular tissue of adult NDRG4-/-; Bves-/- hearts with 
intercalated disc markers such as N-Cadherin and Connexin 43 (Zuppinger et al, 
2000). It would be expected that Bves/NDRG4 disruption would impair 
cardiomyocyte adhesion and intercalated disc formation. Echocardiograms will 
be performed to compare ventricular dimension, cardiac output, and to test for 
abnormal beat synchrony in Bves/NDRG4 depleted hearts. Additionally, 
cardiomyocytes will be isolated and tested with patch-clamp analysis to compare 
conduction efficiencies. If gap junction formation is deregulated in NDRG4-/-; 
Bves-/- hearts then it would be expected that cardiomyocyte conduction and 
beating would be impaired.  
Additional preliminary data presented in Figure 5.7 demonstrate that Bves 
and NDRG4 colocalize in puncta in sections through adult murine brain tissue. 
These puncta are reminiscent of vesicular structures observed in epicardial cells 
and ventricular cardiomyocytes, and suggest that Bves and NDRG4 universally 
participate in cellular trafficking events. Our initial studies would determine the 
type of cells in which Bves and NDRG4 colocalize. NDRG4 has previously been 
detected in many types of brain cells such as the neurons of the cerebrum and 
the Purkinje cells of the cerebellum (Okuda et al, 2008). Additionally, NDRG4 is 
expressed in rat PC12 neurons where it is essential for neurite extension (Ohki et 
al, 2002), a process requiring integrin adhesion to ECM components 
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(Buck and Horwitz 1987; Powell et al, 1997). ECM is critical in the brain for cell 
signaling and general adhesion; some neurodegeneration disorders result from 
ECM deficiencies (Bonneh-Barkay and Wiley 2009). NDRG4 is downregulated in 
the neurodegenerative disorder, Alzheimers Disease (Zhou et al, 2001). Thus, 
neurite extension would be quantified and ECM deposition/cellular adhesion 
tested in Bves/NDRG4 siRNA-depleted, or dominant negative-disrupted PC12 
neurons, using assays outlined in Chapters III and IV. Additionally, in vivo studies 
on brain structure and development would be pursued on NDRG4-/-; Bves-/- 
versus single knockout or heterozygote littermate brain structure with H&E 
staining, Golgi Stain and NeuN antibody labeling (to mark neurons). NeuroSilver 
Staining Kits will be used to identify amyloid plaques and degenerating neurons 
in NDRG4-/-; Bves-/- knockout murine models. The motor phenotype, previous 
studies, and current data predict that NDRG4-/-;  Bves-/- mice will exhibit changes 
in brain morphology accompanied with elevated plaque formation and PC12 
Figure 5.7. Bves and NDRG4 colocalize in murine brain tissue. Bves 
(green) and NDRG4 (red) are both expressed in puncta around the nuclei and 
cell body of brain cells, presumably neurons, in E14.5 murine developing brain 
tissue. 
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neurons will fail to extend processes and deposit ECM components after 
Bves/NDRG4 interference. 
Successful completion of these future studies would further enhance 
current work by demonstrating that Bves and NDRG4 regulate subcellular 
trafficking in vivo. These data would solidify the observations presented here in 
culture. Collectively, these studies would broaden the global relevance of 
Bves/NDRG4 regulated trafficking by demonstrating its effect on multiple tissue 
types and the imperative nature of the interaction to protect from subcellular 
trafficking-related diseases. 
 
Elucidating Bves and NDRG4 Protein Activities 
 Classical scaffold molecules bind to several signaling components 
simultaneously, do not contain enzymatic activity, and are highly diverse, as they 
have evolved to facilitate a variety of signaling processes and events including 
Rho GTPase signaling and exocytosis (Zeke et al, 2009; Good et al, 2011). From 
the data presented in this dissertation I developed a working model of Bves 
function in which it is a scaffold that localizes effector molecules of vesicle 
membrane fusion to deliver cargoes for cell-cell and cell-substrate adhesion. 
Testing Bves role as a scaffold that mediates vesicle fusion requires in depth 
understanding of the coordinated relationships between Bves and its binding 
partners, the exact function of each of binding protein, and the ability cells to 
perform fusion in the absence of Bves. 
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Developing a Map of Bves Binding Relationships 
 Previous data have demonstrated that Bves (358 residues) interacts in the 
C-terminus with GEFT, NDRG4, VAMP3 and Bves molecules. It is known that 
Bves binds to NDRG4 between residues 307-316, to Bves at the KK residues 
(272-273), and to GEFT within the Popeye Domain [Figure 1.7 binding map; 
(Kawaguchi et al, 2008; Smith et al, 2008)]. To elucidate the structure of the Bves 
complex the minimal binding domain of all binding partners will be determined 
with SPOTs analysis. Additionally, competition assays for the binding proteins, 
western blotting and tagged/endogenous pulldowns will be utilized to determine if 
the molecules form a complex. Using fluorescent-labeled proteins, the spatial 
relationships of Bves binding partners will be visualized in real time (to follow 
cells undergoing process extension and adhesion). Additionally, the model 
postulates that Bves binds to other Bves proteins situated on an apposing 
membrane (Figure 5.3). To determine whether this spatial orientation occurs, 
separate in vitro transcription and translation procedures with CFP and YFP 
tagged Bves proteins in the presence of microsomes will be performed. The 
microsomes will be mixed to determine if Bves interacts with apposing Bves 
proteins based on FRET output. Finally, in the model fibronectin, β1-integrin, and 
possibly other cargoes (e.g. E-Cadherin) are co-trafficked in VAMP3 labeled 
endosomes. Antibody labeling and application of pre-labeled molecules would be 
inspected with fixed and real time imaging to confirm these trafficking 
relationships. Together, these data would elucidate whether Bves binding 
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partners function in common or separate pathways to mediate cargo delivery.  
Our previous work indicate that in addition to localizing GEFT, Bves also 
binds to the RhoGTPase activation domain, and thus could normally function to 
restrict or regulate GEFT signaling (Smith et al, 2008). To broaden the Bves 
scaffold map, it will be determined whether Bves influences protein activities, 
localization, or both characteristics of its binding partners. After identifying the 
minimal binding residues of the binding partners, dominant negative peptides to 
the binding domains will be applied and fluorescent-tagged binding partner 
localizations will be monitored after interfering with the Bves interaction. In the 
case of GEFT, to test whether Bves inhibits GEFT activation of Cdc42/Rac1 in 
vitro transcription/translation of GEFT and either Bves-full length, or Bves 
mutated in the GEFT binding domain will be performed. Modified PAK1 pulldown 
Figure 5.8 NDRG4 residues 200-300 are required for Bves binding. 
NDRG4 is a 352 AA cytoplasmic protein with an α/β hydrolase domain that 
spans the majority of the protein, but is thought to be nonfunctional. Pulldowns 
of Bves C-terminus and NDRG4-GFP trunctations indicate that NDRG4 
residues 200-300, within the hydrolase domain, are required for Bves binding; 
diagram adapted from PFAM. 
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assays would be performed to determine whether Bves binding affects Cdc42 
and Rac1 activation in vitro. This would remove the localization constraints that 
occur in cell line models. If Bves only regulates GEFT protein activity, it would be 
predicted that mutated Bves would have a high level of GEFT activity, while full 
length Bves would be less active. If Bves regulates GEFT by localization alone, 
GEFT activation in the presence of full length Bves should remain comparable to 
mutated Bves. Experiments such as these could demonstrate whether Bves 
regulates binding partner proteins based on localization alone, or also regulates 
protein activities. 
 
Determining the molecular function of NDRG4 
Preliminary data indicate that Bves binds to NDRG4 within residues 200-
300, which is a sequence within the NDRG4 α/β hydrolase domain (Figure 5.8). 
This suggests that any putative molecular activity for NDRG4 could require or be 
restricted by Bves binding. NDRG4 could function, like NDRG1, as a 
RhoGTPase or RabGTPase effector protein when, for example, Cdc42, is bound 
to GTP (Kachhap et al, 2007). Our preliminary data indicate that NDRG4 
colocalizes with actin (polymerized by RhoGTPases) at possible sites of 
vesicular export (Figure 5.9A). Thus, it is of interest to determine whether 
NDRG4 is a RhoGTPase or RabGTPase binding effector that facilitates actin 
polymerization. This will be tested using overexpression Co-IP studies of NDRG4 
and constitutively active Rho and RabGTPases such as Cdc42, Rac1, RhoA, and 
Rab4a. We would also test constitutively inactivated RhoGDPases. It would be 
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predicted that NDRG4 is an effector for RhoGTPase molecules responsible for 
actin-based vesicle fusion such as Cdc42, or RhoA and that, like NDRG1, 
NDRG4 will specifically bind to RhoGTPase proteins in their active conformation. 
α-SMA stress fiber formation occurs at sites of epithelial wounding (Darby et al, 
1990), and NDRG4 overexpression may upregulate this process (Figure 5.9B). 
Thus, it would be additionally interesting to test whether NDRG4 disruption 
affects actin polymerization and vesicle trafficking dynamics. Finally, as Bves 
may regulate activity of NDRG4 as well as localization, we will perform in vitro 
Figure 5.9 NDRG4 colocalizes with actin and may stimulate actin 
accumulation in injured epicardial cell sheets (A) Epicardial cells express 
NDRG4 (red) which colocalizes with a-Smooth Muscle Actin (green) at 
possible plasma membrane localized sites of secretion. (B) Scratch wounded 
epicardial cells become enriched in NDRG4 containing puncta at the cell 
surface. (C) Scratch wounded epicardial cell sheets enrich for αSMA at the 
site of the wound. (D) This phenomenon is exacerbated by overexpression of 
GFP-NDRG4. 
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RhoGTPase activity assays (as described above for GEFT) in the presence of 
full length Bves, or Bves mutated in the NDRG4 binding residues. Successful 
completion of these experiments will provide a map of Bves binding interactions, 
elucidate protein-binding dynamics and determine whether Bves directly 
modulates binding partner activities.  
 
Identifying a Role for Bves and NDRG4 in Vesicle Fusion 
The data illustrated in the working model suggest that Bves and NDRG4 
mediate vesicle fusion for cargo delivery. It is imperative to test whether vesicle 
fusion relies on these proteins. This experiment can be approached using TIRF 
microscopy. Briefly, epicardial cells would be depleted for Bves/NDRG4, 
fibronectin starved, then pulsed with DyLight Fibronectin. The basolateral surface 
of the epicardial cells will be monitored for fibronectin binding as a readout of 
vesicle fusion. Other vesicle markers could also be assessed, or fluorescence 
vesicle tracking systems such as GFP-tagged insulin granules could be applied 
and followed (Ohara-Imaizumi et al, 2004). Additionally, applying a dominant 
negative peptide against the KK domain could test whether Bves 
homodimerization regulates vesicle fusion, which could be confirmed in cell lines 
stably expressing truncated Bves using similar methodology. Collectively, these 
studies will provide evidence for Bves function as a regulator of vesicle fusion 
and will establish a molecular framework for Bves-mediated vesicular delivery of 
cell-cell and cell-matrix components. 
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